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ABSTRACT 
 
Unsafe and unnecessary injections are administered in many developing and transitional countries. Injection 
device security is recommended in order to improve injection safety. Injection device stock depletions have 
been reported to contribute to unsafe injection practices. Poor distribution of health products has been 
reported in many parts of Uganda including Mpigi district. As a way of improving injection safety, this study 
explored the challenges encountered in maintaining an effective distribution system. 
A Cross-sectional, descriptive study of public and private-not-for-profit health care units in Mpigi district was 
conducted. 38 health care facilities were selected by stratified disproportionate sampling. Data on device 
security, the use of equipment and the distribution system were collected and analysed using descriptive 
statistics. 
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CHAPTER 1 
 
Orientation to the study 
 
 
1.1 INTRODUCTION 
 
The World Health Organization (WHO 2003a:1) recommends that injection device 
security is ensured in all health care facilities, including those delivering therapeutic 
services. Ensuring injection device security implies appropriate forecasting, financing, 
procurement and supply management so that injectable products, appropriate single 
dose diluents, single use injection devices for injection and reconstitution, and safety 
boxes are supplied in a timely manner in adequate quantities (WHO 2003a:1). 
 
The application and success of this policy depends on a reliable distribution system for 
health care products (WHO 2003a:1). In Uganda, the distribution system for injectable 
medicines, syringes and safety boxes for the discarding of contaminated needles and 
syringes is disjointed. Injectable medicines are often singularly delivered to health care 
facilities without matching quantities of syringes and diluents. The poor distribution 
mechanisms combined with poor forecasting of requirements by managers of health 
care facilities hinder the realisation of injection device security in the districts (Ministry of 
Health of Uganda 2004:3).  
 
This study assessed the level of injection device security for therapeutic services at 
health care facilities in the Mpigi district, in the light of the existing distribution system. 
Challenges in the distribution system for injection devices were investigated and 
recommendations made for the achievement of injection device security both in the 
district in which this study was conducted as well as beyond.  
 
1.2 BACKGROUND TO THE STUDY 
 
Providing medicines by means of injections is the most common health care procedure 
applied worldwide. According to Hutin, Hauri and Armstrong (2003:1075), in developing 
and transitional countries, some 16 thousand million injections are administered each 
 2
year. In addition, more than 90% of injections are given for therapeutic purposes while 5 
to10% are given for preventive purposes, including immunisation and family planning. 
According to Hutin et al (2003:1075), the majority of therapeutic injections in developing 
and transitional countries are often unnecessary and unsafe. In 2000, such unsafe 
injections were believed to have contributed to 30%, 41% and 5% of new infections of 
Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) and Human Immunodeficiency Virus 
(HIV), respectively (WHO 2003a:1). 
 
1.2.1 Injection safety 
 
A safe injection is one that does not harm the recipient, does not expose the provider to 
any avoidable risks, and does not result in waste that is dangerous for the community 
(WHO 2000:1). Injection safety ensures that the existence of conditions required to 
provide safe injections and adherence to safe practices. Reliable and adequate supplies 
of single-use syringes, disposable reconstitution syringes, and the discarding of used 
material in approved safety boxes are necessary to ensure injection safety (WHO 
2003a:1). It is the policy of the WHO that injectable medicine orders be “bundled” with 
the corresponding numbers of auto disable syringes and the safety boxes used for their 
disposal so that contaminated needles and syringes and other sharps are not used 
again (WHO 2003a:1). To ensure effective and safe use of needles and syringes, an 
efficient stock management and distribution system needs to be developed so that 
injection safety equipment is continuously and sufficiently available in all health care 
facilities.  
 
1.2.2 Uganda  
 
1.2.2.1 Topography 
 
Uganda is a landlocked country in east central Africa (see figure 1.1).  It is bordered on 
the north by Sudan, on the east by Kenya, on the south by Tanzania and Rwanda, and 
on the west by the Democratic Republic of Congo. From being a British protectorate, 
Uganda gained independence in 1962, and became a fully independent member of the 
Commonwealth of Nations on October 6, 1962, and a republic in 1967. Uganda has an 
area of 241,038 sq km (93,065 sq mi), and the capital is Kampala.  
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Figure 1.1 Map of Uganda 
(Gorta 2007) 
 
The land surface in Uganda is diversified. About 85% of the country is an elevated 
plateau, draining into the centre to form Lake Kyoga. The main lowlands are located in 
the Rift Valley, which runs down the western side of Uganda, and contains Lakes 
Edward and Albert. In the west are the Ruwenzori Mountains on the southwest border 
with the Democratic Republic of the Congo. Uganda's highest mountain, Mount 
Rwenzori, with two peaks – Margherita Peak at 5,109 m (16,762 ft) and Mount 
Alexander at 5,105 m (16,750 ft) – is located there. There are also highlands on the 
eastern border with Kenya. The remainder of the country, about 5% of the area, 
comprises land at between 1,500 m and 2,000 m (4,900-6,560 ft), inland of Lake 
Victoria, containing some of the most heavily populated areas. Much of the south is 
forested, and most of the north is covered with savannah. Almost 20% of the area of 
Uganda is open water. The country includes Lakes George and Kyoga, and parts of 
Lakes Victoria, Edward, and Albert. These lakes and most of Uganda’s rivers form parts 
of the basin of the upper River Nile, which leaves Lake Victoria and flows to Nimule on 
the Sudan frontier.  
 
Despite being a tropical country lying along the equator, Uganda normally has a mild, 
equable climate, mainly because of its relatively high altitude. The temperature ranges 
from about 15.6° to 29.4° C (60° to 85° F). There are two distinct rainy seasons: March 
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to May, and September to November. The mean annual rainfall varies from some 760 
mm (30 in) in the northeast to about 1,520 mm (60 in) near Lake Victoria.  
 
Uganda’s most important natural resource is its rich soil, which provides the basis for 
the diverse agricultural economy of the country. In addition, Uganda has exploitable 
deposits of gold, copper, cobalt, tin and tungsten, and rich fish resources in the lakes. 
Virtually all the country’s power is produced by hydroelectricity, the plant on the Victoria 
Nile being of major importance. 
 
Uganda has a wide variety of plant life, from the mvuli tree and elephant grass of the 
Uganda plateau to the dry thorn scrub, acacia, and euphorbia of the southwest. The 
country also provides a habitat for many animals, some of which are protected in 
national parks. The chimpanzee inhabits the rainforests, and some elephant, eland, and 
hartebeest, as well as lion and leopard, are found in the grasslands. Many wild animals 
were slaughtered during the Amin regime, but numbers are returning to former levels.  
 
Despite its ideal climate, rich fauna and flora and potential for agriculture, Uganda is 
among the poorest African nations. Access to safe drinking water and sanitation 
services is limited, and cases of cholera have increased in recent years. The average 
life expectancy in Uganda is among the lowest in the world. Uganda's extreme poverty 
has led to significant damage to the country's environment. Civil unrest in the country 
during the 1970s and 1980s resulted in poor land conservation practices and rampant 
poaching. Since the mid-1980s, the political situation in Uganda has improved and 
poaching has been curbed. Soil erosion, overgrazing, and desertification continue. In 
order to provide more land for agricultural use, many forests have been cleared and 
wetlands drained. Of Uganda's forestland, 0.9 per cent (1990-1996) is destroyed each 
year, in part because 89 per cent (1995) of the country's energy requirements are met 
by burning wood.  
 
Uganda is situated in an area of rich biodiversity, incorporating four vegetation regions. 
The country provides habitat for 992 bird species and 338 mammal species. About 9.6 
per cent (1997) of the country's land is protected in parks or reserves. Uganda has 
ratified international agreements intended to protect biodiversity, endangered species, 
marine life, wetlands, and the ozone layer. The country has also signed treaties limiting 
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nuclear testing, chemical and biological weapons, and trade involving endangered 
animal species.   
 
Almost all the inhabitants of Uganda are Black Africans. The official language is English; 
Swahili, Luganda and Luo are also spoken.  About 70% of the people speak an 
indigenous language; they live in the southern half of the country and include the 
Baganda, Basoga, Banyoro, Nkole, and Toro ethnic groups. Most of the remaining 
people speak a Nilotic language; they live in the north and east, and include the Acholi, 
Lango, and Karamojong ethnic groups. In the late 1960s, Uganda also had a sizeable 
Asian population (741,000 of Indian and Pakistani origin in 1969). Idi Amin’s expulsion 
of non-citizen Asians in 1972 led to all but about 4,000 leaving the country. Many 
returned during the 1990s.  
 
Uganda has a population of 30,262,610 (2007 estimate). The country has an average 
population density of about 152 people per sq km (392 per sq mi). About 12 per cent of 
the population is urbanized. Average life expectancy in 2007 was about 50.8 years for 
men and 52.7 years for women. 
 
Uganda is divided into ten provinces, which are subdivided into 80 districts and 154 
counties. The counties are divided into sub-counties, which form the basic 
administrative units.  
 
Health care services in Uganda were severely depleted by war and are currently being 
restored, as AIDS is a growing problem. A national programme to raise public 
awareness was set up. In 2004 there were 21,277 people per doctor and the infant 
mortality rate was 67 deaths per 1,000 live births in 2007. In 1990, 3.4 per cent of the 
country’s GDP was spent on health care (Ministry of Health of Uganda 2002:1).  
 
 A mix of public and private providers provides health care services in Uganda (IHSD 
2000:1). The public sector plays a key role. With decentralisation the districts have 
taken on responsibility for delivering district health care services, receiving grants from 
the Ministry of Health. The role of the Ministry of Health is now focused on providing 
technical support, supervision and monitoring, setting norms and standards, mobilising 
resources and donor coordination. Health services collapsed during the political unrest 
of the 1970s and for most of the 1980s. Since 1986, the political stability and economic 
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growth have led to significant improvements in the socio-economic status of the country 
and to the health care sector in particular (Ministry of Health of Uganda 2002:1). The 
1993 Health Policy clearly sets out consolidation and rehabilitation as the main 
strategies (IHSD 2000:3).  
 
1.2.2.2 The Mpigi district 
 
This study was conducted in the Mpigi district of Uganda.  Figure 1.2 provides a map of 
Uganda’s 80 districts and indicates the location of Mpigi District (in red). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2  Map of Uganda showing the location of the Mpigi District 
(Wikipedia 2006) 
 
The Mpigi district is one of the 80 districts in Uganda. It borders the districts of Mubende 
in the North, Wakiso in the East, Kalangala and Masaka in the South and Sembabule in 
the West. The Mpigi district has over 414 757 people, 206 012 of whom are females 
and 208 745 are males. The major economic activity in the district is agriculture with 
food crops like sweet potatoes, beans, cassava, maize, bananas and groundnuts. Cash 
crops include coffee and cotton. Fruits and vegetables like tomatoes, onions and 
cabbage are grown in the district (Uganda Travel Guide 2007). The district is politically 
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divided into four sub-counties. The counties form the four sub districts of Butambala, 
Gomba, Mawokota South and Mawokota North, which provide health care. The health 
care system is aligned to the administrative structure (see table 1.1).  
 
In the administrative structure, a district council (LC V) oversees the administrative 
functions of the district (UN Department of Economic and Social Affairs 2004:7). Aligned 
with this level is a district hospital at level V of the health care system. This is the 
highest level of the health care system in the district. Medical superintendents, who are 
medical officers and may be assisted by a number of medical officers, nurses, clinical 
officers and midwives, head the district hospitals. A district is subdivided into counties 
and municipalities or towns, depending on their size and other criteria set by the 
Ministry of Local Government. The administrative structure at the county, municipality or 
town level is the local council referred to as LC IV. Aligned with this level is a health 
care centre IV (HC IV), which forms the headquarters of a health care sub district.  The 
HC IV supervises the operations of the lower level health care units, which belong to 
that county. A medical officer manages the health care facility at this level. It offers 
theatre services, maternity services, laboratory services, and inpatient and outpatient 
services. Every county, municipality or town is further subdivided into sub-counties or 
divisions, respectively, forming the lowest level local governments (LC III), At the sub-
county level or division we find the healthcare facility level III (HC III) managed by a 
clinical officer. The HC III offers maternity, laboratory, and inpatient and outpatient 
services, but has no theatre or doctor. The sub-counties, and divisions are further 
subdivided into parishes and wards (LC II), respectively, which are. Aligned with the 
parishes and wards are the health care centres at level II (HC II). An enrolled nurse or 
midwife manages the HC IIs. This is the lowest level health care facility and it offers 
primary health care services. It offers no maternity, theatre, laboratory or inpatient 
services. The parishes and wards are further subdivided into villages (LC I), which are 
the lowest administrative units. The LC 1 level forms the village health teams, a team of 
local residents appointed to oversee the performance of the HC IIs in their community. 
 
The LCV, some LCIV (municipality councils), and LC III are local governments, while 
the LC II and LC I are administrative units. Local governments in Uganda have 
legislative, financial and administrative powers. However, the administrative units 
largely have administrative roles.  
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Table 1.1 The Mpigi district health system structure  
 
Administrative structure  
Description Local council level Corresponding health care structure 
Parish II Health care centre II 
Sub county III Health care centre III 
County (sub-district) IV Health care centre IV 
District V District/General hospital 
 
Source:  Ministry of Health of Uganda (2002:2) 
 
There are 34 health care centres classified as Level II’s (of which six are non-
government organizations [NGOs]), 24 health care centre Level III’s (of which eight are 
NGOs), and two government health care centre Level IV’s. The district also has a 
government hospital in the town of Gombe with 104 beds and the Nkozi Hospital, an 
NGO with 90 beds. 
 
1.2.3 Injection safety in Uganda 
 
Studies in Uganda by Priotto, Ruiz and Kyobutungi (2003:54) and others found that 
there is a high rate of injection use and the proportion of infections caused by unsafe 
injections is believed to be high. A national cross-sectional survey of injection safety 
practices in health care facilities was conducted under the auspices of the Uganda 
National Injection Safety Task Force (UNISTAF) from June to July, 2003. The study 
indicated that one of the most prominent factors contributing to unsafe injection 
practices was the inadequate supply of injection materials, leading to the reuse of 
injection supplies without sterilisation. The majority (65%) of the surveyed facilities 
reported having experienced a shortage of disposable injection supplies in the twelve 
months prior to the survey. This was a serious issue, particularly in the therapeutic 
sector (Ministry of Health of Uganda 2004:3). Subsequent to the study, the Making 
Medical Injections Safer Project (MMIS) was formed to assist the Ministry of Health of 
Uganda to establish an environment where patients, health care workers, and 
communities are better protected from the medical transmission of HIV and other blood-
borne pathogens (MMIS 2005:1).  
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1.2.4 Making medical injections safer 
 
In 2004, as part of the United States of America’s (USA) President’s Emergency Plan 
for AIDS Relief (PEPFAR) focusing on countries with high HIV prevalence, John Snow 
Incorporated (JSI) and its subcontractors, Program for Appropriate Technology in 
Health (PATH), Academy for Educational Development (AED), and the Manoff Group, 
were awarded funds through the Centres for Disease Control and Prevention (CDC) 
and the United States Agency for International Development (USAID) to implement 
“Rapid Interventions to Decrease Unsafe Injections” in eleven countries. The project is 
commonly known as Making Medical Injections Safer (MMIS) (JSI 2005:1). 
 
In Uganda, the MMIS project works with the Ministry of Health’s logistics staff to 
strengthen the capacity of districts to effectively manage the selection, procurement and 
distribution of safe injection technologies as appropriate. Among other strategies, the 
project provides safe injection equipment and safety boxes for the discarding of medical 
contaminated waste to its project districts, of which the Mpigi district forms part. In 
general, the project is guided by the WHO’s three-pronged approach to the 
implementation of injection safety in health care facilities (MMIS 2007:1).  
 
1.2.5 WHO strategy for safe and appropriate use of injections 
 
To prevent injection-associated transmission of blood-borne pathogens, injection 
frequency should be reduced and safe injection practices carried out on a regular basis. 
The WHO recommends a multidisciplinary three-pronged approach to reach these goals 
(WHO 2000:1): 
 
• Provision of sufficient quantities of injection equipment and infection control 
supplies. 
• Effective sharps waste management. 
• Behaviour change among patients and health care workers to reduce injection 
overuse and implement safe practices. 
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1.2.6 Injection device distribution system in Uganda  
 
The majority of medicines and equipment for government health care units are obtained 
from the National Medical Stores, an autonomous government agency charged with the 
procurement, storage and distribution of essential drugs and supplies to the public 
sector. The main source of funding for drugs is the money allocated by the central 
government to the districts for primary health care (PHC) activities. The missionary 
health care units source their drugs and supplies for the provision of health care from 
the Joint Medical Stores. When drugs and equipment are out of stock from the National 
Medical Stores, then public health care facilities are allowed to source from elsewhere.  
 
 
The Ministry of Health of Uganda, through the National Medical Stores, supplies public 
health care facilities with syringes, injectable medicines and diluents through a pull 
system in which the respective unit managers in the various health care services order 
for their requirements. The National Medical Store also supplies MMIS project districts 
with single-use syringes and safety boxes for discarding contaminated waste such as 
used syringes and needles for the curative services on behalf of the project. All these 
items are delivered to district stores pre-packed according to the requisitions made by 
each health care unit. It is the responsibility of the respective district managers in health 
care services to arrange for transportation of these commodities from the district stores 
to the respective health care units. Distribution of commodities to districts by the 
National Medical Stores is intended to be carried out once every two months, but this is 
often not the case. Delays in delivering supplies from the district stores to the health 
units are common because of lack of functional vehicles, fuel or impassable roads to the 
rural health care units (MMIS. 2007:3). Delays in submitting requisitions for re-supply, 
incorrect forecasting and poor record-keeping at health care units often result in stock 
depletions at health care units. In spite of the availability of adequate quantities of 
injection devices at National Medical Stores, supervisory visits continue to show stock 
depletions at health care units, indicating a weakness in the distribution system (MMIS 
2004:2).  
 
This study was designed to assess injection device security at health care units in the 
study district in the light of its distribution system. The researcher wished to investigate 
and identify bottlenecks in the distribution system in the Mpigi District and make 
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recommendations for strategies for improvement to the managers of health care 
facilities for the enhancement of injection device security in Uganda.  
 
1.3 RESEARCH PROBLEM 
 
In 2004, the MMIS project was introduced with the main objective of assisting the 
Ministry of Health of Uganda to improve the injection safety and the management of 
contaminated health care waste (MMIS 2004:4). The pilot phase of the project was 
implemented in four districts, including the Mpigi district. One of the strategies employed 
by the project was to improve the logistics system to ensure full supply of injection 
commodities (MMIS 2004:5). Although the project has procured and freely distributed 
injection devices to districts through the National Medical Stores, stock depletions at 
health care units continue to be reported (MMIS 2005:31). In addition, injectable 
medicines are delivered to districts by National Medical Stores without matching 
quantities of diluents, syringes and safety boxes to discard contaminated waste such as 
needles and syringes (MMIS 2005:34). Safety boxes for use in the curative services are 
scarce and are only regularly availed by the MMIS project to its project districts. The 
National Medical Stores do not routinely supply safety boxes, yet they continue to 
supply syringes and needles to the MMIS project districts. 
 
The National Medical Stores do not always deliver commodities to districts according to 
schedule. In addition, delays in delivery of commodities from the district stores to the 
health care units are also common. District staff often cite the lack of vehicles or 
breakdown of vehicles, lack of fuel or poor geographical terrain as factors that hamper 
timely delivery of supplies to the respective health care units. Although the MMIS project 
has contributed to the improvement of injection devices’ availability at health care units 
by providing free syringes and safety boxes for discarding of used and contaminated 
medical waste, delays in submitting orders, incorrect forecasting, poor communication 
infrastructure and improper record-keeping regularly result in stock depletions at health 
care units (Mutungi 2007:4). 
 
The poor distribution system within the districts and disjointed distribution system of the 
National Medical Stores create an environment in which injection device security cannot 
be ensured at all the health care units in the districts. 
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1.3.1 Research questions 
 
The existence of a poor distribution system for injection devices raises the following 
research questions: 
 
• What is the extent of the inadequacy of quantities of injectable medicines, 
diluents, single use injection devices and safety boxes supplied for therapeutic 
purposes at the health care facilities in the Mpigi district of Uganda? 
• What are the factors that lead to stock depletion of injection devices at health 
care facilities in the Mpigi district? 
 
1.3.2 Purpose and objectives of the study 
 
The overall purpose of this study was to identify the challenges encountered in 
maintaining an effective distribution of injection devices to the Mpigi district.  Based on 
the research findings, recommendations would be made for the improvement of the 
distribution system and for the enhancement of the levels of injection safety in Uganda. 
 
The specific objectives were to: 
 
• Determine whether health care facilities in the Mpigi district have sufficient 
quantities of injectable medicines, diluents, single use injection devices and 
safety boxes for therapeutic purposes. 
• Investigate and identify the factors that lead to stock depletion of injection 
devices at health care facilities in the Mpigi district. 
 
1.4 ASSUMPTIONS UNDERLYING THE STUDY 
 
The following assumptions guided the study: 
 
• Injection materials are not available in sufficient quantities at all health care 
facilities in the Mpigi district, thereby affecting the safety of injections negatively. 
• There is a poor distribution system for injection materials in the study district, 
leading to frequent stock depletions of these materials at health care units. 
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1.5 SIGNIFICANCE OF THE PROBLEM 
 
Safe injections have been known to save lives, but to achieve injection safety injection 
device security has to be ensured at health care facilities. According to the WHO 
(2003a:1), an effectively functioning distribution system is necessary to ensure injection 
device security. The MMIS has been working with the Ministry of Health of Uganda to 
implement injection safety interventions in selected districts through the supply of 
injection commodities. However, midterm evaluation of the project showed that there 
were a number of health care units reporting stock depletion of injection commodities 
due to delays in distribution of these commodities to user units (Mutungi 2007:4). When 
injection devices are not adequate, health care workers may be forced to improvise 
through unsafe practices like reusing syringes, using non-recommended diluents or 
improper disposal of used sharps, including used needles and syringes for injection, 
posing a risk to the health care workers, the patients and the community. Although stock 
depletions at health care facilities had been reported, the reasons for their occurrence 
had not been adequately studied. This study therefore investigated the challenges faced 
by district and health care unit managers in sustaining a good distribution system for 
injection devices. The study would make recommendations for improvements in the 
distribution system of health care commodities. Based on the findings of the study, 
managers at health care facilities in the Mpigi district and other districts in the country 
should be able to plan for an efficiently functioning distribution system and also make 
recommendations to the Ministry of Health of Uganda for the improvement of the 
distribution system of injection devices in the country. 
 
1.6 DEMARCATION OF STUDY FIELD 
 
Health care units in the Mpigi district in Uganda were sampled for inclusion in this study. 
The selected health care units in this district were of different levels of service, ranging 
from hospitals to health care centres. Health care units included in the study were either 
public or private not-for-profit NGO’s. The participants in the study included the persons 
in charge of sub-districts’ health care provision, storekeepers in health care facilities, 
persons in charge of health care units, injection providers and patients who had visited 
the selected health care units at the time of data collection. The study focused on the 
distribution and use of injectable medicines, diluents, syringes and safety boxes used 
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for the discarding of contaminated needles and syringes in the therapeutic services in 
the Mpigi district at the selected health care units.  
 
1.7 CONCEPTUAL FRAMEWORK OF THE STUDY 
 
The study focused on the assessment of injection device security and challenges to its 
achievement at health care facilities in the Mpigi district. Injection device security 
ensures safety of injections and therefore reduces the risk of medical transmission of 
blood borne diseases to patients through unsafe injections. In order to achieve injection 
device security, an efficiently functioning distribution system of injection materials must 
be in place.  
 
To conceptualise injection device security, the Synergy Model (Kerfoot 2002:1) provides 
a viable model for managers who work in health care facilities to use as a basis for a 
professional practice. The core concept of the Synergy Model as described by the 
American Association of Critical care Nurses (AACN 2006:1) is that the needs of 
patients and families influence and drive the characteristics or competencies of a health 
care worker. The synergy results when the needs and characteristics of a patient, 
clinical unit or system are matched with a health care worker’s competencies. The 
Synergy Model has three levels of outcomes of health care, derived from the following 
(Kerfoot 2002:1): 
 
• the patient 
• the health care worker 
• the health care system 
 
The manager in the health care facility must address all three areas in order to create 
excellence in patient care. The manager’s obligation is to create the environment in 
which people can provide effective health care.  
 
In this study, the patients’ needs were viewed as avoidance of infections acquired 
through use of unsafe injections. The health care workers’ competencies included skills 
to administer safe injections through the avoidance of re-use of syringes, proper 
forecasting of required injection commodities and ordering, timely reporting to higher 
levels and advocacy for timely and adequate supplies of commodities. The managers in 
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health care facilities then support the synergised care by developing the required 
infrastructure, providing and maintaining vehicles for delivery of supplies, providing fuel 
for running the vehicles, developing the communication infrastructure, recruitment and 
training of staff and supervision.  
 
Kerfoot (2002:2) maintains that the synergy model is an excellent organisational 
framework to organise the work of the health care worker and the provision of effective 
and efficient patient care. This model describes the characteristics of the patient, the 
health care worker and the organisation within which the care is given. It provides a 
compelling picture of how patient care can be organised to provide a “safe passage” for 
the patient through the health care system. It also provides a framework for patient 
assessment, career advancement for the health care worker and the organising and 
structuring of work between departments (see chapter 2 for full discussion). 
 
1.8 RESEARCH METHODOLOGY 
 
Research methodology is the “application of all steps, strategies and procedures for 
gathering and analysing data in a research investigation in a logical and systematic 
way” (Burns & Grove 2001:26). The selection of a research methodology or strategy is 
the core of a research design and is probably the single most important decision the 
investigator has to make. The research methodology must include the research design, 
definition and selection of the population of interest, the definition of variables 
(characteristics of the individuals in this population), their status and relationships to one 
another, instruments for data collection and the procedure for data analysis (WHO 
2001a:11).  
 
1.8.1 Research design 
 
Mouton (2001:55) defines a research design as “a plan or blue print of how one intends 
to conduct the research”. According to Burns and Grove (2001:223), the design “guides 
the researcher in planning and implementing the study in a way that is most likely to 
achieve the intended goal”.  
 
A quantitative design was used to conduct this study. In this approach, a researcher 
uses deductive reasoning to generate hunches (hypotheses) that are tested in the real 
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world. The researcher applies a scientific approach to the study of a question by moving 
in a systematic fashion from the definition of a problem and the selection of concepts on 
which to focus, through the design of the study and collection of information, to the 
solution of the problem (Polit & Hungler 1995:12). The researcher also controls the 
study by imposing conditions on the research situation so that biases are minimised. 
Evidence in quantitative research is gathered according to a specified plan, using formal 
instruments to collect the needed information. The information gathered is quantitative 
implying that it is in the form of numeric information that can be analysed with statistical 
procedures (Polit & Hungler 1995:13).  
 
This study gathered quantitative information on injection devices at health care units 
and the distribution system in the Mpigi district, using structured interviews and 
observations.  The data was analysed, using statistical procedures, and inferences 
made as to the level of injection device security in the district and the challenges of the 
distribution system. 
 
A health care facility-based observational, descriptive cross-sectional study was 
conducted, employing quantitative data collection methods.  Scientific observation 
involves the systematic selection, observation and recording of behaviours, events, and 
settings relevant to the problem under investigation (Polit & Hungler 1995:364). In this 
study, selected behaviours and events related to injection commodities and their 
distribution system were observed and recorded. When a study is not structured 
formally as an analytical or experimental study, implying that it is not aimed specifically 
to test a hypothesis, it is called a descriptive study, and belongs to the observational 
category of studies (WHO 2001a:16). The purpose of descriptive studies is to observe, 
describe and document aspects of a situation as it naturally occurs, sometimes as a 
starting point for hypothesis generation or theory development (Polit & Hungler 
1995:195-196).  
 
Observations of injection devices and aspects of their distribution system were made, 
described and documented. Cross-sectional studies entail the collection of data on a 
cross-section of the population, which may comprise the whole population or a 
proportion (sample) of it (WHO 2001a:17).  They provide a prevalent rate at a particular 
time (point prevalence) or over a period of time (period prevalence). In this study, data 
were collected from a sample of health care facilities in Mpigi district and the point 
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prevalence of injection device security at the facilities was determined during the 
specific period of data collection. 
 
1.8.2 Population 
 
According to Bryman (2001:85), a population is the “universe of units from which the 
sample is to be selected”. The study population of this study comprised all government 
and NGO health care facilities in the Mpigi district. The district has 47 government 
health care units and 15 NGO health care units. 
 
1.8.3 Sample and sampling procedure 
 
Bryman (2001:85) describes a sample as the “segment of the population that is selected 
for investigation”. The method of selection may be based on a probability or non-
probability approach. A probability sample is one that has been selected using random 
selection so that each unit in the population has a known chance of being selected 
(Bryman 2001:85).  
 
Probability sampling was used to select the sample for this study. The sampling unit 
was the health care facility. Depending on the level of service, the health care units in 
the Mpigi district are stratified as hospital, health care centre IV, health care centre III 
and health care centre II.  
 
Based on this stratification of the health care units, stratified random selection was the 
sampling strategy employed. In stratified random sampling, the population is first 
divided into two or more strata or subgroups and then a predetermined number of 
sampling units selected from each subgroup to form the sample. This enhances 
representativeness of all strata of the sample (Polit & Hungler 1995:286). Since the 
membership of each stratum of health units was unequal, a disproportionate sampling 
design was used in order to obtain sufficient numbers of sampling units from each 
stratum and therefore sharpen the precision and representativeness of the final sample 
(Polit & Hungler 1995:288).  
 
Due to the small number of hospitals (2) and health centre IVs (2) in the district, all the 
hospitals and health centre IVs were included in the study. The remainder of the health 
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units were selected from a list of health care centre IIIs and health care centre IIs by 
proportionate stratified random sampling.  
 
Storekeepers, persons in charge of health care units, injection providers and patients at 
the sampled units were selected for interviews. Information on stock levels and stock 
management was obtained by reviewing stock cards, requisition and issue vouchers 
and physical counts at the selected facilities.  This information was recorded on 
checklists. 
 
1.8.3.1 Sample size estimation 
 
The Mpigi district has 62 health care units that fall under the inclusion criteria for this 
study. Assuming simple random sampling, with injection device security achieved at 
50% of the health care units, with a level of precision of ±10% and a confidence level of 
95%, the sample size is calculated as 38 health care units (Creative Research Systems 
2003:1). A total of 38 health units were therefore selected for the study. Random 
numbers were used to select health units from the list of health care centre IIIs and 
health care centre IIs. An additional 10% of the sample size units (4) were included in 
the selected health care units to compensate for possible non-respondents due to 
failure to reach some units during the data-collection period (Israel 2003:4). 
 
1.8.4 Data-collection Instrument  
 
In quantitative studies, research data are often collected according to a structured plan 
that indicates what information is to be gathered and how to gather it (Polit & Hungler 
1995:310). Structured methods yield data that are relatively easy to quantify and 
analyse. Structured methods also impart objectivity to the data collected by eliminating 
bias due to the researcher’s personal feelings or beliefs (Polit & Hungler 1995:311).  
 
A structured interview schedule and structured observation of availability of injection 
commodities and challenges of the distribution system were used for this study. The 
interview schedule and the checklist for structured observations were developed from 
those used in similar studies by the WHO (2003c:121), the Ministry of Health of Uganda 
(2003:87) and the MMIS (2005:4) project in assessment of injection safety. Quick, 
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Rankin, Laing, and O’Connor’s (1997:331) assessment guide was also consulted for the 
medicine distribution management.  
 
A combination of open-ended and closed questions was used for the structured 
interview schedule to offset the strengths and weaknesses of each type of question 
(Polit & Hungler 1995:336). The structured interview schedule and structured 
observation checklist included questions on the following: 
 
• availability of injection devices 
• distribution infrastructure 
• delivery schedules 
• forecasting and ordering of injection devices 
• record keeping and reporting 
• communication 
• use of injection devices 
 
1.8.4.1 Reliability of the research instruments 
 
Reliability refers to the degree of consistency or accuracy with which an instrument 
measures an attribute (Polit & Hungler 1995:433). Aspects of the concept of reliability 
that were important in this study were internal consistency and equivalence. An 
instrument is said to be internally consistent to the extent that all its subparts measure 
the same characteristic (Polit & Hungler 1995:415).  
 
To assure reliability in this study, an effort was made to include only questions and 
observations that were relevant to the subject of investigation in order to enhance the 
reliability of the instrument.   
 
Equivalence refers to the extent to which two different observers using the same 
instrument yield equivalent measurements of the same traits in the same people (Polit & 
Hungler 1995:416). Since observational methods were used in this study, there was a 
risk of observer error or bias. Careful training, development of clearly defined and non-
overlapping categories and the use of a small number of categories enhanced the 
accuracy of observer ratings and classifications. 
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1.8.4.2 Validity of the research instruments 
 
Validity refers to “the ability of an instrument to measure exactly what it is supposed to 
measure” (De Vos, Strydom, Fouche & Delport 2002:167). Content validity, which is 
concerned with the sampling adequacy of the items for the construct that is being 
measured, was enhanced by using questions from various instruments that had been 
used in other similar studies. The instruments were also subjected to evaluation and 
approval by the study supervisors. A combination of observations and interviews was 
used to check the accuracy of responses from interviewees and therefore minimise bias 
(Brink & Wood 1998:299).  
 
1.8.5 Data analysis  
 
Data analysis entails the breakdown of data into constituent parts to obtain answers to 
research questions and to test research hypotheses (De Vos et al 2002:223). The 
Statistical Package for Social Sciences (SPSS 12) computer program, version 12, was 
used for data analysis. Descriptive statistics were used to analyse and interpret the 
data. These methods were used because this was a descriptive study that wished to 
describe the availability of commodities and challenges in their distribution at the 
respective health facilities. The proportion of health facilities where injection device 
security had been achieved was also determined. 
 
1.8.6 Pre-testing of the research instrument 
 
In a pilot study or pre-test, the research instruments are pre-tested on a small number 
of respondents who are comparable to the sample of correspondents but are not part of 
it (WHO 2001a:178). This ensures that errors of whatever nature can be rectified 
immediately at little cost. The instrument is then presented to the full sample after the 
necessary modifications (De Vos et al 2002:177). 
 
The research instrument in this study was pre-tested on five health facilities in Mpigi 
district. Actual data were collected during the pre-testing and analysed carefully to 
ascertain whether or not they answered the research questions. The results of the pre-
testing were used to refine the research instruments before use in the major study.  Pre-
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test facilities were excluded from the actual study and these results were not included in 
the statistics of the actual study. 
 
1.9 DEFINITIONS OF TERMS  
 
For the purposes of this study, the following terms were used as defined below: 
distribution system, health care facility, injection device security, stock depletion, and 
therapeutic services. 
 
• Distribution system 
 
Quick et al (1997:332) define a distribution system as a “system of administrative 
procedures, transport facilities, storage facilities, and user facilities through which 
supplies move from a central point to the user facilities”. 
 
In this study, the distribution system referred to factors that enabled timely movement of 
sufficient quantities of injection commodities from the district store to the lower level 
health care units so that they could be accessible when required in the Mpigi district of 
Uganda. 
 
• Health care facility  
 
According to Hornby (2000:551), a health care facility refers to “a building where a 
group of doctors see their patients and where some local medical services have their 
offices”.  
 
In this study, a health care facility referred to a building or group of buildings in the Mpigi 
district of Uganda where individuals seek preventative and curative health care 
services. These facilities included health care centres II and III and referral facilities, 
namely health centre IVs and hospitals in the Mpigi district. 
 
• Injection device security 
 
The WHO (2003a:1) defines injection device security as appropriate forecasting, 
financing, procurement and supply management so that injectable products, appropriate 
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single dose diluents, single use injection devices and safety boxes are available in 
adequate quantities.  
 
In this study injection device security denoted the availability of adequate quantities of 
injectable medicines, diluents, single use injection devices and safety boxes for the 
discarding of contaminated needles and syringes at health care facilities in the Mpigi 
district at the time of the researcher’s and/or research assistants’ visit. 
 
• Stock depletion 
 
Quick et al (1997:333) define stock depletion as the complete absence of an item that is 
normally expected to be on hand.  
 
In this study stock depletion referred to complete absence of any of the following 
respective items: injection medicines, diluents, single use syringes and needles and 
safety boxes for discarding contaminated needles and syringes at health care facilities 
in the Mpigi district. 
 
• Therapeutic services 
 
The word “therapeutic” refers to something “designed to help treat an illness” (Hornby 
2000:1241), while the word “service” is defined as “a system that provides something 
that the public needs, organised by the government or a private company” (Hornby 
2000:1075). 
 
In this study therapeutic services referred to services provided at health care facilities to 
diagnose and/or treat diseases but excluded immunisation services and family planning 
services in the Mpigi district. 
 
1.10 ETHICAL CONSIDERATIONS 
 
Permission to conduct the study was sought from the Research and Ethics Committee 
of Makerere University Medical School, Kampala, Uganda, and the Ethics and 
Research Committee of the University of South Africa. In addition, permission to visit 
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the respective health units was sought from the District Health Officer of the Mpigi 
district.  
 
The study was non-invasive, involving observation of participants and interviewing 
them. Written informed consent to participate in the interview was sought from the 
participants who were assured of anonymity and confidentiality. The benefits of the 
study were explained to all participants using a consent letter prior to their participation 
(Mouton 2001:239-247). See Annexures A, B and C for copies of permissions and 
introductory letter to participants. The ethical considerations followed in this study are 
discussed in chapter 3. 
 
1.11 LIMITATIONS OF THE STUDY 
 
Although measures were taken to minimise errors through the use of structured 
instruments and the training of data collectors, the data obtained was vulnerable to 
possible distortion and bias by the interviewer, interviewee and the observers. Unknown 
events happening during data collection might also have affected the results. Another 
limitation of the study was that Mpigi district is a peri-urban community, and therefore 
the results obtained could not necessarily be generalised to rural districts. 
 
1.12 LAYOUT OF THE STUDY 
 
This dissertation consists of five chapters. 
 
Chapter 1 introduces the study area; the problem, and the purpose, objectives and 
research design and methodology of the study, and defines key terms. 
 
Chapter 2 covers the literature review conducted for the study. 
 
Chapter 3 discusses the research design and methodology. 
 
Chapter 4 presents the data analysis and interpretation and results. 
 
Chapter 5 discusses the conclusions and limitations of the study, and makes 
recommendations for practice and further research. 
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1.13 CONCLUSION 
 
This chapter provided a short introduction to Uganda and the Mpigi district to orientate 
the reader to the context under study.  The background to the problem under study; 
purpose, significance and objectives of the study, and the research design and 
methodology, including the population, sampling, data collection and data analysis were 
described. Key terms were defined and the ethical considerations were highlighted. 
 
Chapter 2 discusses the review literature conducted for the study. 
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CHAPTER 2 
 
Literature review 
 
 
2.1 INTRODUCTION 
 
Chapter 1 briefly described Uganda and the Mpigi district, the problem, purpose, aim 
and significance of the study, and the research design and methodology, and defined 
key terms used in the study.  This chapter discusses the literature review conducted on 
injection safety and unsafe practices, the global burden of disease associated with 
unsafe injection practices, strategies used to ensure injection safety and injection device 
security, the distribution system, as well as the synergy model which was the 
conceptual framework for this study. 
 
According to De Vos et al (2002:127), a literature review is aimed at contributing to a 
clearer understanding of the nature and meaning of the problem under study. A 
literature review is accomplished by a thorough and critical review of the existing 
information (WHO 2001a:148). 
 
Mouton (2001:87) states that a review of existing literature is important to 
 
• ensure that previous studies are not duplicated 
• discover the most recent and authoritative theory on the subject 
• find out the most widely accepted empirical findings in the field of study 
• identify the available instrumentation that has proven validity and reliability 
 
The literature review for this study covered injection safety, injection device security, the 
distribution system of injection devices and the synergy model. The review revealed the 
existing knowledge about these concepts and how they are related, research 
undertaken on these concepts, and instruments used in the study of these concepts.  
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2.2 INJECTION SAFETY 
 
Injections are a skin piercing procedure performed with a syringe and needle to 
introduce a substance for prophylactic, curative, or recreational purposes and are the 
most common healthcare procedure worldwide (Kotwal, Priya, Thakur, Gupta, Kotwal & 
Seth 2004:334). In developing and transitional countries, some 16 thousand million 
injections are administered each year. More than 90% of injections are given for 
therapeutic purposes while 5 to 10% is given for preventive services, including 
immunisation and family planning (Hutin et al 2003:1075).  
 
A safe injection is one that does not harm the recipient, does not expose the provider to 
any avoidable risks and does not result in waste that is dangerous for the community 
(WHO 2000:1). Injection safety ensures that the conditions required to provide safe 
injections exist and that safe practices are adhered to. When a patient receives an 
injection, it should be given because the patient needs it (implying that there is no other 
clinically appropriate treatment). An authorised and trained health care provider using a 
sterile needle and syringe that will not or cannot be reused should give it. Immediately 
after the injection, the syringe must be discarded in a puncture-proof receptacle (namely 
a safety box). When the safety box is full, it must be kept in a secure location until it can 
be safely destroyed in an environmentally-responsible manner by an authorised agent 
or in some cases by a health care worker who has been properly trained in health care 
waste management (Nersesian, Cesarz, Cochran, Mboyane & Schmidt 2004:1).  
 
A reliable and adequate supply of single-use syringes, disposable reconstitution 
syringes and safety boxes is necessary to ensure injection safety (WHO 2003a:1). An 
efficient stock management and distribution system therefore needs to be developed to 
ensure continuous, sufficient availability of injection safety equipment in all health care 
facilities.  
 
2.2.1 Unsafe injection practices 
 
According to the WHO (2003a:1), the majority of therapeutic injections in developing 
and transitional countries are unnecessary and unsafe. An unsafe injection is one that 
harms the recipient, exposes the provider to an avoidable risk and results in waste that 
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is dangerous to the community. An unnecessary injection is one where oral alternatives 
are available, where the injected substance is inappropriate or harmful or where the 
symptoms or diagnoses do not warrant treatment by injection (Youwang, Guangping, 
Yu, Anqiang, Yong & Hongpin 2006:409).  
 
According to Reeler (2000:135), injections are often given for the wrong indications, 
such as respiratory infections, diarrhoea, unspecified or undiagnosed fever, skin 
infections and urinary tract infections. Patients often prefer injections because they 
believe them to be “stronger” and “faster” than other forms of medication such as oral or 
rectal routes. Some patients also assume that doctors and nurses regard injections as 
the best treatment. In turn, doctors and nurses often over-prescribe injections because 
they believe that this best satisfies patients, even though patients are often open to 
alternatives. In addition, prescription of an injection sometimes allows the charging of a 
higher fee for service. Better communication between patients and providers can clarify 
such misunderstandings and help to reduce injection over-use (WHO 2002c:1).  
 
According to Youwang et al (2006:413), unnecessary injections should be avoided.  Not 
only would this decrease the administration of unsafe injections by over half, it would 
also reduce the transmission of blood-borne pathogens, save medical resources, and 
reduce the economic burden of patients. 
 
The WHO-UNICEF-UNFPA (1999:1) in a joint statement on the use of auto-disable 
syringes in immunisation services reaffirmed that the re-use of syringes and needles 
places the general public at a high risk of disease and death. Furthermore, the use of 
safety boxes for the collection and disposal of used syringes, needles and other 
injection materials reduce the risk posed to health staff and the general public through 
contaminated needles and syringes.  
 
According to Youwang et al (2006:409), syringes and needles are often rinsed by health 
carer workers in a pot of tepid water between injections. In some countries the 
proportion of injections given with syringes or needles re-used without sterilization is as 
high as 70%. Other unsafe practices, such as poor collection and disposal of 
contaminated injection equipment, expose health workers and the community to the risk 
of needle stick injuries. In some countries unsafe disposal of contaminated syringes and 
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needles can lead to re-sale on the black market endangering the communities through 
the spread of severe diseases (WHO 2002c:2).  
 
According to Reeler (2000:135), injection administration and sterilization practices are 
unsatisfactory in many health care facilities because health care workers have 
insufficient knowledge of and insight into its dangers or because there is lack of 
equipment. In developing countries disposable syringes are often reused despite their 
intended purpose. The disposal of used syringes and needles presents a problem that 
increases the risk of transmitting diseases. Health care centres often dispose of used 
syringes and needles in nearby open pits, a practice which makes it possible for people 
to obtain and reuse the injection equipment.  
 
Research on injection practices in the developing world has revealed rampant re-use of 
injection equipment and poor disposal of used sharps exposing millions of people to 
infection such as HIV, Hepatitis B virus and Hepatitis C virus ( Simonsen, Kane, Zaffran 
& Kane 1999:789; Gisselquist 2006:536; Talaat, El-Oun, Kandeel, Abu-Rabei, 
Bandenschatz, Lohiniva, Hallaj & Mahoney 2003:234;  Kermode, Holmes, Langkham, 
Thomas & Gifford 2005:423; Youwang et al 2006:407; Khan, Luby, Fikree, Karim, 
Obaid, Dellawala, Mirza, Malik, Fisher-Hoch & McCormick 2000:956).  
 
In a study to quantify the prevalence of unsafe injections in the developing world, 
Simonsen et al (1999:795) found that more than 50% of all injections were administered 
with syringes and needles used on consecutive patients without sterilisation.  The study 
also revealed that most developing countries did not have the necessary infrastructure 
for safe disposal of contaminated and used syringes, needles and other equipment.    
 
In random surveys at public health care facilities throughout the Mwanza region in 
Tanzania between 1991 and1993, Gisselquist (2006:536) reported that purportedly 
sterile syringes and needles had been contaminated at 22% to 44% of these facilities; 
sterilization and storage facilities for sterilized equipment were inadequate, and injection 
procedures were often unsafe, resulting in an increased transmission of HIV.  
 
In Egypt, Talaat et al (2003:239) found a high frequency of the use of injections for 
therapeutic purposes among the general population and that injections were often 
prescribed and administered by untrained health care workers.  In addition, the re-use 
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of syringes occurred, possibly contributing to blood-borne pathogen transmission in 
Egypt. 
 
In a study on injection-related practices in two rural north Indian health care settings, 
Kermode et al (2005:426-7) found the practice of using one syringe repeatedly but 
changing the needle in both hospital and community based immunisation clinics, and 
some health care workers perceived this as a safe practice. The fact that nurses were 
withdrawing a small amount of medicine remaining in the needle and the syringe tip 
back into the syringe after removing the needle from the patient was of concern as 
blood cells could enter the syringe in this way. The same syringe with a new needle was 
subsequently used to draw up additional doses of medicine from multi-dose vials that 
could easily become contaminated. Furthermore, Kermode et al (2005:426-7) found that 
health care workers administering vaccines were frequently observed recapping 
needles following administering an injection. This is a dangerous practice as needle 
recapping is the most common cause of needle stick injury, which, in turn, is the most 
common cause of occupational infection with blood-borne viruses. 
 
In a study on the status of injection services, knowledge and attitude of health care 
workers with regard to injection practices at health care facilities in the Jingzhou district 
of China, Youwang et al (2006:414) reported that 25 of the 28 unsafe injections found in 
the field were conducted for the drug allergy test without sterilizing the skin and the rest 
were due to the inappropriate sterilization or the re-use of syringes.  
 
In evaluating the relationship between injections and viral hepatitis infections in a peri-
urban community of Karachi, Pakistan, Khan et al (2000:959) found that 44% of patients 
aged at least 20 years who visited health care clinics were infected with the hepatitis C 
virus. The primary route of transmission was through injections with re-used, 
inadequately sterilized needles and syringes.  
 
The WHO (2004:1) identifies the main factors contributing to transmission of blood 
borne pathogens through injections as  
 
• the repeated use of syringes and needles 
•  overuse of therapeutic injections 
•  lack of awareness and knowledge of risks 
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•  shortages of injection devices 
•  poor waste disposal practices 
• lack of appropriate waste infrastructure 
 
According to Kermode et al (2005:423), the reasons for unsafe injection practices in 
low-income countries are complex and include structural, economic and socio-cultural 
factors. In a study in rural northern India, Kermode et al (2005:423) found that the 
resource constrained circumstances of both patients and hospitals substantially 
influenced the safety of injection practices. Lack of knowledge was also relevant as 
there were limited opportunities for the health care workers to engage in professional 
development and consequently, the implementation of recommended changes was 
slow. Inadequate supplies of necessary equipment also accounted for unsafe practices 
(Kermode et al 2005:430).  
 
Logez, Hutin, Sonda, Thuault and Holloway (2005:1) state that geographical factors 
may hinder access to supplies and affect injection practices. In Burkina Faso, the 
implementation of pharmaceutical depots next to public health care facilities increased 
geographical accessing of essential medicines and basic supplies, among which were 
syringes and needles, thereby contributing substantially to safer injection practices.  
 
2.2.2 Global burden of disease associated with unsafe injection practices 
 
According to Miller and Pisani (1999:808), unsafe injection practices are associated with 
substantial morbidity and mortality, particularly from hepatitis B and C and HIV 
infections. Unsafe injections are believed to have contributed to 30%, 41% and 5%, 
respectively, of new infections of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) and 
HIV in 2000 (WHO 2003a:1). According to the WHO (2002c:2), HBV is highly infectious 
and causes the highest number of infections. Unsafe injections account for 33% of new 
HBV infections in developing and transitional countries out of a total of 21.7 million 
people infected each year. Unsafe injections are the most common cause of HCV 
infection in developing and transitional countries, causing two million new infections 
each year and accounting for 42% of cases. Globally, nearly 2% of all new HIV 
infections are caused by unsafe injections with a total of 96 000 people infected 
annually. In South Asia, up to 9% of new HIV cases may be caused in this way. These 
inadvertently transmitted blood-borne diseases manifest some time after infection and 
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hence may not be appropriately accounted for. Annually, more than 1.3 million deaths 
are estimated to be due to unsafe injection practices (Miller & Pisani 1999:808).   
 
2.2.3 Strategies used to ensure injection safety 
 
According to Miller and Pisani (1999:809), more than 90% of medical injections are 
given outside immunisation programmes. Most are intended for curative purposes, and 
many are probably unnecessary. The pressure to provide injections comes from both 
patients and doctors. To prevent injection-associated transmission of blood-borne 
pathogens, injection frequency should be reduced and safe injection practices carried 
out on a regular basis. Reducing the demand for unnecessary injections and increasing 
the demand for sterile injections requires increased public awareness, health workers’ 
training, and the provision of alternative oral medications. It may also be necessary to 
make structural changes in the health services provision to reduce incentives to provide 
injections (Miller & Pisani 1999:809).  
 
Responding to the problem of unsafe injections requires a better understanding of 
where the problem lies. It is likely that the bulk of infection from injections arises from 
the re-use of contaminated injecting equipment. Auto-disable syringes (which cannot be 
re-used) would do much to cut down infection rates. Likewise, investments need to be 
made in the safe, convenient and effective disposal of injection equipment to avoid the 
spread of infection among health care workers and the public. In addition, greater 
priority should be given to support needle-less technology, such as aerosol or oral 
formulations (Miller & Pisani 1999:810). 
 
According to Reeler (2000:141), anthropological research can contribute to a better 
understanding of why, how and when injections are administered and interventions 
should continuously be adapted to specific contexts in accordance with people’s 
responses.  
 
2.2.3.1 The WHO strategy for safe and appropriate use of injections 
 
The WHO (2000:1) recommends a multidisciplinary three-pronged approach to the 
reduction of injection frequency and promotion of safe injection practices, namely: 
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• Provision of sufficient quantities of injection equipment and infection control 
supplies. 
• Waste management of all sharps used for invasive procedures, including 
syringes and needles. 
• Behaviour change among patients and health care workers to reduce injection 
overuse and implement safe practices. 
 
2.2.3.1.1 Provision of equipment and supplies 
 
Eradication of the re-use of syringes and needles without sterilisation requires 
continuous, sufficient availability of injection equipment and infection control supplies in 
all health care facilities. According to the WHO (2000:2), important activities include: 
 
• selection of appropriate types of syringes and needles for curative care 
• enforcement of international norms and standards by the national regulatory 
authority 
• central bulk procurement of injection equipment and infection control supplies 
• central management of storage  
• efficient distribution system to ensure continuous, sufficient availability of 
injection equipment in all health care facilities nationally 
 
2.2.3.1.2 Behaviour change 
 
The WHO (2000:2) states that the foundation of the safe and appropriate use of 
injections is a behaviour change strategy targeting consumers as well as public, private 
and lay health care workers. According to the WHO (2000:1), important activities 
include  
 
• developing a national communication and behaviour change strategy 
• constructing and developing national standards for safe injection practices 
• incorporating injection safety into minimum standards of care 
• promoting safe technologies 
• promoting rational use of injections 
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• addressing issues that could lead to poor injection practices, including attitudes, 
emotions, incentives, beliefs, power relationships, norms and health care 
systems’ general administration 
 
2.2.3.1.3 Management of sharps waste 
 
The efficient, safe and environmentally-friendly management of contaminated waste is 
the only means of ensuring that disposable syringes and needles are not reused and 
that they do not lead to accidental needle stick injuries (WHO 2000:2). In this regard, 
the WHO (2000:2) emphasises that this includes  
 
• formulating a waste management policy for all medical waste 
• assessing the waste management system needs  
• selecting appropriate waste disposal systems for all levels of health care facilities 
• implementing a regulatory framework 
•  identifying the required human and financial resources to plan and implement 
the disposal of medical waste 
• training and supervising all health care workers to ensure the effective and 
efficient disposal of medical waste 
 
2.2.3.2 Using auto-disable syringes to prevent injection re-use 
 
The Program for Appropriate Technology in Health (PATH) (2001:47) states that the re-
use of injection equipment is responsible for most of the infections such as abscesses, 
skin infections and sepsis that result from injections. To prevent this, several new types 
of syringes have been designed to prevent re-use, including auto-disable syringes that 
automatically become disabled after one use. The WHO and its partners (WHO-
UNICEF-UNFPA 1999:1) recommend the use of auto-disable syringes, “bundled” with 
the supply of vaccines in all mass immunisation campaigns, and also strongly advocate 
their use in routine immunisation programmes. According to Lloyd and Milstein 
(1999:1001), the auto-disable syringe prevents re-use and therefore helps to prevent 
transmission of blood-borne pathogens between patients. Lloyd and Milstein 
(1999:1001) add that auto-disable syringes contribute to safety predominantly in 
developing countries where the reuse of standard disposable syringes is widespread, 
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disposable systems are inadequate, and the resale of used medical equipment is 
common. 
 
In situations where syringes are commonly re-used, the introduction of the auto-disable 
syringes necessitates an increase in the number of syringes purchased and a 
corresponding increase in expenditure. According to Hersh, Carr, Fitzner, Goodman, 
Mayers, Everts,Laurent, Larsen and Bilous 2003:S300), the auto-disable syringe does 
not significantly affect transmission between patients and health care workers 
attributable to accidental needle-stick injuries, nor does it present a lower risk of 
accidents in the community when incorrectly disposed of. However, it does prevent 
unauthorised packaging and resale after use (Cheng 2004:251). 
 
2.2.3.3 Holistic approach to injection safety 
 
Dicko, Oni, Gavinet, Kone, Pierre and Jacquet (2000:167) recommend a holistic 
approach to injection safety in which injection safety is approached together with 
nursing practices, social mobilisation and logistics.  Figure 2.1 illustrates the holistic 
approach to injection safety, which consists of three interrelated components, namely 
nursing practice, social mobilisation and logistics.  
 
Nursing practice is the source of ordering and managing injection supplies and 
equipment, the administration of safe injections and the reporting of adverse events 
following the administration of injections. 
 
Social mobilisation includes the educating and supplying information to the public about 
the facts regarding administration of medicine through the means of injection as well as 
the elimination of unfounded beliefs about the injecting of medicines.  It also includes 
informing the public about the transmission of diseases through injections that are re-
used, and their rights to insist on sterile syringes and needles when being injected by 
authorised and trained health care workers. 
 
Logistics include the timeliness in planning and ordering of injection devices, which 
should correlate with the supplied injectable medicines. Logistics also involves 
budgeting for injection devices and training, supporting and supervising health care 
workers responsible for commodity management. 
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Dicko et al (2000:167) maintain that only the combined effort of all parties will ensure 
that both health care workers and patients are sufficiently protected.   
 
Companies that supply injection devices and equipment should be educated about safe 
injection practices so that improved strategies and technology can be developed. Social 
mobilisation teams should educate people and health care workers about injection 
overuse and promote the elimination of unnecessary injections (World Bank 2003:3).  
 
 
 
 
 
Figure 2.1 Holistic approach to injection safety 
(Dicko et al 2000:167) 
 
Dicko et al (2000: 167) contend that the logistics team should provide each health care 
facility with sufficient supplies of syringes and needles, boxes for the safe disposal of 
used materials, and fuel for burning contaminated sharps before burying them. 
Necessary training should be provided to all staff involved in these operations. This 
broader concept of injection safety should be fixed not only in the minds of providers, 
social mobilisation workers, and logisticians, but also in the minds of all stakeholders, 
including policy-makers, donors and the whole community. 
Khan et al (2000:961) recommend that interventions should be addressed at the 
societal, practitioner and patient levels with an important long-term goal of preventing 
unnecessary injections. However, according to Reeler (2000:142), making a substantial 
reduction in the number of unnecessary injections might be impossible for many years 
 36
to come and it would be more useful to aim at reducing unsafe administration. Reeler 
(2000:142) is of the opinion that people may be more willing to take measures to ensure 
safety than to give up a potent symbol of optimal care. 
 
2.2.4 Making medical injections safer project 
 
In 2004, as part of the USA President’s Emergency Plan for AIDS Relief (PEPFAR) 
focusing on countries with high HIV prevalence, JSI and its subcontractors, Program for 
Appropriate Technology in Health (PATH), Academy for Educational Development 
(AED), and the Manoff Group, were awarded funds through the Centre for Disease 
Control and Prevention (CDC) and the USA Agency for International Development 
(USAID) to implement “rapid interventions to decrease unsafe injections” in eleven 
countries (JSI 2005:1). The project is commonly known as Making Medical Injections 
Safer (MMIS). 
 
According to JSI (2005:1), by the end of the five-year project (2009), MMIS together 
with its national counterparts in the project countries, which include Uganda, aims to 
have established an environment where patients, health care workers, and the 
community are better protected from the medical transmission of HIV and other blood-
borne pathogens.  
 
2.2.4.1 MMIS vision 
 
The MMIS project works in eleven countries in Africa and the Caribbean in order to 
promote a world in which an optimal service is delivered.  According to JSI (2005:1), the 
following measures are taken to ensure that the mission is fulfilled: 
• In every health facility, trained health care workers administer drugs through 
injections which are necessary and which can be safely administered by using 
appropriate safe injection devices 
• Health care waste, such as used syringes and needles, is efficiently managed 
using methods that are safe for the community and the environment 
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2.2.4.2 MMIS collaborations 
 
To support the strategic vision and objectives of the project, the MMIS (JSI 2005:2) 
works with global, regional, and in-country partners to systematise approaches, build 
capacity, and sustain injection safety programmes. Collaboration with host nations is 
central to the MMIS efforts. Lasting success depends on leadership by government and 
private sectors and, ultimately, on local capacities for injection safety and health care 
waste management. According to the JSI (2005:2), the MMIS project works with 
countries to achieve sustainability through 
 
• supporting governments in developing countries with national plans and policies 
• working through national injection task forces 
• promoting south-to-south exchanges of experience 
• building partnerships at international and regional levels to foster collaboration 
 
The task forces and partnerships provide a foundation for making improved injection 
safety a reality. 
 
2.2.4.3 MMIS technical approaches 
 
The MMIS project provides support for sustainable approaches for injection safety 
according to the JSI (2005:2), including: 
 
• Training, support, and capacity building ensuring that only safe and necessary 
injections become a professional and social norm within the health care systems 
and among ancillary services personnel. 
• Safe injection commodity management improving the availability of safe injection 
equipment (syringes with re-use prevention and/or needle stick injury prevention 
features and safety boxes for discarding contaminated waste such as syringes 
and needles and other sharps used for procedures). 
• Advocacy and behaviour change establishing high quality services and reducing 
the risk of needle stick injuries among health personnel and reducing the 
administration of unnecessary injections. 
• Sharps waste management establishing the most cost effective, practical and 
safe means of waste disposal in health care settings. 
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• Monitoring and evaluation of key constraints and opportunities along the path 
toward the overall goal of preventing new infections of HIV and hepatitis B and C. 
 
2.2.5 The injection safety situation in Uganda  
 
In Uganda, the Ministry of Health of Uganda (2004a:2) and Priotto et al (2001:60-61) 
found a high rate of injection use and a high proportion of infections caused by unsafe 
injections. A national cross-sectional survey of injection safety practices in health care 
facilities conducted by the Ministry of Health of Uganda (2004a:2) indicated that the 
most prominent factors contributing to unsafe injection practices included 
 
• over-prescription of injections 
• limited availability of guidelines for health workers on injection safety practices 
including needle stick injuries at all health care levels 
• inadequate supply of injection materials, leading to the re-use of injection 
supplies without sterilisation 
• inadequate facilities for sterilisation  
• lack of adequate facilities for the collection and disposal of injection wastes 
 
Furthermore, over 70% of the respondents received more than three injections per year, 
putting Uganda among the group of countries in the Sub-Saharan region with the 
highest use of injections. In addition, 65% of the surveyed facilities reported having 
experienced shortages of disposable injection supplies in the 12 months prior to the 
survey, particularly in the curative sector. This shortage was attributed to a less-than-
optimal logistics system (including ineffective forecasting and distribution mechanisms). 
Improper management of health care waste was reported at 60% of the health care 
facilities (Ministry of Health of Uganda 2004a:3). 
 
Subsequent to the study, the MMIS (2005:1) project was conducted in Uganda in 2005 
to assist the Ministry of Health of Uganda to establish an environment where patients, 
health care workers, and communities are more efficiently protected from the medical 
transmission of HIV and other blood-borne pathogens via health care practices. Phase 
1 of this project was initially implemented in the districts of Mpigi, Nebbi, Mbarara and 
Pallisa and thereafter, five more districts were subsequently added during each financial 
year. The main strategies of the MMIS (2007:1) project include 
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• working within the existing structures  
• increasing the involvement of families and communities  
• timeliness in the implementation of activities  
• regular monitoring, supervision and evaluation of the implemented activities 
 
The project’s technical approach entails equipping health care workers with knowledge 
and skills in safe injection administration, management of injection commodities and 
appropriate health care waste management. Other approaches include changing the 
behaviours of health care workers and patients to enhance safe injection practices, 
ensuring the availability of safe injection equipment and supplies, and the development 
of health care waste management plans for the safe and appropriate management of 
waste at health care facilities (MMIS 2007:1).  
 
In general, the MMIS project was guided by the WHO’s (2000:1) three-pronged 
approach to the implementation of injection safety in health care facilities.  
 
2.3 INJECTION DEVICE SECURITY 
 
According to the WHO (2003a:1), in the curative health care sector, where 95% of all 
injections are provided, the concept of injection device security entails appropriate 
forecasting, financing, procurement and supply management so that the following items 
are available in adequate quantities: 
 
• injectable products 
• appropriate single dose diluents 
• single use injection devices for the administration of drugs through injection and 
for the reconstitution of medicines 
• safety boxes for the safe discarding of contaminated and used syringes and 
needles 
 
According to Logez et al (2005:2), the common failure of health care systems to ensure 
adequate and sufficient supplies of injection devices may have a negative impact on 
injection safety. Logez, Hutin, Halloway, Gray and Horgerzeil (2004:1106) point out that 
the WHO’s (2003d: 1-23) model list of essential medicines does not mention the need to 
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supply injection devices in quantities that match the supplies of essential injectable 
medicines, although 44% of these essential medicines are listed in injectable form.  In 
addition, a system analysis conducted in 1995 by the logistics project of the WHO’S 
African Regional Office (AFRO) identified the failure to systematically fund sufficient 
supplies of injection devices, as part of immunisation services, to be a key determinant 
of the widespread re-use of syringes and needles in the absence of sterilization facilities 
(Dicko et al 2000:166). In a joint statement in 1999, the WHO, the United Nations 
Children’s Fund (UNICEF) and the United Nations Population Fund (UNFPA) (WHO-
UNICEF-UNFPA 1999:1) recommended that sufficient syringes and safety boxes used 
for disposal of sharps such as the contaminated syringes and needles should be 
supplied with consignments of vaccines to address the issue of insufficient supplies of 
injection devices for immunisation purposes. According to Logez et al (2005:2), this 
recommendation also applies to the curative services where the majority of injections 
are administered. 
 
Nersesian et al (2004:5) emphasise that forecasting, financing, procurement and 
delivering products are the primary logistics elements for enhancing injection device 
security.  
 
2.3.1 Forecasting injection device needs 
 
Effective forecasting for injection devices requires an estimate of the number of 
anticipated injections to be administered. The number of doses of injectable 
preparations procured provides an estimate of the number of needles and syringes 
required since providers should generally have the same number of devices as doses 
for injection administration. Additional needles and syringes are also needed for 
reconstitution, which some injectable preparations require (Nersesian et al 2004:6). 
 
Consumption data also inform forecasts because provider variation may alter the 
quantity and distribution of sizes of syringes needed. Consumption data is also useful 
information for the full supply of injection devices, particularly when logistical systems 
for essential drugs and medical devices are managed in separate systems. However, 
consumption data might be unreliable if injection devices have been under-supplied, as 
this would cause an underestimation of the number of injections administered during a 
specific period (Nersesian et al 2004:6).  
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Another method of forecasting requirements is the morbidity method. According to the 
WHO (2003c:11), this method uses estimates of the number of health care contacts, 
common disease incidences and current standard treatment guidelines. The method is 
based on the rationale that prescribing requires reliable morbidity data. It is most 
appropriate for calculating injection safety needs according to injectable medicines 
needs in new programmes and for comparing the actual use with theoretical needs. The 
morbidity method of forecasting needs may be unreliable if the health information 
system is not well developed or if morbidity statistics are not reliably reported. Morbidity-
based forecasts may also be difficult in circumstances where many treatment modalities 
are employed. In this case, the substitution of treatments makes it particularly difficult to 
estimate the actual number of injection devices used (Nersesian et al 2004:6). 
 
In practice, the best approach may include a combination of the consumption and 
morbidity methods. The consumption method may be used first to improve 
quantification in the short run and then the morbidity method could be applied 
progressively for each type of service, to allow prescribing standards to be reviewed 
and improved. Alternatively, initial estimates might be made by the morbidity method, to 
establish a base from which to start, and once this has been assured the consumption 
method can be introduced. The general approach is to calculate enough injection 
equipment according to each injectable medicine to be supplied for twelve months. An 
appropriate buffer stock at central level will ensure that supplies can be maintained if 
usage increases or if the delivery of orders is delayed (WHO 2003b:11). 
 
2.3.2 Identifying financing 
 
Another critical logistics element for ensuring commodity security is securing sufficient 
financing. The WHO (2003a:2) calls on “all donors and lenders who finance injectable 
products to also finance appropriate quantities of single-use injection devices, single 
dose diluents, safety boxes and the cost of sharps waste management”. There should 
be advocacy for sustainability of financing mechanisms for injection-safety related 
commodities provided both by donors and government. According to Nersesian et al 
(2004:7), it is critical to secure financing for the full supply of injection devices because 
of the budget constraints within the health sector of most developing countries. 
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2.3.3 Procuring injection devices 
 
The current global safe injection strategy calls for single-use injection devices and 
safety boxes for every injection administered. According to Nersesian et al (2004:7), 
one of the major elements in supporting this strategy is coordinated procurement, which 
means procuring quantities of single-use injection devices to match the number of 
doses of injectable preparations procured. It also means procuring the corresponding 
number of safety boxes. Coordinated procurement is crucial to supporting commodity 
security for injection safety. 
 
2.3.4 Supply management for injection devices 
 
A critically important issue to consider about supply management (including distribution) 
for safe injection devices is how to provide the supplies in complementary quantities, 
also called bundling. According to the WHO-UNICEF-UNFPA (1999:4), bundling usually 
refers to distributing injectable products with an appropriate number of syringes, diluents 
(if needed), and safety boxes used for disposal of used sharps including contaminated 
syringes and needles, to ensure that every injection is given safely and the used syringe 
is disposed of safely. It is important to recognise that injection devices typically flow 
through existing supply management systems within countries. Nersesian et al 2004:8) 
maintain that strengthening the system and developing an effective supply management 
for injection safety devices requires a full understanding of the operation, strengths and 
weaknesses of the existing supply management systems.  
 
2.4 INJECTION DEVICE DISTRIBUTION SYSTEM 
 
Quick et al (1997:332) describe a distribution system as a system of administrative 
procedures, transport facilities, storage facilities, and user facilities through which 
supplies move from a central point to the user facilities. According to the WHO 
(2003a:1), the application and success of the policy of injection device security depends 
on a reliable distribution system for health products. In addition, Quick et al (1997:316) 
state that effective commodity distribution relies on effective system design and efficient 
management. 
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2.4.1 Goals of a distribution system 
 
The primary management goal of an effective and efficient distribution system is to 
maintain a steady flow of supplies to facilities where they are needed while ensuring 
that resources are being used in the most effective way. According to Quick et al 
(1997:317), a well managed distribution system is a cost effective system and should 
contain the following characteristics: 
 
• maintain a constant supply of commodities 
• keep commodities in good conditions 
• minimise losses due to spoilage and expiry 
• rationalise commodity storage points 
• use available transport as efficiently as possible 
• reduce theft and fraud 
• provide information for forecasting commodity needs 
 
However, it is imperative that management should regularly monitor the cost and 
performance of the distribution system as important indicators of the health care 
system’s operations (Quick et al 1997:317). 
 
2.4.2 The distribution cycle 
 
According to Quick et al (1997:317), the distribution cycle begins when the 
manufacturer or supplier dispatches commodities and ends when drug consumption 
information is reported back to the procurement unit. The major activities of the 
distribution cycle include procurement, port clearing, receipt and inspection, inventory 
control, storage, requisition of supplies, delivery, dispensing to patients and 
consumption reporting (see figure 2.2). 
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Figure 2.2: The distribution cycle 
(Quick et al 1997:319) 
 
 
2.4.2.1 Procurement 
 
The distribution frequency intersects the procurement process at the point at which 
commodities are available for delivery to the health facilities (Quick et al 1997:317). 
 
 
2.4.2.2 Port clearing 
 
Unless injection devices are acquired locally or the international supplier takes 
responsibility for it, port clearing is the first step in making injection devices available for 
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distribution. Port clearing involves identifying shipments as soon as they arrive in port, 
processing all importation documents, completing any customs requirements, storing 
commodities properly until they leave the port, surveying the shipment for losses and 
signs of damage, and collecting the commodities as soon as they have been cleared 
(Quick et al 1997:317). 
 
2.4.2.3 Receipt and inspection 
 
Stores staff must carry out a complete inspection of every shipment as soon as it is 
received from the supplier. The shipment must be kept separate from other stock until 
this inspection has been completed. Inspectors should check for damaged and missing 
items and for compliance with the contract conditions concerning type of commodity, 
quantity, presentation, packaging and labelling.  
 
2.4.2.4 Inventory control 
 
Establishing and maintaining effective inventory records and procedures are the basis 
for coordinating the flow of commodities through the distribution system and the primary 
protection against theft and corruption. The inventory control system is used for 
requisitioning and issuing drugs, for financial accounting and for preparing the 
consumption and stock balance reports necessary for ordering re-supplies. An 
appropriate inventory management system should be adapted to suit the capacity and 
needs of personnel at all levels in the health program (Quick et al 1997:317).  
 
2.4.2.5 Storage 
 
Storage facilities range from large mechanised warehouses at the national level to small 
wooden boxes sitting in health centres or carried by community health workers. Proper 
location, construction, organisation, and maintenance of storage facilities help maintain 
device quality, minimise theft, and maintain regular supply to health facilities (Quick et al 
1997:317). 
 
2.4.2.6 Requisition of supplies 
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The forms and procedures for requisitioning are a key element of the inventory control 
system. The requisition system may be manual or computerised but designed to 
simplify distribution by facilitating inventory control, providing an audit trail for tracing the 
flow of supplies, assisting in financial accounting and listing commodities issued (Quick 
et al 1997:317). 
 
2.4.2.7 Delivery 
 
Injection devices may be delivered by warehouses or collected by health care facilities. 
Transport may involve air, water, railway, or on- and off-road vehicles. Transport 
managers should select methods of transportation carefully and schedule deliveries 
realistically and systematically, to provide punctual and economic service. Vehicle 
breakdown; availability of fuel, lubricants, and spare parts; seasonal variations in access 
routes; safety along specific supply lines, and other local factors must all be considered 
in transport planning (Quick et al 1997:318). 
 
2.4.2.8 Dispensing to patients 
 
The distribution process achieves its purpose when injection devices reach hospital 
wards, outpatient clinics, health care centres, or community health care workers and are 
appropriately prescribed and used (Quick et al 1997:317). 
 
2.4.2.9 Consumption reporting 
 
The closing link in the distribution cycle is the flow of information on consumption and 
stock balances backing up the distribution system for the procurement or requisition 
office for quantifying needs. If adequate inventory and requisition records are kept, 
compilation of reports should be straightforward (Quick et al 1997:318). 
 
2.4.3 Basic design features of an injection device distribution system  
 
Designing a distribution system requires systematic cost-effectiveness analysis and 
operational planning. Once the system is in place, regular performance monitoring is 
needed to ensure that the system functions as intended (Quick et al 1997:318). The 
major elements of a distribution system (as illustrated in figure 2.3) include the degree 
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of centralisation, distribution network, type of distribution system, re-supply intervals, 
storage, and movement of commodities to user facilities.  
 
 
 
 
 
 
Figure 2.3 Design characteristics of a distribution system 
(Quick et al 1997:320) 
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2.4.3.1 Degree of centralisation 
 
In a typical central supply model, commodity procurement and distribution are 
coordinated at the national level. Commodities received at the central medical stores 
are distributed to lower-level warehouses and onward to the health facilities. In a 
decentralised system, the districts or regions are responsible for receiving, storing, and 
distributing commodities. In some cases, they may also be responsible for procurement 
(Quick et al 1997:319). 
 
2.4.3.2 Distribution network 
 
Commodities are distributed from the primary to intermediate stores, which may be 
independent but often on the site of a regional or district hospital. Intermediate stores 
distribute commodities to individual health facility stores. Determining the optimum 
number of storage levels should be done according to programme needs and resource 
constraints, weighing benefits against cost considerations (Quick et al 1997:321). 
 
2.4.3.3 Type of distribution system 
 
An essential decision must be made as to which levels of the system should order 
commodities and which, if any, will passively receive commodities distributed from 
higher levels. There are two basic alternatives, namely the 
 
• pull system, in which each level determines what types and quantities of 
commodities it requires and then places orders with the central supply source 
• push system, in which supply sources at some level in the system determine 
what types and quantities of commodities are required and deliver these to lower 
levels 
 
When using a pull system, managers of operational units are expected to work out their 
own demand estimates and buffer stocks and submit requisitions to central stores 
indicating their requirements. In a push system, operational units are expected to supply 
certain stock and consumption information to the supply source, so that issuing officers 
can plan allocations (Quick et al 1997:323). 
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2.4.3.4 Re-supply intervals 
 
Once the choice between a push and a pull system has been made, the next step is to 
select an appropriate re-supply interval (Quick et al 1997:323). This will determine 
whether deliveries are made to user units quarterly, monthly, weekly, or at any other 
time. The optimum re-supply interval needs to be worked out depending on the 
following factors: 
 
• storage capacity at each level of the system 
• availability, order size, carrying capacity, and cost of transport 
• seasonal factors that affect transport reliability 
• staffing levels and competence of staff at each level of the system 
• other factors such as expiry dates, security against pilferage and locally relevant 
concerns 
 
2.4.3.5  Storage 
 
The geographic distribution of the population and health facilities determines where 
commodities are needed. Store locations should be chosen to make the most cost-
effective use of existing public and private transport networks. Stores at health facilities 
may consist of a simple storeroom with shelving. Storage facilities should always be 
protected against theft and damage by water, pest or fire. Well-sited stores are vital to 
the success of a distribution system (Quick et al 1997:324). 
 
2.4.3.6 Movement of commodities to user facilities 
 
Supplies may be moved between the warehouse and the receiving facility using two 
options: collection or delivery. In the case of the collection system, the receiving facility 
takes on the responsibility of collecting supplies from the warehouse. In a delivery 
system, the warehouse is responsible for delivering supplies with either in-house 
transport or a private-sector contract. The general advantages and disadvantages 
associated with collection and delivery are summarised in table 3.1. 
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Table 2.1  Comparison of delivery and collection systems 
 
System Advantages Disadvantages 
Delivery • If proper delivery routes, order 
intervals, and delivery schedules 
are in place, the total cost of 
transport will be less. 
• Deliveries of supplies can be 
combined with other important 
scheduled and compulsory visits 
to the field. 
• Commodity selection, assembly 
and packing operations can be 
scheduled and accomplished 
efficiently. 
• Needs reliable transport 
facilities. Outright purchase or 
leasing of vehicles gives rise to 
high capital and operating 
costs. 
• If the delivery route is long, 
there is the possibility of 
breakage and loss of quality. 
• Security lapses may occur due 
to lack of a responsible officer 
accompanying goods in many 
instances. 
• Health facilities may be closed 
when the delivery truck arrives, 
or there may not be a 
responsible officer on hand to 
receive supplies. 
• The delivery truck may be in a 
hurry to get to the next 
destination, making it difficult 
to check for short shipments, 
damage, and other problems 
before the truck departs. 
Collection • Provides an opportunity for 
issuing personnel to meet people 
from the field and discuss 
common problems, and for field 
officers to meet and exchange 
ideas among themselves. 
• Frees central-level staff from 
providing transport facilities to 
the field. 
• Provides greater incentives to 
obtain supplies regularly, since 
the facility is responsible for 
collecting supplies. 
• Allows field personnel to attend 
to other business in town. 
• Offers the possibility of a greater 
choice of methods of transport. 
• Allows better checking, handling 
and security of goods received. 
• Takes a lot of health facility 
staff time. 
• Time may be wasted waiting 
for the assembly of supplies, 
or supplies might not be ready 
for collection at the first visit. 
• Total cost of transport may be 
high. 
• Health centre personnel may 
tend to increase the frequency 
of visits for various reasons. 
 
 
2.4.3.7 Transport 
 
Transport is frequently the least reliable link in the distribution system and is often a 
source of great frustration. Transport planning requires the selection of the appropriate 
means of transport and the procurement and maintenance of vehicles or other 
conveyances. The best use of available transport should be made through careful route 
planning and delivery scheduling (Quick et al 1997:325). 
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2.4.3.8 Delivery schedules 
 
Good planning is needed to ensure that each facility receives supplies regularly and on 
time. A number of factors must be considered when determining the appropriate 
delivery intervals for each store and health facility. These factors include storage 
capacity of health care facility stores, cost per unit supplied, efficient vehicle usage and 
climatic factors (Quick et al 1997:325). 
 
2.4.4 Resources for distribution management 
 
In order to maintain an effective distribution system, an input of four key resources is 
required, namely a strong logistics team, suitably qualified staff, a reliable information 
system, and a good communication infrastructure (Quick et al 1997:326).  
 
2.4.4.1 The logistics team 
 
A logistics team should be established to be responsible for operational planning, 
implementation and monitoring of the logistics tasks. Team managers must stress the 
importance of improving commodity availability and reducing distribution costs. 
 
2.4.4.2 Staffing 
 
A distribution system cannot work unless there are enough suitably qualified staff 
members to run it. The logistics team must therefore determine the staffing levels 
required to administer and operate the commodity distribution system effectively. There 
must be sufficient funds available to recruit and train additional staff, if necessary. 
 
2.4.4.3 Information systems 
 
Reliable management information is vital for coordinating the distribution network. The 
information system consists of forms and procedures to record inventory levels, costs 
and sales processes, and receipts for issues of commodities. Forms, records, and 
reports are the core of the supply information system. All necessary forms should be 
available and all staff should be trained in their use. The record system may be manual 
or computerised. Reports should be prepared regularly by individual health units to 
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district offices, which report to regional offices, which report to the central office. Such 
reports are used to project commodity needs, revise budgets, and assess commodity 
use. 
 
2.4.4.4 Communication 
 
Effective communication is essential to a drug distribution system. Well-planned and 
operational telecommunications reduce the need for travel, save staff time, and reduce 
wear and tear on vehicles. The maximum use should be made of available 
telecommunication resources, and appropriate investments made in communication 
technology. The provision of a radio transmitter and a fax machine to a facility could 
help to contain travel costs. 
 
2.4.5 Performance monitoring and cost analysis 
 
Performance monitoring should be carried out regularly using appropriate indicators to 
ensure that system performance is maintained. Depending on the results of monitoring, 
frequent minor adjustments may be required to respond to changing needs. It is crucial 
to compile and analyse data on current operating costs in order to model the potential 
cost impact of various alternatives to the existing distribution system should there be a 
need to revise it. The first tasks in the evaluation of options are to calculate the in-house 
costs of the distribution system (storage space, stores operation, equipment, staff, stock 
holding expenses and transport, administrative overheads, upgrading and costs of 
contracting out) and then to estimate the costs of other alternatives for making 
comparisons (Quick et al 1997:327). 
 
2.4.6 Injection device distribution system in Uganda  
 
The Ugandan distribution system for medicines and equipment for government health 
units is designed around a central supply model, in which commodity procurement and 
distribution are coordinated at the national level. Commodities received at the national 
medical stores, an autonomous government agency, are distributed to lower-level 
health facilities through district warehouses.  
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Commodities are distributed from the national medical stores to intermediate stores 
located at the centre of each district. District stores then distribute the commodities to 
individual health facility stores. A pull system is in place in which health facility 
managers’ work out their demand estimates for syringes, injectable medicines and 
diluents and forward orders to National Medical Stores indicating their requirements. 
Delivery of ordered commodities from national medical stores to the district stores is 
scheduled for every two months. Stores at health facilities consist of a simple storeroom 
or a cupboard. Commodities are collected from district warehouses by the heads of 
health sub-districts who distribute these to the lower levels within their directorates. 
Each health sub-district has a vehicle used for the distribution.   
 
The main source of funding for health supplies is the government fund allocated to the 
districts for primary health care activities. Public health facilities can only source drugs 
and equipment from elsewhere when they are out of stock at the national medical 
stores.  
 
The faith-based (missions, religious organisations) health NGOs source their drugs and 
health supplies from Joint Medical Stores (or private pharmacies) from where each 
health care unit collects its supplies.  
 
2.5 THE SYNERGY MODEL 
 
The synergy model provides a viable model for health managers to use as a basis for a 
professional practice. The core concept of the synergy model is that the needs of 
patients and families influence and drive the characteristics or competencies of a health 
worker. Synergy results when the needs and characteristics of a patient, clinical unit or 
system are matched with a health worker’s competencies (AACN 2006:1).  
 
Each patient brings a unique set of characteristics to the health care situation. Eight 
characteristics are associated with patients experiencing critical events: resiliency, 
vulnerability, stability, complexity, resource availability, participation in care, participation 
in decision-making, and predictability. These characteristics underlie the patient’s 
needs. Depending on each patient’s needs, certain competencies of health care 
workers are required for providing care to acute and critically ill patients and their 
families. The health care worker characteristics of the synergy model are clinical 
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judgement, advocacy and moral agency, caring practices, collaboration, systems 
thinking, response to diversity, clinical inquiry, and facilitation of learning. Synergy 
occurs and optimal outcomes may result when the health care provider’s competence 
complements the patient’s needs (Becker, Kaplow, Muenzen & Hartigan 2006:131).  
 
2.5.1 The AACN synergy model for patient care 
 
During the 1990s, the American Association of Critical Care Nurses (AACN) 
Certification Corporation convened a think tank that developed a conceptual framework 
for certified practice. The framework was based on the premise that certified practice is 
more than tasks and should be grounded in nurses’ meeting the needs of patients and 
optimising patients’ outcomes (Becker et al 2006:131).  
 
Outcomes are considered patients’ conditions measured along a continuum. Six major 
quality indicators were identified under the synergy model (Becker et al 2006:133):  
 
• satisfaction of patients and their families  
• rate of adverse incidents  
• complication rate  
• adherence to a discharge plan  
• mortality rate  
• each patient’s length of stay 
 
The synergy model is congruent with three levels of outcomes of health care: those 
derived from the patient, the health care worker and the health care system (see figure 
2.5). 
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Figure 2.4 The AACN synergy model for patient care 
(Becker et al 2006:134) 
 
Outcomes derived from the patient include functional changes, behavioural changes, 
trust, satisfaction, comfort and quality of life. Outcomes derived from nursing 
competences include psychological changes, the presence or absence of 
complications, and the extent to which treatment goals were reached. Outcome data 
derived from the health care system include readmission rates, length of stay, and cost 
utilisation per case (Becker et al 2006:133). According to Kerfoot (2002:1), managers in 
health care must address all three these areas in order to create excellence in patient 
care. The manager’s obligation is to create the environment in which good people can 
provide good care.  
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2.5.2 Assumptions of the synergy model 
 
Becker et al (2006:133) state that there are nine basic assumptions of the synergy 
model, which provide the guide for identification of characteristics of patients and 
competencies of nurses in the model, namely 
 
• Each patient is a biological, social and spiritual entity who is at a particular 
developmental stage. The whole patient (body mind and spirit) must be 
considered. 
• Each patient, the patent’s family and the community contribute to providing a 
context to the nurse-patient relationship. 
• Patients can be described by a number of characteristics. All characteristics are 
connected and contribute to each other. Characteristics cannot be looked at in 
isolation. 
• Nurses can be described in a number of dimensions. Interrelational dimensions 
paint a profile of the nurses. 
• A goal of nursing is to restore each patient to an optimal level of wellness as 
defined by the patient. 
• Nurses create the environment for the care of patients. The context or 
environment of care also affects what a nurse can do. 
• Impact areas are interrelated, and the nature of the interrelatedness may change 
as a function of experience, situation or setting changes. 
• Nurses may work to optimise outcomes for patients, patients’ families, health 
care providers, and the health care system/organisation. 
• Nurses bring their background to each situation, including various levels of 
education/knowledge and skills/experience. 
 
2.5.3 The synergy model in practice 
 
The synergy model is an organisational framework to organise the work of the health 
care worker and patient care. According to Kerfoot (2002:2), the model describes the 
characteristics of the patient, the health worker and the organisation within which the 
care is given. It provides a compelling picture of how the work of patient care can be 
organised to provide a “safe passage” for the patient through the health care system. It 
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also provides a framework for patient assessment, career advancement for the health 
care worker and the organisation of work between departments.   
 
2.5.4 The synergy model applied to injection safety 
 
In order to ensure injection safety, the patients’ needs should be viewed as the desire to 
avoid infections acquired through the use of unsafe injections. Health care workers’ 
competencies to fulfil patients’ needs entail skills to administer safe injections by 
avoiding the re-use of syringes, proper disposal of used sharps such as contaminated 
syringes and needles, ensuring proper forecasting and ordering of required injection 
commodities, timely reporting to higher levels, and advocacy for timely and adequate 
supplies of commodities. Health managers then support the synergised care through 
the development of the required infrastructure, provision and maintenance of vehicles 
for delivery of supplies, provision of fuel for running the vehicles, developing the 
communication infrastructure, and recruiting and supervising staff.  
 
2.6 CONCLUSION 
 
This chapter discussed the literature review, which indicates that the subject of injection 
safety has been widely researched. Unsafe injections are common, especially in the 
developing world exposing many people to blood-borne infections like HIV/AIDS, 
Hepatitis B and Hepatitis C. Among the reasons for the administration of unsafe 
injections is the lack of adequate supplies, resulting in the re-use of injection equipment 
without sterilisation. Health care workers also lack adequate skills required for 
administering safe injections. The distribution system of health commodities must be 
carefully designed in order to ensure timely and adequate supplies of injection devices 
to health care facilities. 
 
Chapter 3 describes the research methodology of this study. 
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CHAPTER 3 
 
Research design and methodology 
 
 
3.1 INTRODUCTION 
 
Research methodology is the application of all steps, strategies and procedures for 
gathering and analysing data in a research investigation in a logical and systematic way 
(Burns & Grove 2001:26). The selection of the research methodology or strategy is the 
core of a research design and is probably the single most important decision the 
investigator has to make. The research methodology must include the research design, 
definition and selection of the population of interest, the definition of variables 
(characteristics of the individuals in the population), their status and relationships to one 
another, data-collection instrument and data-analysis procedure (WHO 2001a:11).  
 
The selection of the research methodology for this study was guided by the desire to 
achieve the specific objectives. The specific objectives guiding this study were to 
 
• Determine whether health care facilities in the Mpigi district of Uganda have 
sufficient quantities of injectable medicines, diluents, single use injection devices 
and safety boxes for therapeutic purposes. 
• Investigate the factors that lead to stock depletion of injection devices at health 
care facilities in the Mpigi district of Uganda. 
 
3.2 RESEARCH DESIGN 
 
Mouton (2001:55) defines a research design as a plan or blueprint of how one intends 
to conduct the research. According to Burns and Grove (2001:223), the design guides 
the researcher in planning and implementing the study in a way that is most likely to 
achieve the intended goal.  
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The research design used for this study was quantitative, observational, descriptive and 
cross-sectional. These terms are described below.  
 
3.2.1 Quantitative 
 
A quantitative design was used to conduct this study. In quantitative studies, 
researchers use deductive reasoning to generate hunches that are tested in the real 
world. The researcher applies a scientific approach to the study of a question of interest 
by moving in a systematic fashion from the definition of a problem and the selection of 
concepts on which to focus, through the design of the study and collection of 
information, to the solution of the problem (Polit & Hungler 1995:12). The researcher 
also controls the study by imposing conditions on the research situation so that biases 
are minimised. 
 
In quantitative research, evidence is gathered according to a specified plan, using 
formal instruments to collect the needed information (Somekh & Lewin 2005:215). The 
information gathered is quantitative, implying that it is numeric information that can be 
analysed by statistical procedures (Polit & Hungler 1995:13).  
 
In this study, quantitative information was gathered on injection devices at health care 
units and the distribution system thereof in the Mpigi district using structured interviews 
and observations.  The data were analysed using statistical procedures and inferences 
made as to the level of injection device security in the Mpigi district in Uganda and the 
challenges encountered by the distribution system. 
 
3.2.2 Observational 
 
Scientific observation involves the systematic selection, observation and recording of 
behaviours, events, and settings relevant to a problem under investigation (Polit & 
Hungler 1995:364; Somekh & Lewin 2005:138-139).  
 
In this study, selected behaviour and events related to injection commodities and their 
distribution system were observed and recorded during the period of data collection in 
the Mpigi district in Uganda.  
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3.2.3 Descriptive 
 
When a study is not structured formally as an analytical or experimental study, implying 
that it is does not aim specifically to test a hypothesis, it is called a descriptive study, 
and belongs to the observational category of studies (WHO 2001a:16).   In addition, 
Salks and Allsop (2007:6) describe a descriptive study as “providing current information 
or intelligence on a problem”. 
 
The purpose of descriptive studies is to observe, describe and document aspects of 
situations as they naturally occur, sometimes as a starting point for hypothesis 
generation or theory development (Polit & Hungler 1995:195-196).  
 
In this study, observations of injection devices and aspects of their distribution system 
were made, described and documented.  
 
3.2.4 Cross-sectional  
 
Cross-sectional studies entail the collection of data from a cross-section of the 
population, which may comprise the whole population or a proportion (sample) of it 
(WHO 2001a:17).  Somekh and Lewin (2005:216) point out that cross-sectional studies 
involve the collection of quantitative data on at least two variables at one point in time 
and from a number of cases.  The WHO (2001a:17) concurs, adding that cross-
sectional studies provide a prevalent rate at a particular point in time (referred to as 
point prevalence) or over a period of time (referred to as period prevalence).  
 
In this study, data was collected from a sample of health care facilities in Mpigi district 
and the point prevalence of injection device security at the facilities was determined at 
the specific time of data collection. 
 
3.3 POPULATION AND SAMPLE  
 
This section describes the study population and how the sample of health care units 
was selected from the population for inclusion in the study. 
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3.3.1 Population 
 
According to Bryman (2001:85), a population is the totality of persons, events, 
organisation units, case records or other sampling units from which the sample is 
selected and with which the research problem is concerned. The population can also be 
regarded as the group to which results of a study are generalised (Trochim 2006:32).  In 
addition, Somekh and Lewin (2005:217) refer to a population as a “complete set of units 
being studied when time, costs and accessibility often prohibit the collection of data 
from every member or about every item”. 
 
The population for this study comprised all health care facilities administered by the 
Government of Uganda and NGO health care units in Mpigi district.  
 
3.3.2 Sampling frame 
 
Once the study population is identified, a listing of the accessible population from which 
the sample will be drawn is obtained. This is referred to as a sampling frame (Trochim 
2006:32). The sampling frame for this study comprised a list of government health care 
facilities and NGO health care units at the various levels of the health care structure. 
The Mpigi district has 47 government health care units and 15 NGO health care units, 
making a total population of 62 health care units. Table 3.1 summarises the sampling 
frame. 
 
Table 3.1 Sampling frame for health care units in the Mpigi district 
 
Level of health unit 
Ownership 
Total number Government NGO 
Health care centre II 28 6 34 
Health care centre III 16 8 24 
Health care centre IV 2 0 2 
Hospital 1 1 2 
Total 47 15 62 
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3.3.3 Sampling and sample  
 
A sample is the segment of the population that is selected for investigation (Bryman 
2001:85). According to Somekh and Lewin (2005:218), a sample is studied in order to 
understand the population from which it is drawn. A complete coverage of the 
population is seldom possible and even if it were possible, time and cost considerations 
usually make this a prohibitive undertaking. Sampling is the science and practice of 
selecting information from populations in a manner that allows defensive inferences to 
be drawn from those data (Saks & Allsop 2007:157). The use of samples may therefore 
result in more accurate information because with a sample, time, money and effort can 
be concentrated to produce better-quality research information (De Vos et al 2002:199).  
 
The method of sample selection may be based on a probability or non-probability 
approach. A probability sample is one that has been selected using random selection so 
that each unit in the population has a known chance of being selected (Bryman 
2001:85). The best-known kinds of probability sampling are stratified random sampling, 
simple random sampling, systematic sampling, cluster sampling, and panel sampling 
(De Vos et al 2002:203).   
 
This study employed stratified random selection as the sampling strategy. In this 
strategy, the population is first divided into two or more strata or subgroups that are 
mutually exclusive, the members of which are homogeneous or across important groups 
in the population with regard to some characteristic such as level of service (Saks & 
Allsop 2007:159). The desired number of units is then selected proportionately within 
each of the different strata. This means selecting each sample according to the number 
of units in that stratum, implying larger samples from larger strata, and smaller samples 
from smaller strata. This enhances representativeness of all strata of the sample (De 
Vos et al 2002:205; Polit & Hungler 1995:286; Saks & Allsop 2007:159). 
  
Health care units in the Mpigi district are stratified according to the level of service as 
hospital, health care centre IV, health care centre III and health care centre II. Since the 
membership of each stratum of health care units was unequal, a disproportionate 
sampling design was used in order to obtain sufficient numbers of sampling units from 
each stratum and therefore sharpen the precision and representativeness of the final 
sample (Polit & Hungler 1995:288; Saks & Allsop 2007:160).  
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Because of the small number of hospitals (n=2) and health care centre IVs (n=2) in the 
district, all the hospitals and health care centre IVs were included in the study. The 
remainder of the health care units were selected from a list of health care centre IIIs and 
health care centre IIs by proportionate stratified random sampling. Since the sampling 
frame had 34 health care centre IIs and 24 health care centre IIIs, health care units 
forming the sample from these two strata were selected in a ratio of 7:5. Storekeepers, 
persons in charge of health sub-districts, injection providers and patients found at the 
sampled units were selected for interviews. Information on stock levels and stock 
management was obtained by reviewing stock cards, requisition and issue vouchers 
and taking physical counts of items at the selected facilities.  This information was 
recorded on checklists. 
 
3.3.4 Sample size estimation 
 
According to Somekh and Lewin (2005:218), the sample size is the crucial factor rather 
than the relative size or proportion of the population sampled.  Saks and Allsop 
(2007:158) state that the larger the sample size, the smaller the error will be in 
estimating the characteristics of the whole population, but the more it will cost to 
administer a survey and analyse the data.  The sample size is dependent on the 
accuracy required and the likely variation of the population characteristics being 
investigated. 
 
In this study, an analytical (scientific) approach was used to determine the sample size 
for this study. According to Salks and Allsop (2007:219), this approach depends on the 
assessment of errors of interference and a desire to minimise sampling error. Sampling 
error measures the amount of variability between sample results; the less variable the 
sample results are, the closer the sample results are to the population results. The main 
determinant of the sample size is therefore, how accurate the results need to be and 
depends on whether the study is descriptive or analytical (WHO 2001a:74). 
 
This study was descriptive in design with the objective of obtaining an estimate of the 
population parameter, which means the proportion of health units where injection device 
security had been achieved. According to the WHO (2001a:76), the calculation of the 
sample size for a descriptive study depends on two parameters: the width of the 
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confidence interval and the confidence coefficient. The sample size (n) can be 
calculated using this formula:   
 
n = (z1-α/ δ) 2 p (1-p) 
 
Where 
1-α is confidence level 
δ is confidence interval 
p is prevalence of population parameter 
 
The Mpigi district consists of 62 health care units that fell under the inclusion criteria of 
this study. Assuming simple random sampling, with injection device security achieved at 
50% of the health units (prevalence), with a level of precision of ±10% and a confidence 
level of 95%, the sample size was calculated as 38 health units. Therefore, 38 health 
care units were selected for the study. Using disproportionate random sampling, two 
hospitals, two health care centre IVs, 20 health care centre IIs and 14 health care centre 
IIIs were selected. An additional 10% of the sample size units (two health care centre IIs 
and two health care centre IIIs) were added to the selected health care units to 
compensate for possible non-respondents due to failure to reach some health care units 
or closure of roads during the data-collection period. This procedure was consistent with 
the random sampling methodology (Israel 2003:4). 
 
3.4 DATA-COLLECTION INSTRUMENTS  
 
Structured interview schedules and structured observation checklists about the 
availability of injection commodities and challenges faced by the distribution system 
were used for this study. Research data, particularly in quantitative studies, are often 
collected according to a structured plan that indicates what information is to be gathered 
and how to gather it. Structured methods yield data that are relatively easy to quantify 
and analyse. Structured methods also enhance the objectivity of the data collected by 
eliminating bias due to the researcher’s personal feelings or beliefs (Polit & Hungler 
1995:310-311).  
 
An interview schedule is a list of more or less structured questions that are read by an 
interviewer (with or without probing) in interrogating a respondent either face to face or 
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via telephone or post (Somekh & Lewin 2005:220). The interviewer then records the 
respondent’s responses either verbatim (for open-ended questions) or according to pre-
specified (or pre-coded) answers or categories thereof (WHO 2001a:171).  
 
A checklist is a list of categories of behaviours or events that may or may not be 
manifested by the subjects. The observer’s task is to watch for instances of the 
behaviours or events and to tick off the appropriate behaviours or events to designate 
their occurrence (Polit & Hungler 1995:310-372).  
 
3.4.1 Instrument development 
 
The interview schedules and checklists for structured observations were developed 
from those used in similar studies by the WHO (2003c:121), the Ministry of Health of 
Uganda (2003:87) and the MMIS (2005:4) project in assessment of injection safety. 
Quick et al’s (1997:331) assessment guide for medicine distribution management was 
also consulted. The items included in the interview schedules and the checklists were 
carefully chosen to elicit responses that were specific to the research objectives. A 
combination of open-ended and closed questions was used for the interview schedule 
to offset the strengths and weaknesses of each type of question (Polit & Hungler 
1995:336).  
 
The language of communication was English and in case of patients’ exit interviews, 
translation to the appropriate local language was done whenever necessary. The 
interview schedules and structured observation checklists included questions on the 
following:  
 
• availability of injection devices 
• distribution infrastructure 
• delivery schedules 
• forecasting and ordering of injection devices 
• record keeping and reporting, communication 
• the use of injection devices. 
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3.4.2 Reliability of the research instruments 
 
The reliability of an instrument that yields quantitative data is a major criterion for 
assessing its quality and accuracy. In general, reliability refers to the extent to which the 
independent administration of the same instrument consistently yields the same (or 
similar) results under comparable conditions (De Vos et al 2002:168). Two aspects of 
reliability were used in this study, namely internal consistency and equivalence. An 
instrument is said to be internally consistent to the extent that all its subparts are 
measuring the same characteristic (Polit & Hungler 1995:415). Questions and 
observations that were relevant to the subject of investigation were used in order to 
enhance the reliability of the instrument.   
 
Equivalence refers to the extent to which two different observers using the instrument 
yield equivalent measurements of the same traits in the same people or situations (Polit 
& Hungler 1995:416). Careful training, development of clearly defined and non-
overlapping categories and the use of a small number of categories enhanced the 
accuracy of observer ratings and classifications. 
 
3.4.3 Validity of the research instruments 
 
Validity refers to the ability of an instrument to measure exactly what it is supposed to 
measure (De Vos et al 2002:167). Content validity is concerned with the sampling 
adequacy of the items for the construct that is being measured. This was assured by 
using questions from various instruments that had been used in other similar studies. 
The instruments were also subjected to evaluation and approval by the study 
supervisors. A combination of observations and interviews was used to check the 
accuracy of responses from interviewees and therefore minimise biases (Brink & Wood 
1998:299).  
 
3.4.4 Structure of the research instruments 
 
Six research instruments were used for data collection as outlined below: 
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• Instrument 1: Structured interview schedule for the person in-charge of the health 
sub-district 
• Instrument 2:  An inventory of equipment and supplies at the facility (stores) by 
means of a checklist 
• Instrument 3:  Structured interview schedule for the store keeper 
• Instrument 4:  Checklist of observations of equipment and supplies at the facility 
• Instrument 5:  Structured interview schedule for the provider of medicines by way 
of injections 
• Instrument 6:  Structured interview schedule for the exit interview with patients. 
 
3.4.5 Pre-testing of the research instrument 
 
The research instruments were pre-tested on a small number of respondents who were 
comparable to the sample of correspondents but who were not part of it (WHO 
2001a:178). This ensured that errors of whatever nature could be rectified immediately 
at little cost. After the necessary modifications had been made following the pre-test, the 
instruments were administered to the full sample (De Vos et al 2002:177). 
 
The research instruments in this study were pre-tested at five health care facilities in the 
Mpigi district, which were excluded from the main study. Actual data were collected 
during the pre-testing and analysed carefully to ascertain whether or not they answered 
the research questions. The results of the pre-testing were used to refine the research 
instruments before using them in the actual study.  
 
3.6 DATA COLLECTION 
 
Permission to conduct this study was granted by the Research and Ethics Committee of 
Makerere University Medical School, Kampala, Uganda. Permission was also requested 
from and granted by the District Health Officer of the Mpigi district to visit the respective 
health care units (see Annexure A and C). A team of four research assistants was 
carefully selected and properly trained for the data collection. The research assistants 
were given instructions about confidentiality of information, patience and perseverance, 
being pleasant, the need to have a positive attitude, and the importance of following 
instructions. The researcher supervised the research assistants throughout the data 
collection period and process. The researcher checked the completed instruments at 
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the end of each day for omissions, incomplete answers, unclear statements or illegible 
writing. The research assistants were requested to revisit the health care units to collect 
missing or unclear information whenever this was deemed necessary. Data were 
collected for a period of five days, during January 2008. 
 
3.7 ETHICAL CONSIDERATIONS 
 
According to De Vos et al (2002:63), ethics refer to a set of moral principles that are 
suggested by an individual or group and are widely accepted, and offer rules and 
behavioural expectations about the most correct conduct towards experimental subjects 
and respondents, sponsors and other researchers. A number of key phrases describe 
the system of ethical protections that have been created to try to protect the rights of 
research participants. According to Trochim (2006:22), the principle of voluntary 
participation requires that people should not be coerced into participating in research. 
Closely related to the notion of voluntary participation is the requirement of informed 
consent. Essentially, this means that prospective research participants must be fully 
informed about the procedures and risks involved in the research and must give their 
consent to participate.  
 
Ethical standards also require that researchers should not put participants in situations 
where they might be at risk of harm as a result of their participation. Harm can be 
defined as both physical and psychological (De Vos et al 2002:64). The privacy of 
research participants should be ensured during the research process. According to 
Trochim (2006:22), two standards are applied in order to help protect the privacy of 
research participants:  
 
• First, a researcher should guarantee confidentiality by assuring participants that 
their identifying information will not be made available to anyone who is not 
directly involved in the study.  
• The second standard is the principle of anonymity, which essentially means that 
the participant will remain anonymous throughout the study. 
 
The principles of voluntary participation, informed consent, minimisation of harm, 
confidentiality and anonymity were strictly upheld in this study. The risk of harm was 
minimal because the study was non-invasive, involving observation of participants and 
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interviewing them. The scope and benefits of the study were explained to all the 
participants prior to being interviewed, using an introductory letter from the Mpigi district 
health officer and a consent form and thereafter written consent to participate in the 
interview was sought (Mouton 2001:239-247). The participants were also assured of 
anonymity and confidentiality. Anonymity was maintained by not recording the 
interviewees’ names on the interview schedules, and the data collected was kept in the 
researcher’s possession in a safe place to ensure confidentiality.  
 
According to Trochim (2006:22), researchers should consider all relevant ethical issues 
in formulating research plans so that they are protected against potential legal 
implications of neglecting to address important ethical issues of participants. This is 
usually done through an Institutional Review Board (IRB), a panel of persons that 
reviews proposals with respect to ethical implications and decides whether additional 
actions need to be taken to assure the safety and rights of participants. The Institutional 
Review Boards of Makerere University Medical School, Uganda and the Department of 
Health Studies, University of South Africa reviewed and approved the research proposal 
for this study. Permission was also sought from the District Health Officer of the Mpigi 
district to visit the respective health units. Copies of permissions and the introductory 
letter to the participants and the consent form are attached in Annexures A, B, C and D.  
 
3.8 LIMITATIONS OF THE STUDY 
 
Although measures were taken to minimise errors through using structured instruments 
and training data collectors, the information obtained was vulnerable to interviewer, 
interviewee and observer distortions and biases.  
 
Another limitation was that being a cross-sectional study the state of affairs found on the 
day of visit might have been influenced by recent special activities or events in the 
district. In addition, Mpigi district is peri-urban in nature and therefore the results 
obtained could not necessarily be generalised to rural districts. 
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3.9 DATA ANALYSIS  
 
Data analysis entails the breakdown of data into constituent parts to obtain answers to 
research questions and to test research hypotheses (De Vos et al 2002:223). In most 
social research, data analysis involves three major steps, namely cleaning and 
organising the data for analysis, describing the data and testing hypothesises and 
models (Trochim 2006:101 ).  
 
Data preparation involves checking or logging the data in; checking the data for 
accuracy; entering the data into the computer; transforming the data; and developing 
and documenting a data base structure that integrates the various measures (Trochim 
2006:101). With the help of a statistician, the Epi-Info computer program was used for 
data entry and the Statistical Package for Social Sciences (SPSS), version 12 was used 
for analysis. 
 
Descriptive statistics were used to describe the basic features of the data in the study, 
providing simple summaries about the sample’s measures. Together with simple 
graphics analysis, descriptive statistics form the basis of quantitative analysis of data 
(Trochim 2006:101). Descriptive statistics were derived from the formed SPSS 
database to analyse and interpret the data. Descriptive statistics were used because 
this was a descriptive study, which aimed at describing the availability of commodities 
and challenges in their distribution at the respective health facilities. The proportion of 
health facilities where injection device security had been achieved was also determined. 
 
3.10 CONCLUSION 
 
This chapter covered the research design and methodology and described the 
population, sampling and sample, research instrument, data collection, ethical 
considerations, study limitations and data analysis in detail. 
 
Chapter 4 presents and discusses the results of this study. 
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CHAPTER 4 
 
 
Data analysis and interpretation 
 
 
4.1 INTRODUCTION 
 
This chapter discusses the data analysis and interpretation and the findings of this study. 
The data was analysed and the results were presented with the aid of percentages, tables 
and graphs, where possible.  
 
The overall aim of this study was to identify the challenges encountered in maintaining an 
effective distribution of injection devices in the Mpigi District of Uganda. Variables such as 
the availability, the use and the distribution system of injection devices were used in order 
to accomplish the research objectives. 
 
The specific objectives guiding this study were to: 
 
• Determine whether health care facilities in the Mpigi district of Uganda have 
sufficient quantities of injectable medicines, diluents, single use injection devices 
and safety boxes for therapeutic purposes. 
• Investigate the factors that lead to stock depletion of injection devices at health care 
facilities in the Mpigi district of Uganda. 
 
The data collection and discussion of the results were done using a set of six instruments 
outlined below: 
 
• Instrument 1: Structured interview schedule for the person in-charge of the health 
sub-district 
• Instrument 2: An inventory of equipment and supplies at the facility (stores) by 
means of a checklist 
• Instrument 3: Structured interview schedule for the store keeper 
• Instrument 4: Checklist of observations of equipment and supplies at the facility 
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• Instrument 5:Structured interview schedule  for the provider of medicines by way of 
injections 
• Instrument 6: Structured interview schedule for the exit interview with patients 
 
4.2  PRESENTATION OF FINDINGS 
 
Data was collected from 38 health care units in the Mpigi district. The research assistants, 
who were guided and introduced to the selected health care unit staff by members of the 
District Health Team, filled in the research instruments. Figure 4.1 illustrates the distribution 
of health care facilities visited. 
 
HCII
53%HCIII
37%
HCIV
5%
HOSP
5%
.
 
Figure 4.1 
Distribution of health care units by level (N=38) 
 
Of the assessed health care units, 53% (n=20) were at health centre II level (HCII); 37% 
(n=14) were at level III (HCIII); 5% (n=2) were at level IV (HCIV), and 5% (n=2) were at 
hospital level. All the HCIVs (2) and the hospitals (n=2) in the Mpigi district were selected 
for the study. Of the 38 health care units, 26.3% (n=10) were NGO health care units while 
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73.7% (n=28) were public health care units. Figure 2 illustrates the distribution of the 
selected health units by ownership. 
Ownership: Public or NGO?
73.7%
26.3%
Public NGO
 
Figure 4.2 
Distribution of health care units by ownership (N=38) 
 
The data collected from all 38 health care units were subjected to computer-aided analysis, 
in line with the research questions of the study and with the assistance of a statistician.  
 
4.2.1 Interview of the person in-charge of the health sub-district (instrument 1) 
 
The four heads of health sub-districts in the Mpigi district were interviewed to find out the 
challenges affecting the distribution of injection devices to the lower level health care units 
under their jurisdiction as managers. According to Kerfoot (2002:2) and in line with the 
synergy model which guided this study, health managers should support the synergised 
care through the development of the required infrastructure, provision and maintenance of 
vehicles for delivery of supplies, provision of fuel for running the vehicles, developing the 
communication infrastructure, recruiting and supervising staff.  
 
4.2.1.1 Type of distribution system 
 
The persons-in-charge of the health sub-districts in Mpigi were asked whether the 
distribution to lower levels was done through a push or pull system. All four respondents 
reported that distribution of health care products to lower levels was done through a pull 
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system. According to Quick et al (1997:323), each level in a pull system determines the 
types and quantities of commodities they require and places orders with the supply source. 
This is consistent with the Ministry of Health of Uganda’s (2005a:107) policy that managers 
of health care units should work out their own demand estimates and submit requisitions to 
the national medical stores. 
 
4.2.1.2  Timeliness in submission of requisitions 
 
A pull system requires that managers of lower level health care units submit requisitions to 
the supply source. The study showed that in two health care sub-districts, 80% to 100% of 
the lower health care units reportedly submitted requisitions on time while only between 
50% and 59% of the lower health care units in the other two health sub-districts submitted 
requisitions on time. Timely requisition of requirements is necessary to ensure that re-
supplies of health care commodities are delivered to health care units in time to avoid stock 
depletions.   
 
4.2.1.3 Method of communication  
 
Three (75%) out of the four health sub-districts managers reported that communication to 
lower level health care facilities was done by telephone while three (75%) health sub-
district managers also reported that they made physical visits to the lower level health care 
units. None of the four health sub-districts reported having a radio link or fax for 
communication to the lower level health care units. According to Quick et al (1997:327), 
efficient telecommunication is essential for an effective health care commodity distribution 
system because it reduces the need to travel, saves staff time, and reduces the wear and 
tear of the distribution vehicles. In addition, reports and requisitions are received on time 
for decision making and timely processing of orders, respectively, in order to avoid stock 
depletions. 
 
4.2.1.4 Method of delivery 
 
Supplies may be moved between the warehouse and the receiving facility using a 
collection or delivery distribution system. Two (50%) of the four health sub- districts 
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reported that they delivered health care commodities to lower level health care units while 
the delivery system in the other two (50%) health sub- districts was reportedly by collection 
by the lower level health care units. According to Quick et al (1997:326), a delivery system 
offers the opportunity for higher levels to supervise fieldwork while having the disadvantage 
of requiring investment in reliable transport facilities. A collection system, on the other 
hand, provides an opportunity for issuing personnel to meet people from the field and 
discuss common problems while the cost of transport to the lower facility staff may be high. 
 
4.2.1.5  Frequency of deliveries 
 
The two health sub-districts that reported that they operated a delivery system were asked 
how often deliveries were made to the lower level health care facilities. One (50%) health 
sub-district manager reported that deliveries were made quarterly while the other health 
care sub-district reported making deliveries semi-annually. According to the Ministry of 
Health of Uganda (2003:30), health care units are supposed to receive supplies on a bi-
monthly basis. Late delivery of supplies to health care units could cause stock depletions if 
the health care unit did not anticipate the delay. 
 
 4.2.1.6  Mode of transport  
 
The persons-in-charge of the four health sub-districts were asked about the modes of 
transport used to deliver supplies to lower level health care units. All four health sub-
districts reported that a district-managed vehicle was used while public transportation was 
reported by two health sub-districts. According to Quick et al (1997:325), transport is often 
the least reliable link in the distribution system, causing great frustration. Transport 
planning is therefore important if health care commodities are to reach the user health care 
facilities in a timely manner to avoid stock depletions. 
 
4.2.1.7  Availability of distribution vehicles and fuel 
 
Although all (100%) the health sub-district managers (n=4) reported that the vehicles used 
for distribution of supplies to the lower level health care facilities were available, there was 
not enough fuel to run them. According to the Ministry of Health of Uganda (2003:32), 
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shortages in funding for fuel often makes distribution difficult and this could lead to late 
delivery of health care commodities to user health care units, causing stock depletions. 
 
4.2.1.8  Monitoring and evaluation of distribution costs 
 
Two (50%) persons-in-charge of health sub-districts reported that they had in place a 
system for monitoring and evaluating distribution costs of supplies. The remaining 2 (50%) 
health sub-district managers reported that they did not have an effective system for 
monitoring distribution costs. Analysis of data on the current operating costs of the 
distribution system is necessary so that the current costs can be compared with costs of 
the alternative options (Quick et al 1997:327). This information helps the health care unit 
managers to operate an efficient and cost effective distribution system.  
 
4.2.1.9  Availability of private sector pharmacies  
 
All the persons-in-charge of the health sub-districts (n=4) reported that there were no 
private sector pharmacies within the catchment areas of their lower level health care units. 
In Burkina Faso, Logez et al (2005:1) showed that implementation of pharmaceutical 
depots next to public health care facilities increased geographical access to essential 
medicines and basic supplies, such as syringes and needles, contributing substantially to 
safer injection practices. The presence of private pharmacies within the catchment areas of 
health care facilities would be expected to fill the stock gap during stock depletions at 
health care facilities thereby supplementing the public sector distribution system. 
 
4.2.1.10  Availability of private sector storage and transport providers 
 
Three (75%) of the health sub-district managers reported that there were no private sector 
storage and transport providers that could be used for handling supplies and delivering 
services to areas where they are needed. According to Quick et al (1997:330), the private 
sector is able to distribute drugs more efficiently than the public sector and with a well-
developed private sector it might be appropriate to contract out both storage and 
distribution to a private company. 
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4.2.1.11  Physical capacity of health care facility stores 
 
Three (75%) persons-in-charge of the health sub-districts reported that the physical 
capacity of each health care facility store had sufficient space to handle the volume of 
supplies distributed to them. Only one (25%) person-in-charge of a health sub-district 
reported that the physical capacity of the health care facility stores in his health sub-district 
was not adequate. According to Quick et al (1997:324), available storage space should 
always be greater than the calculated maximum stock holding to allow for emergencies and 
for program expansion. 
 
4.2.1.12    Problems affecting regular supply 
 
The survey team interviewed the four persons-in-charge of the health sub- districts of the 
Mpigi district to find out the problems affecting the regular supply of products to health care 
units. Each person’s response was recorded and the responses are summarized in table 
4.1. 
 
Table 4.1:  Problems affecting regular supply of products to health care units 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Problem 
Frequency 
(N=4) Percent 
Lack of transport 1 25 
Lack of allowances for drivers 1 25 
Lack of support staff for loading and offloading supplies 1 25 
Fuel not enough 2 50 
Stock depletion 1 25 
Delay in submitting requisitions 2 50 
Late delivery from NMS 2 50 
Poor service levels 1 25 
Inadequate funding 1 25 
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Table 4.1 shows that 50% (n=2) of the health sub-districts mentioned the delay in 
submission of orders by lower level facilities, the lack of fuel for running distribution 
vehicles, and the delay in delivering goods to the district by the national medical stores as 
problems affecting the regular supply of products to health care facilities. One (25%) of the 
persons in-charge of the health sub-districts mentioned lack of transport, lack of 
allowances to pay drivers, lack of support staff for loading and offloading supplies, stock 
depletion, delivery of less items than ordered and inadequate funding as the other 
problems affecting the regular supply of commodities to the health care facilities. 
 
According to the WHO (2000:2), eradication of the re-use of syringes and needles without 
sterilisation requires an efficient distribution system to ensure the continuous, sufficient 
availability of injection equipment and infection control supplies in all health care facilities.  
 
4.2.1.13  Support required to streamline the distribution of commodities 
 
The heads of the health sub-districts were asked what kind of support they required in 
order to streamline the distribution of commodities to the health care units. Table 4.2 
summarises their responses. 
 
Table 4.2: Support required in streamlining the distribution system (N=4) 
 
Support required Frequency Percentage 
Provision of fuel for the distribution vehicles     2 50 
Delivery of commodities directly to the health sub 
districts 2 50 
Timely delivery 2 50 
Improve transport infrastructure 1 25 
Provide allowances for drivers 1 25 
 
 
The results show that 50% (2) of the heads of the health sub-districts needed support in 
the form of the provision of fuel to run the distribution vehicles. Two (50%) respondents 
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mentioned the need to deliver supplies directly to the health sub-district stores by the 
national medical stores. Currently, the national medical stores deliver commodities to the 
district store from where the health sub-districts collect. Two (50%) respondents mentioned 
that there should be timely delivery of commodities to the district by the national medical 
stores in order to improve the distribution system of health care commodities and thereby 
avoid stock depletions at the health care facilities. One (25%) of the respondents stated 
improvement in the transport facilities and the provision of allowances for the drivers. 
 
4.2.2  An inventory of equipment and supplies at the facility store (instrument 2) 
 
This instrument was used to determine the availability of injection devices at the facility on 
the day of the survey and three months prior to the survey. The inventory records required 
for proper stock management were also scrutinized in order to identify the problems that 
could lead to stock depletions of injection devices at the health care facilities. 
 
4.2.2.1  Availability of stock card or register 
 
The commodity stores at each of the selected health care facilities were visited in order to 
observe the availability of stock cards or registers used to manage each of the items 
selected for the study which included: safety boxes for the disposal of contaminated sharps 
such as used syringes and needles; auto-disable syringes (of sizes 2ml, 5ml and 10ml); 
injectable drugs (quinine, fortified procaine penicillin, benzyl penicillin and benzathine 
penicillin) and diluents for the injectable medicines (dextrose solution 5% and water for 
injection). Among the injectable drugs, 34 (94.4%) facilities were found to be using stock 
cards for quinine; 33 (91.7%) facilities were using stock cards for fortified procaine 
penicillin; 35 (97.2%) facilities were using stock cards for benzyl penicillin and 32 (88.9%) 
facilities were using stock cards for benzathine penicillin. Among all facilities (n=36), 32 
(88.9%) were using stock cards for 2ml auto-disable syringes and needles; 34 (94.4%) 
were using stock cards for 5ml auto-disable syringes and needles while 31(86.1%) were 
using stock cards for 10ml auto-disable syringes and needles; 33 (89.2%) were using stock 
cards for safety boxes used for disposal of contaminated sharps such as used syringes 
and needles; 13 (85.7%) facilities that manage dextrose injection 5% (HCIII, HCIV and 
hospitals), had stock cards for the item while 25 (71.4%) facilities had stock cards for water 
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for injection. Figure 4.3 shows the difference in availability of stock cards between 
government and non-government facilities by commodity category. The figure illustrates 
that public health care facilities maintain stock cards for safety boxes (92.6%, n=27) and 
auto-disable syringes and needles (93.6%, n=26) at a higher rate than non-government 
facilities (80%, n= 10 for safety boxes; 80%, n= 10 for auto-disable syringes and needles), 
and the results show that the stock card availability for diluents is less common at 
government health care facilities (59.8%) than at non-government facilities (85%). Public 
health care facilities are far more likely to maintain stock cards for safety boxes, syringes 
and needles and injectable drugs than for the diluents. 
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Figure 4.3 
Availability of stock cards by commodity category 
 
The instructions for the health management information system for commodity 
management require that any commodity which is kept for more than one week should be 
tracked, using a stock card (Ministry of Health of Uganda 2005a:99). The stock card 
includes information on where the commodities were issued to or from, the quantity issued, 
and the balance on hand. According to the Ministry of Health of Uganda (2003: 25), the 
stock card provides valid and timely information, which can be used by the stock manager 
to forecast and request for sufficient quantities in order to avoid stock depletions and 
thereby meet the needs of the clients at service delivery points. This study found an 
improvement in availability of stock cards at health care facilities compared to the study 
conducted in Uganda by the MMIS project (2005:7) to evaluate the first phase 
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implementation of the project in its four pilot districts of Mbarara, Nebbi, Pallisa and Mpigi, 
which showed that only 30% of health care units had stock cards for management of health 
care commodities in the therapeutic services. 
 
4.2.2.2  Updating of the stock card or register 
 
According to the Ministry of Health of Uganda (2005a:108), stock cards should be updated 
as soon as possible after receiving or issuing commodities in the store. Stock movements 
that are not immediately recorded on the stock card may be forgotten and the information 
on the stock card may become unreliable in the forecasting of re-supply quantities of the 
affected commodity (Ministry of Health of Uganda 2004b:8). Such unreliable information 
and inaccurate forecasting may result in stock depletions at the health care facility. The 
stock cards used to manage the selected injection devices at the selected health care units 
were scrutinized to find out whether they had been updated in the past 30 days prior to the 
survey. The results indicated that on average, the stock cards of injectable medicines were 
updated at 81.9% of the health care units; 66.4% of the facilities had stock cards of the 
diluents updated, while slightly above half of the health care units (54.5% and 57.6%) had 
the stock cards for safety boxes and syringes updated, respectively. Figure 4.4 illustrates 
the proportion of facilities that had stock cards updated in the 30 days prior to the survey by 
category of commodity. 
 
54.5 57.6
81.9
66.4
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
80.0
90.0
Safety boxes Syringes Injectables Diluents
P
er
ce
nt
ag
e 
of
 fa
ci
lit
ie
s
 
Figure 4.4 
Facilities with updated stock cards by commodity category 
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The results for the safety boxes, syringes and needles and the diluents were consistent 
with the MMIS (2005:8) survey, which showed that about 60% of health units had had their 
stock cards updated in the past 30 days. Personnel in charge of the health care facility 
store should regularly update the commodity stock cards so that the information required 
for effective commodity management is available at all health care faculties. 
 
4.2.2.3  Balance on stock card or register 
 
According to the Ministry of Health of Uganda (2003:26), accurate data on the current stock 
status is vital for effective decision making at every level of the distribution system. This 
information is useful for determining how long the available stock would last, if a commodity 
were over- or under-stocked and how much to order. Inaccurate data, when used to make 
such decisions, could lead to inaccurate forecasting of requirements causing stock 
depletions of injection devices at the health care facilities. Information was collected 
regarding the accuracy of the quantity recorded on the stock card as the balance available 
for each of the selected injection devices at the health care facilities on the day of the 
survey. For each commodity studied, the quantity of stock on hand recorded on the stock 
card was compared with a physical stock count. The overall median percent discrepancy 
between the stock card record and the physical count for those facilities that had stock card 
records revealed that there was a median discrepancy of 31% (n=20) for safety boxes, 
79% (n=17) for 2 ml auto-disable syringes, 51% (n=13) for 5ml auto-disable syringes, 68% 
(n=15) for 10 ml auto-disable syringes, 50% (n=5) for dextrose solution 5%, and 50% 
(n=17) for water for injection. The median discrepancy for quinine was 17% (n=14), 60% 
(n=13) for fortified procaine penicillin, 25% (n=15) and 100% (n=10) for benzathine 
penicillin. Figure 4.5 illustrates the median percentage discrepancy for safety boxes, auto-
disable syringes and the diluents (dextrose solution 5% and water for injection). Overall, 
the results revealed that the median percentage discrepancy between the stock card 
record and the physical count for all the commodities studied ranged from 50% to 79% 
except for safety boxes, quinine and benzathine penicillin. These results were consistent 
with the MMIS study (2005:10), which showed an overall percentage discrepancy between 
physical count and stock card balances of 62% (n=93) in the four districts of Uganda that 
were surveyed.  
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Figure 4.5 
Median percentage discrepancy between stock card record and physical count 
 
These results showed that the general quality of the data recorded on the stock cards in 
the facilities surveyed was poor. This was explained by the fact that commodity 
management at health care units was done by health care workers rather than dedicated 
storekeepers who may fail to allocate time to balancing the stock card records. 
 
4.2.2.4  Stock depletions 
 
Quick et al (1997:317) state that the primary management goal of an effective and efficient 
distribution system is to maintain a steady flow of supplies to facilities where they are 
needed. According to Logez et al (2005:2), the common failure of health care systems to 
ensure adequate and sufficient supplies of injection devices may have a negative impact 
on injection safety. According to the WHO (2000:2), eradication of the re-use of syringes 
and needles without sterilisation requires the continuous, sufficient availability of injection 
equipment and infection control supplies in all health care facilities. When facilities 
experience stock depletions, they are unable to practise according to the set standards. 
Stock availability is the ultimate indicator of a logistics system’s performance and provides 
an indication of the overall effectiveness and efficiency of the entire system, from 
forecasting and procurement to distribution, storage, and inventory management (Ministry 
of Health of Uganda 2003:20). 
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At each health care facility visited for this study, stock cards were reviewed to collect 
information on the availability of the selected commodities on the day of the visit and during 
the three-month period prior to the survey from November 1, 2007 to January 31, 2008. A 
three-month period was reviewed in order to capture an accurate picture of stock 
availability at each health care facility and to allow for monthly variation in consumption and 
availability. Figure 4.6 shows the percentage of facilities that experienced stock depletion 
of safety boxes, auto-disable syringes and needles, dextrose solution 5% and water for 
injection during the three-month period for all facilities combined (all levels), shown 
separately for public and private facilities. Facilities without stock card records were 
excluded from the analysis. 
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Figure 4.6 
Stock depletions (November 1, 2007 – January 31, 2008) 
 
The study showed that in the three months prior to the survey, among the public health 
care facilities, there were stock depletions of safety boxes at 6.3% (n=16) of the facilities, 
2ml auto-disable syringes at 22.2% (n=18) of the facilities, 5ml auto-disable syringes at 
21.1% (n=19) of the facilities and 10ml auto-disable syringes at 15.8% (n=19) of the 
facilities. There were no recorded stock depletions of safety boxes (n=4), 2ml auto-disable 
syringes (n=5), 5ml auto-disable syringes (n=6) and 10ml auto-disable syringes (n=4) at 
any of the NGO health care facilities with stock card records. 
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Analysis of stock depletions in the three months prior to the survey for diluents showed that 
75% (n=8) and 55.6% (n=9) of the public and NGO health care facilities, respectively, 
experienced stock depletion of dextrose solution 5%. In addition, 26.7% of the public health 
care facilities recorded stock depletions of water for injection in the same period. The NGO 
facilities (n=4) did not record any stock depletion of water for injection during this period. 
Stock depletion of recommended diluents may force health care workers to use substitute 
diluents there by affecting the safety of medicines administered to patients through 
injections.  
 
The study also showed that stock depletions of injectable medicines were common at both 
the public and NGO health care facilities (see Table 4.3). Above 50% of the public health 
care facilities registered stock depletions for all the injectable drugs studied while about 
one third of the NGO health care facilities registered stock depletions for all injectable 
drugs except benzyl penicillin during the three-month period. 
 
Table 4.3:  Percentage of facilities with stock depletions of injectable medicines over 
the three-month period November 1, 2007 – January 31, 2008 
 
Ownership Quinine 
Number 
of 
facilities 
with 
records 
Fortified 
procaine 
penicillin 
Number 
of 
facilities 
with 
records 
Benzyl 
penicillin
Number of 
facilities 
with 
records 
Benzathin 
penicillin 
Number 
of 
facilities 
with 
records 
Public 68.2 22 81.2 22 90.9 22 95 20 
NGO 28.6 7 33.3 6 16.7 6 50 8 
 
The results of stock depletions were consistent with the Ministry of Health of Uganda 
(2003:20) survey, which showed that public health care facilities were much more likely to 
experience stock depletions of essential drugs than NGO facilities. The second health 
sector strategic plan  (2005/06 – 2009/2010) of the Ministry of Health of Uganda 
(2005b:60) sets a target of less than 20% stock depletion for all the items required for 
delivery of the Uganda national minimum health care package. The results of this study 
showed that much more effort is required in order to reduce the occurrence of stock 
depletions. 
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4.2.2.5  Frequency of stock depletions 
 
Frequent stock depletions of commodities may imply that stock management is inefficient 
at the health care facility. A national cross-sectional survey of injection safety practices in 
health care facilities conducted by the Ministry of Health of Uganda (2004a:2) indicated that 
65% of the surveyed facilities reported having experienced stock depletions of disposable 
injection supplies in the 12 months prior to the survey and that this stock depletion was 
attributed to a less-than-optimal logistics system, including ineffective forecasting. 
 
The frequency of stock depletions at the health care facilities, which had experienced stock 
depletions for any of the surveyed commodities and where records were available, was 
recorded. The results showed that most of the affected health care units had experienced 
stock depletions only once during the three-month period reviewed. One health care unit 
had experienced stock depletions of quinine five times and another health care unit had 
experienced stock depletions of dextrose solution 5% four times during the three-month 
period. 
 
4.2.2.6  Duration of stock depletions 
 
According to the Ministry of Health of Uganda (2003:22), an assessment of the duration of 
stock depletions gives a measure of the severity of the problem of stock depletion at the 
health care facilities. In addition, the Ministry of Health of Uganda (2003:22) states that an 
assessment of the average duration of stock depletion is a measure of the probability that a 
client who sought health care during the stock depletion period did not receive the 
commodity or the service needed. Stock depletion of injection devices at a health care 
facility could lead to unsafe administration of medicines to patients by means of injections. 
 
The stock cards used to manage the commodities selected for the study were scrutinized 
in order to assess the duration of stock depletion where it had occurred. Facilities without 
stock card records were excluded from the analysis since the data for the duration of stock 
depletion was not available. The study found that the median duration of stock depletion for 
syringes, diluents and injectable medicines during the three-month period ranged from one 
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month to three months. There was no stock depletion recorded on the stock cards for 
safety boxes during this period. Figure 4.7 shows the median stock depletion for syringes.  
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Figure 4.7 
Duration of stock depletion of syringes 
 
Figure 4.7 illustrates that median duration of stock depletion was 60 days for 2ml auto-
disable syringes (n=3), 34 days for 5ml auto-disable syringes (n=4) and 60 days for 10ml 
auto-disable syringes (n=1). The few facilities that experienced stock depletions for 
syringes and needles agreed with the results of the MMIS study (2005:31-32), which 
showed that most health care facilities surveyed in the four districts of Uganda where the 
project was implementing injection safety programmes had never had any stock depletions. 
However, the duration of stock depletion in the MMIS study (2005:31) was much shorter 
(less than 10% of the reviewed period) when it occurred.  
 
This study also showed that at some health care units, the stocks of injectable medicines 
were depleted for longer than two months out of the three-month period reviewed. Figure 
4.8 illustrates the median duration of stock depletions of the injectable medicines and the 
diluents. 
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Figure 4.8 
Median duration of stock depletion of injectable drugs and diluents 
 
The median duration of stock depletion was 77 days (19) for fortified procaine penicillin, 85 
days (21) for benzyl penicillin, 90 days (22) for benzathine penicillin. Among the injectable 
medicines, only quinine had a median duration of stock depletion of less than two months 
(45 days; 16). Analysis of the duration of stock depletion for the diluents studied showed 
that the median duration of stock depletions of dextrose solution 5% and water for mixing 
injectables was 69 days (13) and 56 days (4), respectively.  
 
These results show that up to half (52.6%) of the surveyed health care facilities 
experienced stock depletions of injectable medicines with median durations of over two 
months. The results agreed with the national survey of the Ministry of Health of Uganda 
(2003:22), which showed that health care facilities were experiencing stock depletions for 
long periods of time. The long duration of stock depletion of injectable medicines observed 
in this study can be attributed to the delay by the national medical stores to fulfil the two 
scheduled deliveries of essential commodities to the Mpigi district from 1 September 2007 
to 31 December 2007. 
 
4.2.2.7  Total number of products issued 
 
According to Nersesian et al (2004:6), consumption data informs forecasts and gives useful 
information for the full supply of injection devices. The Ministry of Health of Uganda’s 
(2005:115) guidelines require the commodity manager at every health care unit to 
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determine the average monthly consumption of each health care commodity at their health 
care unit so that they are able to accurately determine the quantities to requisition for in 
order to avoid stock depletions. The consumption data is derived from the quantities issued 
out of the store as tracked by the respective commodity stock cards.  
 
The stock cards for the commodities selected for the study were scrutinized in order to 
determine how many health care facilities had records of consumption over the three-
month period prior to the survey. Figure 4.9 depicts the results of the analysis for safety 
boxes, syringes and diluents. 
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Figure 4.9 
Percentage of facilities with consumption data for safety boxes, syringes and 
needles and diluents (N=38) 
 
The results show that on average just above half (55.3%, n=38) of the facilities had the 
consumption data for safety boxes and syringes and needles for the three-month period 
prior to the survey. Consumption data was very poor for the diluents (dextrose solution 5% 
and water for injection) with just above one third (34.4%, n=38) of the health care facilities 
having consumption data. 
 
Figure 4.10 illustrates the results of the analysis for the injectable medicines. The results 
showed that the average number of facilities with consumption data for fortified procaine 
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penicillin, benzyl penicillin and benzathine penicillin was 55.3%, (N=38). The consumption 
data for quinine was available at 71.1% (N=38) of the facilities. 
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Figure 4.10 
Health care facilities with consumption data for injectable medicines 
(N=38) 
 
The results show that the distribution system for injection devices is not well managed at 
most of the health care facilities in the Mpigi district since according to Quick et al 
(1997:317) an efficient distribution system should provide information for forecasting 
needs. 
 
4.2.2.8  Physical count of injection devices 
 
The physical count of the available stock of commodities can be used to estimate of how 
long the commodities in stock will last to serve clients at the health care facility. Health care 
facility staff can ration commodities in order to avoid stock depletions. Rationing or 
selectively offering commodities according to certain health conditions implies that all 
clients’ needs will not be met and the logistics distribution system has not met its goal 
(Ministry of Health of Uganda 2003:23). 
 
A physical count of the commodities studied was carried out and the stock ledger or stock 
cards were reviewed to gather historical data on the quantities consumed by clients or 
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issued out of the store during the three-month period prior to the survey. The historical data 
on the consumption was then used to estimate the average monthly consumption or 
monthly issue rates which were compared to the physical inventory to establish the number 
of months of stock of injection devices available to be used on the day of the survey. Figure 
4.11 illustrates the results of the analysis. Facilities without consumption data were 
excluded from the analysis. 
 
According to the Ministry of Health of Uganda’s (2005:101) guidelines for drug 
management, the minimum amount of stock that managers should keep is two months’ 
consumption. In addition, the guidelines state that the maximum amount of stock that a 
health care facility should not exceed is five months’ consumption.  
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Figure 4.11 
Average number of months of stock of injection devices available at each level of 
health care facility 
 
This study found that the safety boxes were overstocked at all levels of the health care 
units except at hospital level where the average number of months of stock was the 
recommended maximum of five months. A review of the stock status of auto-disable 
syringes revealed that the 10ml size were overstocked at all levels of health care units with 
the average number of months of stock exceeding five months. The 2ml auto-disable 
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syringes were overstocked at HCII and HCIV levels while the 5ml auto-disable syringes 
were overstocked at HCII level. The overstocking of safety boxes and syringes could be 
explained by the fact that these two categories of injection devices are supplied to the 
health care facilities through a parallel supply channel to that of the injectable medicines. In 
addition the common stock depletion of injectable medicines in the three-month period prior 
to the survey could have contributed to the observed overstocking of the safety boxes and 
syringes at the health care units. The average stock level of 2ml and 5ml auto-disable 
syringes, however, was below the recommended minimum of two months supply at HCIIIs 
and hospitals, respectively. 
 
The analysis of the stock status of the injectable medicines revealed that fortified procaine 
penicillin and benzathine penicillin were overstocked at the hospital level. All the injectable 
medicines were under stocked at the HCIII level with an average number of months of 
stock for each commodity studied of less than two months. Benzyl penicillin was also under 
stocked at the hospital level with the average number of months of stock of 1.5 months. 
 
Among the diluents, dextrose solution 5% was under stocked at HCIII and hospital levels 
while water for injection was under stocked at HC IV and hospital levels. 
 
The results of the analysis of the stock status are consistent with the Ministry of Health of 
Uganda’s survey (2003:24), which showed that stock levels for most commodities were low 
at higher levels of the health care system and higher at the lower levels of the system. 
 
4.2.2.9  Conditions of storage 
 
According to the Ministry of Health of Uganda (2003:33), all health care commodities 
require specific procedures and conditions for safe storage to protect their integrity and 
effectiveness, maximize their shelf life, and make them readily available for distribution. 
When all the levels of the system follow the same standards of storage, clients can be 
assured that they will receive high-quality products. Quick et al (1997:317) point out that 
proper organisation and maintenance of storage facilities helps to maintain device quality, 
minimise theft, and maintain regular supply to health facilities. 
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At each facility, the survey team visually inspected the storage area for each of the 
categories of the commodities studied (safety boxes, syringes and needles, injectable 
medicines and diluents). The survey instrument included a checklist of seven standard 
storage conditions necessary to ensure the effective and efficient storage of all 
commodities (Ministry of Health of Uganda: 2004b:27-28). These included: 
 
• Physical arrangement of the items in the store according to expiry dates also known as 
FEFO (First Expiry, First Out ) in which items with the nearest expiry dates are issued 
first 
• Capacity to handle the volume of commodities in the store 
• Ventilation of the store 
• Cleanliness of the store 
• Presence of pallets to hold the commodities off the floor so that they are not spoilt by 
moisture 
• Presence of shelves to increase the storage surface area and to create organized 
compartments of storage for easy access and 
• Restricted access to the store to prevent loss of the items due to theft 
 
Figure 4.12 illustrates the level of compliance with the seven selected conditions for proper 
storage of health care commodities in the surveyed health care facilities. On average, 
72.6% (n=38) of the facilities fulfilled all seven conditions of storage for the injectable 
medicines while 71.1% (n=38) fulfilled all seven conditions of storage for diluents. In 
comparison to injectable medicines and diluents, storage conditions for syringes and 
needles and safety boxes were fulfilled by fewer health care facilities, with an average of 
60.2% (n=38) of the facilities fulfilling all seven conditions of storage for safety boxes and 
58.3% (n=38) fulfilling all seven conditions of storage for auto-disable syringes and 
needles. 
 
The individual storage conditions were also analysed to identify the problem areas in need 
of improvement or reinforcement. Figure 4.13 shows the average percentage of health care 
facilities that met each of the seven selected conditions for the storage areas of each of the 
categories of injection devices studied. 
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Figure 4.12 
Health care facilities complying with the seven minimum storage conditions for each 
category of injection devices (N=38) 
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Figure 4.13 
Health care units complying with individual storage conditions (N=38) 
 
At least half of the health care facilities visited met all of the selected storage criteria except 
the presence of pallets. Approximately 40% (38) of health care facilities did not have 
sufficient space for the existing commodities or space for reasonable expansion (such as 
for the receipt of expected commodity shipments in the near future). The results show that 
9.2% (38) of the health care facilities had pallets in their stores. This is an area that needs 
urgent attention in order to ensure that the quality of the health care products at the 
facilities’ stores is not compromised. 
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These results were comparable to the Ministry of Health of Uganda’s survey (2003:33-34), 
which indicated that the minimum storage criteria were met by at least half of the facilities 
visited and that half of the facilities  did not have sufficient storage space. 
 
4.2.3  Interview of the storekeeper (instrument 3) 
 
In order to establish the performance level of the distribution system in the Mpigi district, 
the member of staff identified at each health care facility as the person responsible for 
commodity management was interviewed. An injection provider was interviewed if the 
health care facility did not have a storekeeper or if the storekeeper was not available on the 
day of the survey. The collected data was based on the storekeeper’s answers only and 
not the observations of the data collectors. 
 
4.2.3.1  Presence of a storekeeper 
 
The staff responsible for stock management or, if not available, an injection provider were 
interviewed. Overall, 26 (78.8%) health care facilities had a store-keeper responsible for 
commodity management at the facility although the store-keepers were found at only 20 
(60.6%) health care facilities on the day of the survey (see figure 4.14).  
Is there a store keeper at this facility?
No, 21.2%
, Yes present
60.6%
, Yes not present
18.2%
 
Figure 4.14 
Percentage of health care facilities with a storekeeper (N=33) 
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According to Quick et al (1997:326), a distribution system cannot work unless there are 
enough suitably qualified staff members to administer and operate the commodity 
distribution system effectively.  Of the facilities, 21.2% (33) did not have a person 
specifically responsible for stock management and an injection provider was interviewed. 
 
The respondents were asked how they learned to complete the logistics forms used at the 
facility. Of all the stock managers interviewed, 57.9% (38) reported that they learned to 
complete the forms used at the facility during logistics training while 34.2% reported 
learning during on-the-job training; 5.3% reported self-learning, and 2.6% reported that 
they learned elsewhere.  
 
Figure 4.15 shows the proportions of stock managers at each level of the surveyed health 
care facilities who reported each method of learning.  
 
A greater proportion of staff at the hospitals and HCIII levels were more likely to have 
learned completing the forms through formal training in logistics while HCII staff were more 
likely to have learned through on-the-job training. This is consistent with the results of the 
Ministry of Health of Uganda’s survey (2003:28), which showed that staff at the higher 
levels of the health care system was more likely to receive formal logistics training than 
staff at lower levels. People in charge of commodity management at all levels of the health 
care system should be suitably trained to efficiently operate the distribution system so as to 
avoid stock depletions. 
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Figure 4.15 
Training in completing logistics forms (N=38) 
 
 
4.2.3.2 Availability of logistics forms 
 
According to Quick et al (1997:326), reliable management information is vital for 
coordinating the distribution network. The information system consists of forms and 
procedures to record inventory levels, costs and sales processes, receipts for issues of 
commodities. Forms, records, and reports are the core of the supply information system. 
All necessary forms should be available and all staff should be trained in the use of these 
forms (Quick et al 1997:327). 
 
According to the Ministry of Health of Uganda’s (2005:99-108) procedures for the health 
management information, there are three forms that must be used at each of the health 
care facilities for the management of health care commodities. These forms are described 
below: 
 
• The stock card, which is used to track the movements and balance of all 
commodities stored at any place in the health care unit for more than a week 
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• The requisition and issue vouchers, used to make internal and external orders for 
issuing of commodities from or to the health sub-district store or the national 
medical stores, and 
• The record of issuing, used for recording the disbursement of commodities to clients 
and making consumption reports 
 
The storekeepers were interviewed to find out whether the stock cards, the requisition and 
issue vouchers and the consumption reports were available to manage health care 
products at their facilities (see figure 4.16). 
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Figure 4.16 
Health care units having logistics forms (N=38) 
 
The results show that all the health care facilities reported having stock cards to manage 
health care products. However 10% (38) of the facilities did not have requisition and issue 
vouchers or the consumption reports. These results show a marked improvement since the 
MMIS survey (2005:7) to evaluate the first phase of implementation of its activities in the 
four districts of Uganda, which indicated that only 49% of health care facilities reported 
having stock cards to manage health care commodities in the therapeutic services. 
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4.2.3.3  Use of stock cards 
 
Timely information can greatly improve stock managers’ ability to identify, forecast, and 
procure sufficient quantities to meet the needs of the facilities in the supply chain and 
ultimately the needs of the clients at service delivery points (Ministry of Health of Uganda 
2003:25). This information is derived from stock card records of each of the commodities 
managed by the facilities. The storekeepers were asked if they were using stock cards to 
manage syringes, safety boxes and injectable medicines. All the health care facilities (38) 
reported using stock cards to manage syringes and injectable medicines, and only 2 (5.3%) 
reported not using stock cards to manage safety boxes. 
 
4.2.3.4  Use of the information on stock cards 
 
The information on stock cards should be used to prepare reports to project commodity 
needs, revise budgets, and assess commodity use (Quick et al 1997:327). The 
storekeepers were interviewed to find out how the information on the stock cards was 
used. The respondents could give more than one use of the cards (see figure 4.17). 
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Figure 4.17 
Percentage of health care facilities using stock cards for each purpose 
(N=38) 
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The majority of health care units (above 89%, n=38) reported that they used the 
information from stock cards for calculating consumption and needs; 71.1% reported using 
the information for requesting supplies from higher levels. Only 65.8% reported that they 
used the information on stock cards for reporting to higher levels. The health management 
information system, however, requires that all health care units should use stock cards to 
prepare monthly reports on stock depletions and the duration of stock depletions at their 
health care facilities (Ministry of Health of Uganda 2005a:113). The other uses of the 
information on the stock card reported included accountability for the supplies at the health 
care units and tracking of expiry dates of health care products in the stores. 
 
4.2.3.5  Logistics reports and their frequency 
 
According to Quick et al (1997:327), logistics reports should be prepared regularly by the 
individual health care units to the health sub-district offices, which report to the central 
office. Such reports are used to project commodity needs, revise budgets, and assess 
commodity use in order to ensure constant availability of supplies at the health care units.  
 
The storekeepers were interviewed in order to find out if they were sending any logistics 
reports to the higher level. All the staff interviewed (38) reported that they sent logistics 
reports to the higher level; 89.5% of the health care units reported that they were supposed 
send the reports to the higher level monthly and were actually sending the reports on a 
monthly basis. Four (10.5%) health care units reported that they were actually sending the 
logistics reports to the higher level on a quarterly basis (see figure 4.18).  
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Monthly, 89.5%
Quarterly, 
10.5%
 
Figure 4.18 
Frequency of logistics reports (N=38) 
 
4.2.3.6  Method of communication 
 
According to Quick et al (1997:327), an efficient communication system is essential for an 
effective health care commodity distribution system because reports and requisitions are 
received on time for decision making and timely processing of orders respectively in order 
to avoid stock depletions. The storekeepers at the selected health care facilities were 
interviewed to ascertain the methods of communication available and actually used to 
report to the higher level. The respondents could give more than one of the options on the 
interview schedule, such as postal service, telephone, fax radio link, physical visit, and any 
other means (see table 4.4). 
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Table 4.4:  Methods of communication used for reporting 
 
Method Frequency Percentage of facilities 
Postal service 0 0 
Telephone 20 52.6 
Fax 1 2.6 
Radio link 0 0 
Physical visit 17 44.7 
Other 0 0 
Total 38 100 
 
 
More than half (52.6%, n=38) of the health care facilities reported that they used the 
telephone to send reports to the higher level; 44.7% (n=38) reported physically taking the 
reports to the higher level. According to Quick et al (1997:327), an efficient 
telecommunication system such as the radio link and the faxing system should be invested 
in so as to save staff time and to reduce vehicle wear and fuel expenses due to physical 
visits. 
 
4.2.3.7  Ordering intervals 
 
According to the Ministry of Health of Uganda (2003:31), all health care facilities should 
forward their orders to the next highest level of the logistics system every two months. 
Timely requisition of requirements ensures that re-supplies of health care commodities are 
delivered to health care units in time to avoid stock depletions.   
 
The storekeepers were asked how many times they were supposed to make orders and 
how many times they had done so in the year prior to the day of data collection (see figure 
4.19). 
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Figure 4.19 
Number of orders made in the past year 
(N=38) 
 
The majority of the storekeepers (71.1%; 38) reported that they were supposed to order 
quarterly. No storekeeper reported that they were supposed to order semi-annually. 
Nevertheless, from the results, 11.1% of the health care facility storekeepers reported that 
they had actually made their orders only twice in the past year. Some of the interviewed 
staff did not know how many times their facilities had placed orders in the past year 
because the actual store persons in charge of commodity management were not available 
at the time of the survey. 
 
4.2.3.8  Determination of re-supply quantities 
 
According to the Ministry of Health of Uganda (2005b:58), managers of operational units 
are expected to work out their own demand estimates and buffer stocks and submit 
requisitions to central stores indicating their requirements. This order-based system is 
called a push system.  
 
The researcher interviewed the storekeepers to find out which persons were responsible 
for determining their re-supply quantities and how the re-supply quantities were 
 105
determined. Of the storekeepers, 35 (92.1%) reported that they used a pull system in which 
they were expected to work out their demand estimates. The high number of facilities 
operating on a pull system shows that most facilities were following the government 
guidelines. 
 
In addition, 26(68.4%) store keepers reported that they were using a formula to calculate 
their re-supply quantities. 6 (15.8%) store keepers reported that a higher level determined 
their re-supply quantities (push system) while 6(15.8%) reported that they were using 
experience to estimate their requirements. These results agreed with the Ministry of Health 
of Uganda’s guidelines (2005a:100), which state that all health care units should use a 
formula to determine their re-supply quantities. Facilities using the experience of the store 
persons to estimate the re-supply quantities could easily experience stock depletions due 
to a lack of a basis for the estimation. 
 
4.2.3.9  Transportation of commodities 
 
Transport planning is important if health care commodities are to reach the user health 
care facilities in a timely manner to avoid stock depletions (Quick et al 1997:325). Of the 
storekeepers, 29 (78.4%) reported that it was the responsibility of their facilities to collect 
commodities while 8 (21.6%) reported that a higher level facility delivered commodities to 
their facility. Functional vehicles and sufficient fuel to run them are essential for a 
distribution system whether the commodities are collected from a higher-level facility or 
when they are delivered to the health care facility by a higher level facility. 
 
Slightly over half (51.4%, 37) of the storekeepers reported that the most commonly used 
mode of transport for commodities to the health care units was a district-managed vehicle; 
13 (35.1%) reported using public transportation, while 3 (8.1%) reported that they used 
privately hired vehicles. Each health sub-district at either hospital or HCIV level is allocated 
a vehicle for transportation of health care commodities to the lower level health care units. 
However, due to poor vehicle maintenance and lack of fuel, these vehicles are often 
grounded, necessitating the lower level health care units to devise means of collecting the 
supplies from the health sub-district stores. This causes further delay, which may result into 
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stock depletions at the health care units. Figure 4.20 illustrates that there is a problem with 
transportation of commodities to almost half of the health care facilities in the Mpigi district. 
 
What mode of transportation is often used to 
transport commodities to your facility? (N=37)
35.10%
51.40%
8.10%
2.70%
2.70%
Public transportation District-managed vehicle Private, hired vehicle
On foot Other
 
Figure 4.20 
Mode of transportation of supplies (N=37) 
 
4.2.3.10  Re-supply intervals 
 
According to Quick et al (1997:323), an appropriate re-supply interval should be selected 
depending on factors such as the storage capacity of health care facilities, the availability 
of transport and the seasonal factors that affect transport. The Ministry of Health of Uganda 
(2003:30) states that health care units should receive supplies on a bi-monthly basis. The 
late delivery of supplies to health care units may cause stock depletions if the delay was 
not anticipated.  
 
The storekeepers were interviewed to ascertain the frequency at which they were 
supposed to receive supplies and the frequency at which they were actually receiving 
supplies (see figure 4.21). 
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Figure 4.21 
Comparison of the scheduled and actual re-supply intervals (N=38) 
 
 
The results show that 73.6% (n=38) of the health care facilities reported that they were 
scheduled to receive re-supplies quarterly, but only 52.6% actually received re-supplies on 
a quarterly basis, and 13.2% reported receiving supplies semi-annually. Yet there was no 
health care facility scheduled to receive re-supplies on a semi annual basis. 
 
Of the health care units, 21% reported that receipt of supplies to their facilities did not 
follow a regular schedule. These results showed a deviation from the actual re-supply 
interval from the scheduled bi-monthly re-supply interval planned by the Ministry of Health 
of Uganda and was an indication of the delay in delivering supplies from the national 
medical stores. 
 
Storekeepers were also asked how long it took to receive supplies from the time they made 
their orders for re-supply (see figure 4.22). 
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Figure 4.22 
Interval between ordering and receiving re-supplies (N=38) 
 
The results showed that 31.6% (n=38) of the health care units took between one month to 
seven weeks to receive re-supplies, while 28.9% took three months and longer to receive 
supplies from the time they placed their orders for re-supply. The Ministry of Health of 
Uganda’s plan is for health care facilities to receive re-supplies every two months after 
ordering. The results also indicated that there was a delay in re-supplying about one third 
of the facilities. Nevertheless, it was not known from this result whether the delay was 
within the district or from the national medical stores. Such unanticipated delays could 
result in stock depletions at health care facilities, thereby negatively affecting the injection 
device security at those health care facilities. 
 
4.2.3.11  Expired injectable medicines or syringes 
 
Effective inventory management reduces the chance of experiencing stock depletions by 
helping to prevent losses through expiration. Expired products can no longer be offered to 
clients and therefore they contribute to the threat of stock depletion if they are not 
separated from usable stock in a timely manner and replaced with usable stock.  
 
Five respondents (13.2%) reported that they had expired injectable medicines at their 
facility. The results, however, indicated that expiry of medicines was not a big problem in 
the Mpigi district. It should be noted that some amount of commodity loss due to expiration 
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is expected in any logistics system, but large quantities should be investigated. Managers 
should transfer excess supplies that are likely to expire to other facilities that may be able 
to use them faster.  
 
4.2.3.11  Losses of supplies due to damage or theft 
 
Seven respondents (18.4%) reported that they had incurred losses of supplies due to either 
damage or theft in the three months prior to the survey. According to Quick et al 
(1997:324), storage facilities are vital to the success of a distribution system and should 
always be protected against theft and damage by water,  pest or fire. 
Furthermore, most health care systems in developing countries operate with limited 
funding, and health commodities are precious and rarely in full supply. Losses of otherwise 
usable commodities due to damage or theft should therefore be avoided at all cost.  
 
4.2.3.12  Physical capacity of the stores 
 
The available storage space at the health care facilities should be sufficient to allow for 
emergencies and for programme expansion. Of the respondents, 23 (60.5%) reported that 
the physical capacity of their stores was not enough to hold all the facilities’ supplies at any 
given time. Figure 4.23 indicates that the physical capacity of the storage facilities in the 
Mpigi district should be given priority so that health care commodities are secured from 
damage or theft, which could increase the chances of stock depletions at the health care 
facilities. 
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Is the physical capacity of your store enough to 
hold all supplies at the facility at any given time? 
(N=38)
39.5%
60.5%
Yes No
 
Figure 4.23 
Physical capacity of stores (N=38) 
 
4.2.3.13  Stock depletion of syringes 
 
The primary management goal of an effective and efficient distribution system is to 
maintain a steady flow of supplies to facilities where they are needed. The storekeepers 
were asked whether they had registered any stock depletion of any size of syringes in the 
past three months and for how long. Of the respondents, 73% (n=37) reported that they 
had not registered any stock depletion of any size of syringe in the reviewed period; 5 
(13.5%) reported having registered a stock depletion of at least one size of syringe for a 
period of one to three weeks; 2 (5.4%) registered a depletion for a period of 4-12 weeks, 
and 2 (5.4%) for a period of over three months. Only 1 (2.7%) respondent reported a stock 
depletion of 6 days or less. The results revealed that almost one quarter of the surveyed 
health care units had experienced a stock depletion of at least one size of the syringes in 
the three months prior to the survey (see table 4.5).  
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Table 4.5: Duration of stock depletion of syringes 
 
Duration of stock depletion 
Frequency 
(N=37) Percentage 
Not in 3 months 27 73.0 
6 days or less 1 2.7 
1-3 weeks 5 13.5 
4-12 weeks 2 5.4 
Over 3 months 2 5.4 
Total 37 100.0 
 
 
Stock managers should be vigilant in order to avoid stock depletions of injection devices 
because any stock depletion negatively affects the injection practices at the health care 
facilities.  
 
4.2.3.14  Availability of safety boxes 
 
Safety boxes are puncture resistant and moisture resistant containers used for the disposal 
of contaminated sharps including used syringes and safety boxes. According to Reeler 
(2000:135), unsafe disposal of used syringes and needles increases the risk of transmitting 
diseases. Health care centres often dispose of used syringes and needles in nearby open 
pits, a practice which makes it possible for people to obtain and reuse the injection 
equipment. Safety boxes should therefore be available at all health care facilities to 
facilitate the safe disposal of contaminated sharps including used syringes and needles. 
 
All the storekeepers interviewed (n=38) reported that they always had safety boxes at their 
facility. This result indicated that health care facilities were generally practising appropriate 
sharps waste disposal. 
 
 112
4.2.3.15  Stock depletion of safety boxes 
 
The respondents (n=38) were asked if they had ever registered a stock depletion of safety 
boxes in the three months prior to the survey. Of the respondents, 97.4% reported that they 
had never registered a stock depletion of safety boxes at their facility. Only one (2.6%) 
respondent reported having registered a stock depletion of safety boxes for a period of 4 
to12 weeks. Health care unit managers should collaborate with nearby units so that 
available commodities can be efficiently utilized.  
 
4.2.3.16  Stock depletion of water for injections 
 
According to the WHO (2003a:1), the concept of injection device security entails 
appropriate supply management so that injection devices including appropriate single dose 
diluents are available in adequate quantities. Water for injection is a sterile preparation 
used for the reconstitution or dilution of some injectable medicines. The lack of suitable 
diluents affects the quality of the reconstituted injectable medicines and therefore 
compromises the safety of the injected medicine. 
 
The storekeepers were asked if they had been out of stock of water for injection in the last 
three months and for how long (see table 4.6).   
 
Table 4.6:  Duration of stock depletion of water for injection 
 
Duration of stock depletion 
Frequency 
(N=37) Percentage 
Not in 3 months 34 91.9 
6 days or less 0 0.0 
1-3 weeks 1 2.7 
4-12 weeks 1 2.7 
Over 3 months 1 2.7 
Total 37 100.0 
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Of the respondents, 34 (91.9%) reported that they had never registered any stock depletion 
of water for injection in the past three months prior to the survey. One (2.7%) respondent 
reported a stock depletion of 1 to 3 weeks, another (2.7%) reported a stock depletion of 
one month to three months and another (2.7%) reported a stock depletion of over 3 
months. The commodity was generally available in sufficient quantities at all health care 
facilities. 
 
4.2.3.17  Stock depletion of dextrose solution 5% 
 
Dextrose solution 5% is used for the intravenous administration of some injectable 
medicines like quinine used in the treatment of complicated malaria. In Uganda, dextrose 
solution 5% is stocked by HCIIIs, HCIVs and hospitals. Stock depletions of dextrose 
solution 5% at health care facilities presents a challenge to the health care workers who 
would need to use it for the administration of drugs such as quinine. 
 
Storekeepers were asked if they had registered any stock depletion of dextrose solution 
5% in the last three months and for how long  (see figure 4.24).  
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Figure 4.24 
Duration of stock depletion of dextrose solution 5% (N=17) 
 
The results revealed that there were no stock depletions of dextrose solution 5% reported 
by respondents at the hospitals (n=2) and at half (50%, n=14) of the HCIII health care 
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units. All the respondents at HCIV health care units (n=2) and at one HCIII (7.1%) reported 
having registered a stock depletion of 4 to 12 weeks prior to the survey; 5 (35.7%) 
respondents at HCIII health care units reported stock depletions of over three months while 
only one (7.1%) respondent at a HCIII health care unit reported a stock depletion which 
lasted 1 to 3 weeks. The stock depletion of dextrose solution, reported at the HCIV health 
care units and the HCIII health care units, should be avoided because these are referral 
facilities for very ill patients who cannot obtain appropriate health care from the lower level 
HCII health care units. 
 
4.2.3.18  Delivery of injectable drugs with adequate quantities of syringes 
 
The current global safe injection strategy calls for the use of single-use injection devices for 
every injection administered. According to Nersesian et al (2004:7), supporting this strategy 
requires coordinated distribution of quantities of single-use injection devices to match the 
number of doses of injectable preparations supplied.  
 
Storekeepers were asked if the stocks of injectable drugs used for the curative services 
were delivered or available with adequate or matching quantities of syringes and needles. 
Of the respondents, 36(94.7%) reported that the injectable drugs were available with 
adequate quantities of syringes and needles while only 2 (5.3%) reported that the 
injectable drugs did not match the syringes and needles. 
 
4.2.3.19 Delivery of stocks of syringes and needles with adequate quantities of 
safety boxes 
 
A critically important issue to consider about supply management (including distribution) for 
safe injection devices is how to provide the supplies in complementary quantities, also 
called bundling. Syringes should be distributed with the appropriate number of safety boxes 
used for disposal of contaminated sharps including used syringes and needles, to ensure 
that the used syringe after every injection is disposed of safely. 
 
Of the respondents, 97.4% reported that syringes and safety boxes used for curative 
services were delivered with adequate quantities of safety boxes (see figure 4.25). 
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Are stocks of syringes and needles delivered with 
adequate quantities of safety boxes? (n=38)
97.4%
2.6%
Yes No
 
Figure 4.25 
Delivery of syringes and needles with safety boxes (N=38) 
 
 
4.2.3.20  Supply of syringes and needles 
 
The storekeepers (n=38) were asked if they had been supplied with adequate quantities of 
syringes and needles for the services provided to the patients (see figure 4.26). Of the 
respondents, 35 (92.1%) reported that they had been supplied with adequate quantities of 
syringes and needles. Only 3 (7.9%) reported that they had not been supplied with enough 
syringes and needles. 
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Have you been supplied with adequate quantities 
of syringes and needles for the services that you 
provide? (n=38)
92.1%
7.9%
Yes No
 
Figure 4.26 
Supply of adequate quantities of syringes and needles (N=38) 
 
4.2.3.21  Supply of safety boxes 
 
Of the respondents, 37 (97.4%) reported that they had been supplied with adequate 
quantities of safety boxes for the services they provided to their patients. Only one (2.6%) 
respondent reported that he had not been supplied with adequate quantities of safety 
boxes (see figure 4.27). 
 
Have you been supplied with adequate quantities 
of safety boxes for the services that you provide? 
(n=38)
97.4%
2.6%
Yes No
 
Figure 4.27 
Supply of adequate quantities of safety boxes (N=38) 
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4.2.3.22  Support supervision 
 
Supervision of individual staff members helps to promote adherence to standards and to 
identify the problems that contribute to poor quality services. The storekeepers were asked 
when last someone from outside the facility had personally supervised them and how long 
ago the supervision was conducted (see figure 4.28). 
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Figure 4.28 
Time since last supervisory visit 
 
The results showed that about one third (32.4%) of the respondents had been supervised 
within one month prior to the survey. The same number (32.4%) reported that they had 
been supervised within five weeks to three months while 35% had been supervised over 
three months previously. Regular supervision of all health care workers should be carried 
out to ensure that they are competent to meet their patients’ need of safe health care 
services. 
 
4.2.3.23  Activities done during supervision 
 
Support supervision should add value to the quality of services rendered by the staff at 
health care facilities. The problems encountered by staff while trying to fulfil their roles 
should be identified during supervisory visits and rectified, if possible. 
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The respondents were asked which activities the supervisors had carried out during their 
last supervisory visit. The majority of the respondents (89.2%, n=37) reported that the 
supervisors checked supplies. Only 2 (5.4%) respondents reported that on-job training was 
performed (see figure 4.29). 
 
What was done during the supervisory visit? 
(n=37)
89.2%
5.4% 5.4%
Supplies checked On-job-training Other
 
Figure 4.29 
Activities performed by supervisors (N=37) 
 
4.2.3.24  Ensuring regular supplies 
 
The respondents were asked what could be done to ensure regular supply of injectable 
medicines, diluents, syringes and needles and safety boxes (see table 4.7). 
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Table 4.7: Activities to ensure regular supply (N=38) 
 
What could be done? Frequency Percentage 
Timely delivery 24 63.1
Provision of vehicles for transport of 
commodities 7 18.4
Supply of adequate quantities 7 18.4
Timely ordering 6 15.8
Supply all items on order 6 15.8
Regular supervision 5 13.1
Prompt order processing 4 10.5
Others 7 18.4
 
From the results in Table 4.7 it was evident that the biggest problem affecting regular 
supplies of injection devices to the health care units was the late delivery of supplies. The 
other significant factors included lack of transport, supply of inadequate quantities, late 
ordering by health care facilities, supply of less items than ordered and irregular 
supervision. These areas should be addressed if the health care workers’ competencies 
are to be synergised with the needs of their patients in accordance with the synergy model. 
 
4.2.3.24  Support required to do job better 
 
In order to determine the problems faced by the storekeepers in ensuring efficient 
commodity management, respondents were asked what kind of support they required to do 
their jobs more effectively (see table 4.8). 
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Table 4.8:  Support required by storekeepers (N=38) 
 
Support required Frequency Percentage 
Training 24 63.1
Support supervision 11 28.9
Provide more space 5 13.1
Supply adequate quantities 4 10.5
Provide stock cards 3 7.9
Increase funding for drugs 2 5.3
Provide vehicles for transport of 
commodities 2 5.3
Others 7 18.4
 
From the results it was evident that most (63.1%) of the respondents felt they should 
receive training in managing the stores more efficiently. About one third (28.9%) of the 
respondents said that they would benefit from regular support supervision while 13.1% 
wanted more storage space. The other forms of support mentioned included supply of 
adequate quantities of commodities (10.5%), provision of stock card forms (7.9%), increase 
in the funding for drugs (5.3%), and provision of vehicles for transporting commodities. 
  
4.2.4 Observations of equipment and supplies at the facility (instrument 4)   
 
The WHO (2000:1) recommends the provision of sufficient quantities of injection equipment 
and infection control supplies including appropriate management of all sharps used for 
invasive procedures such as syringes and needles. In line with this recommendation, 
health care facilities should stock sufficient quantities of safety boxes used for the disposal 
of contaminated sharps such as the used syringes and needles. This instrument helped to 
determine whether health care units had appropriate sharps containers for the disposal of 
sharps waste. 
 
4.2.4.1 Presence of sharps containers 
 
Observations of equipment and supplies in the out-patients injection room, in the in-
patients’ wards and in the laboratory revealed that all out-patients’ injection rooms had a 
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sharps container for the disposal of contaminated sharps such as used syringes and 
needles (see figure 4.30). Among the health care facilities with laboratories (n=19), 
16(84.2%) had a sharps container in the laboratory while only eight (53.3%, n=15), which 
admit patients on the wards, had a sharps container on the injection trolley. In order to 
avoid accidental needle stick injuries, safety boxes should be provided to all areas where 
medicines are administered by means of an injection. The absence of safety boxes in 
these areas could be an indication that supplies were not sufficient at the health care 
facility. The small number of facilities with safety boxes on the injection trolleys might be 
partly explained by the lack of injection trolleys at most of the visited health care facilities. 
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Figure 30 
Presence of sharps containers 
 
4.2.4.2  Presence of safety boxes 
 
In order to provide the intended protection against needle stick injuries, all sharps 
containers provided to the health care facilities should be puncture resistant and moisture 
resistant. In addition, they should bear appropriate hazard markings for infectious sharps 
and they should be printed with clear conspicuous instructions regarding assembly and 
use. Sharps containers with all these characteristics are known as safety boxes. 
 
The results revealed that the sharps containers observed at 37 (97.4%) health care units 
were puncture resistant and moisture resistant, bore appropriate hazard markings for 
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infectious waste, and were printed with conspicuous instructions regarding assembly and 
use, implying that the majority of the visited health care units were using safety boxes to 
manage sharps waste except at one health care unit. 
 
4.2.4.3  Presence of over flowing sharps containers 
 
Overflowing or pierced safety boxes were observed at 8 (21.1%) health care facilities. This 
result contrasted the findings of the MMIS study (2005:11) in Uganda, which put the 
percentage of the surveyed health care facilities with overflowing or pierced safety boxes at 
less than 5%. Safety boxes should be filled up to the three-quarter mark and then 
discarded. This ensures that needles do not stick out and cause needle stick injuries to the 
health care workers or the health care waste handlers. The presence of overflowing safety 
boxes could be an indication that inadequate quantities of safety boxes have been 
provided to the health care units. Sufficient quantities of safety boxes should be provided to 
all areas where medicines are administered by use of injections and staff should be 
educated on the dangers of overfilling the safety boxes. 
 
4.2.4.4  Evidence of re-use of injection equipment 
 
This question helped determine whether health care workers were re-using injection 
equipment due to insufficiency of supplies. There was no evidence that syringes or needles 
were being re-used at each of the health care facilities visited.  
 
 4.2.4.5  Evidence of used sharps around the health care centre or the disposal site 
 
Used sharps were observed around the health care centre and/or the disposal site at 5 
(13.5%) of the health care facilities. Most of these used sharps were observed at the 
disposal site. The presence of used sharps at the disposal site indicated that proper sharps 
disposal was not practised and could imply that sufficient sharps boxes for the disposal of 
used sharps were not provided. The presence of used sharps at the disposal sites exposed 
the community and the waste handlers to needle stick injuries.  
 
 123
4.2.5 Structured interview of the provider of medicines by injections (instrument 5) 
 
The purpose of interviewing the providers of medicines by injections was to establish their 
competency in providing safe injections to the patients, within the conceptual framework of 
the synergy model. Becker et al (2006:131) state that certain competencies of health care 
workers are required to provide care to patients and synergy occurs when the competence 
of the health care provider complements the needs of the patient. Dicko et al (2000:167) 
recommend a holistic approach to injection safety in which injection safety is approached 
together with nursing practices.   
 
4.2.5.1  Patients bringing their own needles and syringes 
 
This question was asked to determine whether the health care workers had planned for or 
advocated for the supply of sufficient quantities of injection devices to cater for the needs of 
their patients. Whenever supplies are insufficient, health care workers request their 
patients to bring their own needles and syringes to the health care facilities. All the 
respondents (n=38) reported that patients never carried their own injection equipment to 
the health care facilities. This contrasted with the MMIS study (2005:23), which indicated 
that 30% of health care units reported that patients brought their own syringes and needles 
to the health care units. This study found that health care facilities in the Mpigi district had 
been provided with sufficient quantities of syringes and needles. 
 
4.2.5.2  Possibility of buying new, disposable needles and syringes 
 
The presence of private pharmacies within the catchment areas of health care facilities 
would be expected to fill the stock gap during stock depletions at health care facilities 
thereby supplementing the public sector distribution system. The respondents were asked 
if it were possible to buy new, disposable needles and syringes in a sealed packet in the 
community. 
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Is it possible to buy new, disposable needles and 
syringes in this community? (n=38)
65.8%
34.2%
0.0% 10.0% 20.0% 30.0% 40.0% 50.0% 60.0% 70.0%
Yes
No
 
 
Figure 4.31 
Possibility of buying new needles and syringes in the community (N=38) 
 
According to Figure 4.31, it was possible to buy new disposable syringes and needles in 
the catchment areas of 65.8% of the facilities while a significant percentage of facilities 
(34.2%) reported that it was not possible to obtain new disposable syringes within their 
catchment areas.  
 
Logez et al (2005:1) state that geographical hindrances of access to supplies may affect 
injection practices and points out the case of Burkina Faso, where the implementation of 
pharmaceutical depots next to public health care facilities increased geographical 
accessing of essential medicines and basic supplies, among which were syringes and 
needles, contributing substantially to safer injection practices. The health care facilities 
where there are no private pharmacies for the patients to access injection equipment 
should be adequately stocked to ensure that the safe injection practices are upheld at 
those facilities. 
 
4.2.5.3  Sources of syringes and needles 
 
The purpose of this question was to determine whether the sources of injection equipment 
in the community were legal. This was an indicator of the quality of the injection devices 
obtained from those sources. Procurement of health products from unlicensed drug outlets 
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carries the risk of obtaining expired or contaminated commodities, which in the end, affects 
the safety of the injections administered using such devices. Figure 4.32 indicate that the 
majority of the respondents (71.4%) reported that syringes and needles could be bought 
from drug shops while 14.3% reported that syringes and needles could be bought from 
private clinics. Only 3 (10.7%) reported that syringes could be obtained from a private 
pharmacy while 1 (3.6%) reported other means. Private pharmacies should be accessible 
to many people since they were the only authorised retail outlets for injection devices in 
Uganda.   
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Figure 4.32 
Sources of syringes and needles (N=28) 
 
4.2.5.4  Availability of safety boxes 
 
The respondents were asked if they had ever had safety boxes at their health care facility. 
According to Miller and Pisani (1999:810), investments need to be made in the safe, 
convenient and effective disposal of injection equipment to avoid the spread of infection 
among health care workers and the public. The WHO (2000:2) adds that the efficient, safe 
and environmentally-friendly management of contaminated waste is the only means of 
ensuring that disposable syringes and needles are not reused and that they do not lead to 
accidental needle stick injuries. All the respondents (n=38) reported that they had safety 
boxes for the disposal of contaminated sharps such as syringes and needles at their health 
care facilities. 
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4.2.5.5  Stock depletions of safety boxes 
 
According to Logez et al (2005:2), the common failure of health care systems to ensure 
adequate and sufficient supplies of injection devices may have a negative impact on 
injection safety. Stock depletions of safety boxes at a health care facility implies that used 
sharps including contaminated syringes and needles are not properly disposed of, putting 
health care workers and the community at the risk of needle stick injuries. 
 
Of the respondents, 36 (94.7%) reported that they had not had a stock depletion of safety 
boxes in the past three months prior to this study; 2 (5.3%) respondents reported having 
had a stock depletion in the past three months, one of them reporting a stock depletion 
duration of up to one month while the second respondent reported a stock depletion of 
between four weeks and three months. The two reported incidences of stock depletions of 
safety boxes occurred at a HCII level health care facility. 
 127
 
In the last three months have you been 
out of stock of safety boxes at any 
time? (n=38)
5.3%
94.7%
Yes No
 
Figure 4.33 
Stock depletion of safety boxes (N=38) 
 
Figure 4.33 illustrates the results, which were comparable to those of the MMIS survey 
(2005:31), which showed that less than 10% of the surveyed health care units had 
experienced stock depletions of safety boxes in six months. 
 
4.2.5.6  Stock depletions of syringes 
 
A stock depletion of injection devices has a negative impact on injection safety. The 
respondents were asked if they had experienced a stock depletion of any of the sizes of 
syringes and needles in the three months prior to this survey. Figure 4.34 revealed that 25 
(65.8%) respondents had not experienced a stock depletion of any size of the syringes in 
the reviewed period while 13 (34.2%) respondents reported having experienced stock 
depletion of at least one size of the syringes at least once in the past three months.  
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Have you been out of stock of any size of single-
use disposable syringes in the last 3 months? 
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Figure 4.34 
Stock depletion of single-use disposable syringes 
 
No respondents reported stock depletions from either the hospitals (n=2) or the HC IVs 
(n=2). However, among the HC III respondents (n=14), 6 (42.9%) reported stock 
depletions, while 7(35%) of the HCIIs (n=20) reported stock depletions of at least one size 
of the syringes and needles during the reviewed period. Managers of health care facilities 
should ensure that the appropriate sizes of syringes and needles required to render the 
services offered by their health care units are available at all times. 
 
The respondents who reported stock depletions (n=13) were asked how long the stock 
depletions had lasted. According to figure 4.35, the majority of the respondents (58.3%) 
had experienced stock depletions at their health care facilities for a period of one week to 
one month. 2 (16.7%) respondents reported a duration of stock depletion of more than one 
month to three months while 2(16.7%) reported a duration of stock depletion of over three 
months. 2(16.7%) reported that the stock depletions at their facilities had lasted for a period 
of less than one week.  
 
 
 129
How long was the stock depletion? 
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Figure 4.35 
Duration of stock depletion of syringes and needles (N=12) 
 
4.2.5.7  What was done during stock depletion 
 
This question was asked in order to establish whether health care workers were re-using 
contaminated syringes and needles during stock depletions. The re-use of contaminated 
syringes and needles exposes the patients to the risk of acquiring blood borne infections 
such as HIV/AIDS and hepatitis B. 
  
The results are shown in Table 4.9 in which 46.2% of the respondents (n=13) reported that 
they used a syringe with another gauge when the appropriate size was depleted. 23.1% 
said they borrowed syringes from another health care facility while one respondent (7.7%) 
reported that he stopped giving injections. None of the respondents reported that they had 
re-used contaminated syringes and needles during a stock depletion. The results show that 
the health workers were aware of the dangers of re-using contaminated injection 
equipment. In accordance with the synergy model, the knowledge of the safe injection 
practices by the health care workers is seen here as an important factor in taking care of 
the patients’ needs such as the need to avoid acquisition of blood-borne infections during 
the process of seeking health care services.  
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Table 4.9: What the health workers did during a stock depletion 
 
What did you do when the stock of 
injection devices was depleted?  
Frequency 
(n=13) Percentage 
Stopped giving injections 1 7.7% 
Borrowed from other facility/unit 3 23.1% 
Used other gauge in stock 6 46.2% 
Told patients to buy 3 23.1% 
sterilized used devices 0 0.0% 
Stock depletion lasted a short time 0 0.0% 
Other 0 0.0% 
Total 13 100 
 
The results also show that some health care workers (23.1%, n=13) told the patients to go 
and buy the syringes and needles during a stock depletion. However, according to 
Kermode et al (2005:423), the resource-constrained circumstances of both patients and 
hospitals substantially influence the safety of injection practices. 
 
4.2.5.8  Re-use of syringes and needles 
 
This section of the interview schedule was used to establish whether health care workers 
were re-using contaminated syringes or needles either on the same patient or on another 
patient. 37(97.4%) respondents (n=38) reported that they would never re-use a syringe or 
a needle either on the same patient or on a different patient. One (2.6%) health care 
worker reported that he would re-use syringes and needles on a patient if they had been 
previously used for mixing drugs.   
 
These results are in contrast to those of a study conducted by Simonsen et al (1999:795), 
which revealed that more than 50% of all injections in the developing world were 
administered with syringes and needles used on consecutive patients without sterilisation. 
Kermode et al (2005:426-7) also found that the practice of using one syringe repeatedly but 
changing the needle was evident in both hospital and community based immunisation 
clinics, and that some health care workers perceived this to be a safe practice.   
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The re-use of the syringes and needles, which have been used to reconstitute drugs, 
negatively affects the safety of injections and should be discouraged. Kermode et al 
(2005:427) states that the practice of re-using syringes by attaching new needles while 
drawing drugs from multi-dose vials should be discouraged as the drug could easily get 
contaminated with blood cells from the used syringe. 
 
4.2.5.9  Training in injection safety 
 
Depending on the needs of each patient, certain competencies of the healthcare workers 
are required for providing care to the patient. According to Becker et (2006:131), the health 
care worker characteristics of the Synergy Model (which guided this research) are clinical 
judgement, advocacy and moral agency, caring practices, collaboration, systems thinking, 
response to diversity, clinical inquiry, and facilitation of learning. Synergy and optimal 
outcomes occur when the competence of the health provider complements the needs of 
the patient.  
 
The respondents were asked if they had received training on injection safety. The purpose 
of this question was to establish whether the health care workers were competent enough 
to administer safe injections and to advocate for the provision of the required injection 
devices. The non-availability of injection devices may affect the health worker’s ability to 
perform safe injection practices even if they had the knowledge. However, knowledge of 
the safe injection practices drives the health care workers to advocate for the provision of 
adequate quantities of injection devices so as to avoid stock depletions.  
 
Figure 4.36 shows that 29 (76%) respondents had been trained in injection safety whereas 
9 (23.7%) had not received training in injection safety. 
 
A study conducted in Egypt by Talaat et al (2003:239) indicated that untrained health care 
workers were contributing to a high frequency of the use of injections for therapeutic 
purposes among the general population. According to Kermode et al 2005:430), when 
there are limited opportunities for the health care workers to engage in professional 
development, recommended practices are slow to be implemented. 
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Have you received training on injection 
safety? (n=38)
76.3%
23.7%
Yes No
 
Figure 4.36 
Training in injection safety (N=38) 
 
All health care workers therefore need to appreciate the principles of injection safety such 
that the needs of their patients are synergised with their own competences. 
 
The respondents also were asked how long ago they had received the training in injection 
safety. Of the respondents, 23 (60.5%) reported that they had received the training over six 
months in the past while 6 (15.8%) had received the training less than six months before 
the day of the survey (see figure 4.37).   
How long ago was the training? (n=38)
15.8%
60.5%
23.7%
Less than six months Six months or more Not trained
 
Figure 4.37 
Time since the training in injection safety (N=38) 
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Knowledge in health care keeps changing with new technology and the challenges 
presented by emerging diseases and epidemics. Health care workers should keep abreast 
with the current knowledge in their area of practice so that their patients’ needs are 
appropriately catered for. 
 
4.2.6 Exit interview with patients (instrument 6) 
 
Exit interviews with patients were conducted to assess whether the patients’ needs were 
being met by the health care facilities in line with the synergy model, which guided this 
study. According to Becker et al (2006:133), the goal of health care is to restore each 
patient to an optimal level of wellness as defined by the patient. The patients’ needs, in the 
context of injection safety, was the desire to avoid being infected with diseases such 
HIV/AIDS through the use of unsafe injections. 
 
4.2.6.1 Patients who received an injection 
 
Patients who had just been seen by health care workers at each facility were asked if they 
(or their children) had received an injection from the health care facility on the day of the 
survey. This question helped in the identification of patients who had had an experience 
with being treated at the health care facility using injection devices. At least one patient 
who had received an injection at the time of the survey was found at 12 (31.6%) of the 
health care facilities. Figure 4.38 indicates that of the patients (n=12) who had received an 
injection 8 (66.7%) were children and 4 (33.3%) were adults. The results revealed a higher 
frequency of injection use among children compared to adults. 
 
4.2.6.2  Source of syringe or needle 
 
The respondents were asked if they had brought their own needles or syringes for the 
injections they received at the health care facilities.  
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Did you or your child receive an injection 
today?(n=12)
33.3%
66.7%
Adult received an injection Child received an injection
 
Figure 4.38 
Patients who received an injection (N=12) 
 
This question helped to determine whether there was enough injection equipment at the 
health care facilities such that patients did not have to carry their own injection equipment. 
None of the patients (n=12) interviewed had carried their own needle and syringe for the 
injection they had received. 
 
4.2.6.3  Disposal of the used syringe and needle 
 
To establish whether health care facilities had safety boxes for immediate disposal of used 
sharps such as used syringes and needles, respondents were asked what the injection 
provider had done to the used syringe and needle after the injection. According to Table 
4.10, 11(91.7%) respondents reported that the used syringes and needles were disposed 
into a closed container.  
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Table 4.10:  Disposal of used syringe and needle (N=12) 
 
What did the health worker do with the 
used syringe and needle? Frequency Percent 
Immediately disposed them into a closed 
container 8 66.7 
Cut off needle with a needle cutter and 
disposed the syringe into a closed container 3 25 
Disposed them into an open container or area 
0 0 
Gave them back to me 0 0 
Other 1 8.3 
Total 12 100 
 
This result is supported by the MMIS (2005:48) study, which showed that 80% of the health 
care workers disposed used needles and syringes into a closed container. 
 
4.2.6.4  Number of injections received in the last three months 
 
To prevent injection-associated transmission of blood-borne pathogens, injection frequency 
should be reduced and safe injection practices should be carried out on a regular basis 
(Miller & Pisani 1999:809). The reduction in injection frequency reduces the demand for 
injection devices thereby reducing the frequency of stock depletions of injection devices at 
health care facilities.  
 
In order to determine the frequency of administration of medicines by way of injections at 
the health care units in the three months prior to this survey, respondents were asked how 
many times they had received injections at the health care facilities in the previous three 
months. Out of the 12 respondents, 7 (58.3%) had not received any other injections from 
the health care facilities in the previous three months and 5 (41.7%) had received only one 
injection from the health care facility during the three months prior to the survey. The result 
translated into an injection frequency of about 1.6 injections per person per year. Although 
the result was not representative because of the small sample, it indicated that there was 
reduced injection frequency in the Mpigi district in comparison to the Ministry of Health of 
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Uganda’s study (2004a:3), which showed that over 70% of the respondents in their survey 
had received more than three injections per year.  
 
4.2.6.5  Number of times patients brought own syringe and needle 
 
This question was asked to determine the availability of injection equipment at the health 
care facilities in the three months prior to the survey. All the respondents (n=5) reported 
that they had not carried their own syringe or needle for the injections they had received at 
the health care facilities in the last three months prior to the survey. The results of this 
study are in contrast to those of the MMIS (2005:49) study in Uganda, which showed that 
21.6% of respondents reported that they sometimes brought their own injection equipment 
to the health care facility.  The findings of this study revealed that there was an 
improvement in the availability of injection equipment at the health care facilities in the 
Mpigi district.  
 
4.3  SUMMARY OF THE RESULTS 
  
The researcher used the synergy model to explore whether the characteristics of the health 
care worker, the Mpigi district health care system and the needs of the patients who had 
been prescribed treatment by injection administration of medicines were synergised to 
provide a “safe passage” for the patients through the health care system. 
 
4.3.1  Health care worker characteristics 
 
The health care workers demonstrated knowledge of safe injection practices. The results 
showed that contaminated syringes and needles were not re-used and used syringes and 
needles were properly disposed of in safety boxes. Supplies of syringes and needles and 
safety boxes were adequately provided, however, the diluents and injectable drugs were 
not fully supplied. The most common challenges in ensuring the full supply of injection 
devices included the delay in making orders for re-supplies and the lack of information for 
stock management decisions.  
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4.3.2  Health care system 
 
Suitably qualified staff were available at the health care units. Injection devices such as 
syringes and safety boxes were delivered to health care units in adequate quantities. 
However there was need to support the synergised care through advocacy for the timely 
delivery of supplies from the national medical stores, the provision and maintenance of 
vehicles for delivery of supplies, the provision of fuel for running the vehicles, the increase 
in the physical capacity of health care facility commodity stores and the performance of 
regular support supervision of health care workers. 
 
4.3.2  Patient needs 
 
The patients were aware of the risks of re-using contaminated injection equipment and they 
reported that the used syringes and needles were properly disposed of in closed containers 
at the health care facilities. 
 
4.4  CONCLUSION 
 
This chapter discussed the data analysis and interpretation of the findings with reference to 
the literature review wherever possible. The data were presented in tables and figures.   
 
Chapter 5 concludes the study by discussing the limitations and makes recommendations 
for practice and further research.  
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CHAPTER 5 
 
Conclusions, limitations and recommendations 
 
 
5.1 INTRODUCTION 
 
As a way of improving injection safety, this study explored the challenges encountered 
in maintaining an effective distribution system using a cross-sectional, descriptive study 
of thirty eight health care facilities in the Mpigi district of Uganda. This chapter discusses 
the conclusions with reference to the objectives and findings, and the limitations of the 
study and makes recommendations for practice and further research. 
 
5.2 CONCLUSIONS  
 
Upon completion of the data analysis the researcher made conclusions based on the 
objectives, which were to: 
 
• Determine whether the health care facilities in the Mpigi district of Uganda have 
sufficient quantities of injectable medicines, diluents, single use injection devices 
and safety boxes for therapeutic purposes. 
• Investigate the factors that lead to stock depletion of injection devices at health 
care facilities in the Mpigi district of Uganda. 
 
 
5.2.1 Objective 1 
  
Determine whether the health care facilities in the Mpigi district have sufficient quantities 
of injectable medicines, diluents, single use injection devices and safety boxes for 
therapeutic purposes. 
 
Instruments 2, 3, 4, 5 and 6 contributed to the data collected on this objective. 
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5.2.1.1   Availability of injectable medicines 
 
The study revealed that stock depletions of injectable medicines were common at both 
the public and the NGO health care facilities. Stocks of injectable medicines were 
depleted for periods of up to three months at some health care facilities. Injectable 
drugs were available in sufficient quantities on the day of the survey at the hospitals, the 
HCIV health care units, and the HCII health care units. However, not all the HCIII health 
care units had adequate quantities of injectable medicines. Injectable medicines are 
required in the treatment of the seriously ill, such as during emergency situations, and 
therefore should be available at health care units in sufficient quantities to serve the 
intended clients.  
 
5.2.1.2   Availability of diluents 
 
The study revealed that water for injection was available at most of the health care units 
although it was under stocked at the hospitals and the HCIV health care facilities. Stock 
depletion of dextrose solution 5% was common, especially at HCIV health care units 
and HCIII health care units, with stock depletions lasting over two months at some 
health care units. Stock depletion of the diluents encourages substitution with other non-
recommended liquid preparations in the reconstitution of injectable medicines (when 
required). Substitute diluents could affect the quality and safety of the injectable 
medicines with which they have been mixed.  
 
5.2.1.3   Availability of single-use injection devices 
 
Single-use syringes and needles were available in adequate quantities at most of the 
health care facilities. Most of the respondents reported that they had not registered any 
stock depletion of syringes and needles in the three months prior to the survey. Most of 
the health care workers had received training in safe injection practices, although some 
remained untrained. The observed reduced injection frequency at the health care units 
visited could have contributed to the reduced consumption and therefore the observed 
availability of syringes and needles at the health care facilities. The health care workers 
were not re-using single-use syringes and needles at all the health care facilities visited 
and the interviewed patients reported that they never carried their own syringes and 
needles to the health care facilities, further confirming that the facilities were adequately 
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stocked. The depletion of injectable medicines could further explain the apparent 
overstocking of syringes, especially the 10ml size, at many of the health care facilities. 
The training of health care workers on safe injection practices reduces the frequency of 
injections and the consumption rates of injection devices.  
 
5.2.1.4   Availability of safety boxes 
 
Most of the health care units were overstocked with safety boxes. There were no used 
sharps at or around the health care facilities and overfilled safety boxes were not 
observed at most of them, further indicating that safety boxes for the disposal of used 
sharps including syringes and needles were adequately available at the health care 
facilities. Moreover, the interviewed patients indicated that they had observed health 
care workers disposing the used syringes and needles in closed containers. Safety 
boxes were not found on most of the wards and the health care units lacked trolleys for 
carrying the safety boxes during injection administration on the wards.   
 
5.2.2 Objective 2 
 
Investigate the factors that lead to stock depletion of injection devices at the health care 
facilities in the Mpigi district of Uganda. 
 
Instruments 1, 2 and 3 contributed to the data collected on this objective.  Data on the 
basic features of a drug distribution 
n system were gathered in order to identify the weaknesses that could lead to stock 
depletions of injection devices in the Mpigi district of Uganda. 
 
5.2.2.1   Late requisitions 
 
Health care facilities submitted their re-supply orders late thereby increasing the re-
supply intervals. The increase in the re-supply intervals caused late deliveries of 
supplies, leading to stock depletions. 
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5.2.2.2   Late deliveries 
 
There were delays in delivering supplies from the national medical stores to the districts 
and from the district stores to the health sub-district stores and finally to the lower level 
health care units. Some of the health care units reported that they had received health 
care commodities only twice in the past year prior to the survey instead of the 
scheduled six deliveries in a year. The late delivery of health care commodities to health 
care centres resulted in stock depletions of injectable medications and diluents. 
 
5.2.2.3   Lack of transport 
 
The health sub-districts had vehicles for the collection of supplies from the districts to 
the health sub-district stores and onwards to the lower level health care units, but there 
was inadequate funding for the fuel required to run the vehicles. Most of the health care 
units used public means of transport to collect supplies from the health sub-districts. 
Generally, there was no effective system for monitoring the distribution costs. 
 
5.2.2.4   Poor communication systems 
 
The majority of the health care workers used personal telephones to communicate to 
the higher levels. Reports were collected and requisitions delivered by physical visits. 
Reports and requisitions might not be sent in time for appropriate action if staff did not 
have credit on their personal telephones and/or if they were too busy to travel.  
 
5.2.2.5   Absence of private sector pharmacies 
 
There were no private sector pharmacies in the catchment areas of the public and NGO 
health care facilities to supplement the public sector distribution system. The absence of 
private sector pharmacies meant that the health care units risked having stock 
depletions on the occasions that the national medical stores delayed supplying the 
district.   
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5.2.2.6   Insufficient storage space 
 
Most of the health care facilities did not have sufficient space to hold all the supplies 
delivered to them. In addition, health care commodities, such as safety boxes, syringes 
and needles, were stored on the floor and in corridors at most of the health care 
facilities. The health care facilities that did not have sufficient space to store all the 
health care commodities supplied to them often left their supplies at the health sub-
district stores from which they drew small quantities at a time. Such facilities risked 
having stock depletions on the occasions that there was no transport for their collection.  
 
5.2.2.7   Poor logistics management information system 
 
Injection device security is threatened by inadequate information systems. Stock cards 
for the management of diluents were not available at many of the health care facilities. 
Stock cards were more likely to be used at the public health care facilities than at the 
NGO facilities. In general, the stock cards were not updated for syringes and safety 
boxes and the quality of the data captured on the stock cards was poor at many of the 
health care facilities. Several facilities did not have consumption data records. The lack 
of records and the poor quality of the data recorded on the stock cards indicated that 
the stock managers were not effectively monitoring their stock levels and therefore 
could not make informed decisions.  
 
5.2.2.8   Irregular supervision 
 
Support supervision was not regularly conducted.  Some storekeepers reported that 
they had not been supervised in over three months. Support supervision can be used as 
a tool for monitoring the distribution system performance in order to resolve problems 
quickly and improve the performance of staff.  
 
5.3 LIMITATIONS 
 
The researcher found the following limitations in this study, which could restrict the 
generalisability of the research results: 
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• The study was conducted in one district of Uganda and therefore the results of 
the study may not be generalised to all the districts in the country. In addition, 
unlike other non-project districts, the Mpigi district has implemented activities of 
the MMIS project since 2004 and has benefited from improved injection device 
management. 
• The stock cards were poorly maintained at most of the health care units and a 
lot of data was missing. The analysis of data on inventory management was 
therefore based on very few cases, thereby affecting the generalisability of the 
results.  
• The reduced injection frequency at all the health care facilities visited meant that 
fewer than planned exit interviews with patients were conducted. 
• The Mpigi district has only two HCIV health care centres and two hospitals. The 
findings with regard to the injection device security for these levels of the health 
care system were based on too few cases to be generalised. 
• The literature review revealed very few sources on the subject of injection device 
security. 
 
5.4 RECOMMENDATIONS 
 
Based on the study findings, the researcher makes the following recommendations for 
the improvement of the injection device distribution system and further research. 
 
5.4.1 Improvement of the injection device distribution system  
 
5.4.1.1   Delivery of supplies 
 
The national medical stores should regularize deliveries of essential medicines and 
other health care supplies to the districts as per the scheduled bi-monthly deliveries to 
avoid stock depletions. There should be a mechanism of monitoring the stock status at 
the health care facilities such that stocks from overstocked facilities can be transferred 
to the health care facilities with stock depletion. 
 
The managers of the health sub-districts should allocate adequate funds to cover the 
cost of the fuel required to run the distribution vehicles. Motorcycles should be provided 
to the lower level health care units for the collection of supplies from the health sub-
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district stores. The managers should also put in place a mechanism of monitoring the 
distribution costs so that the most efficient distribution mechanisms are used. 
 
5.4.1.2   Requisition of injection devices 
 
All the health care unit managers should submit their requisitions every two months as 
per the Ministry of Health of Uganda’s guidelines. Injectable medicines requiring 
reconstitution should be ordered with matching quantities of the appropriate diluents.  
 
5.4.1.3   Availability of safety boxes  
 
Safety boxes should be provided to all areas where medicines are administered by use 
of injections and staff should be educated on the dangers of overfilling the safety boxes. 
The health care facilities should also be provided with trolleys for carrying injection 
devices, including safety boxes, during injection administration on the wards. 
 
5.4.1.4   Communication 
 
To save staff time and reduce the wear and tear on vehicles, the district management, 
with the assistance of the Ministry of Health of Uganda, should make appropriate 
investments in communication technology to reduce the need for staff to travel long 
distances. Where feasible, radio transmitters and Internet services should be provided 
to the health care facilities to avoid unnecessary travel costs and delays. 
 
5.4.1.5   Private pharmaceutical sector incentives 
 
The Government of Uganda should provide incentives to the private sector investors to 
open pharmacies within the district in order to supplement the public sector health 
commodity distribution system. 
 
5.4.1.6   Storage 
 
The physical capacity of the health care facility storerooms should be increased by the 
installation of shelves and the quality of the health care commodities maintained by the 
provision of pallets. 
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5.4.1.7  Support supervision 
   
The members of the district health management team and the staff from the Ministry of 
Health of Uganda should carry out support supervision of the staff involved in 
commodity management on a regular basis. The supervision should entail on-the-job 
training in proper commodity management practices. The appropriate maintenance of 
stock card records should be emphasized. Training in commodity management should 
also be conducted, especially targeting the lower level storekeepers. 
 
5.4.1.8  Future research  
 
The researcher recommends that further research be conducted on the following topics: 
 
• A comparative study of injection device security between an MMIS project 
implementing and a non-MMIS project implementing district in Uganda. 
• Exploring the relationship between the availability of injection devices and their 
use by the health care workers. 
• Determining the challenges and the motivating factors for proper record-keeping 
by stock management personnel at health care facilities. 
• Determining the challenges faced by the national medical stores in delivering 
health care commodities to the districts according to schedule. 
 
5.5 CONCLUSION 
 
Ensuring injection device security enhances safe injection practices at health care 
facilities and saves lives. An inefficient distribution system of health care commodities is 
a hindrance to the achievement of injection safety. Managers of health care 
programmes should therefore implement an efficient system of supply management and 
financing so that injection devices are supplied in a timely manner and in adequate 
quantities at all health care facilities.  
 
 146
BIBLIOGRAPHY 
 
AACN – see American Association of Critical Care Nurses 
 
American Association of Critical care Nurses (AACN). 2006. The AACN synergy model 
for patient care. http://www.certcorp.org/certcorp/certcorp.nsf/vwdoc/SynModel. 
(Accessed on 20/5/2007). 
 
Babbie, E & Mouton, J. 2004. The practice of social research. Cape Town: Oxford 
University Press. 
 
Becker, D, Kaplow, R, Muenzen, PM & Hartigan, C. 2006. Activities performed by acute 
and critical care advanced practice nurses: American Association of critical-care nurses: 
study of practice. American Journal of Critical Care, 15(2):130-148. 
 
Brink, PJ & Wood, MJ. 1998. Advanced design in nursing research. 2nd edition. London: 
Sage. 
 
Bryman, A. 2001: Social research methods. New York: Oxford University Press. 
 
Burns, N & Grove, SK. 2001. The practice of nursing research: conduct, critique and 
utilisation. 4th edition. Philadelphia: WB Sauders. 
 
Creative Research Systems. 2003. Sample size calculator. 
http://www.surveysytem.com/sscalc.htm. (Accessed on 21/5/2007). 
 
De Vos, AS, Strydom, H, Fouche, CB & Delport, CSL. 2002. Research at grass roots for 
the social sciences and human service professions. 2nd edition. Pretoria: Van Schaik. 
 
Dicko, M, Oni, AQQ, Gavinet, S, Kone, S, Pierre, L & Jacquet, B. 2000. Safety of 
immunization injections in Africa: not simply a problem of logistics. Bulletin of the World 
Health Organization, 78(2):163-168. 
 
Gisselquist, D. 2006. New information on the risks of HIV transmission in Mwanza, 
Tanzania. Journal of Infectious Diseases, 194:536-7. 
 
Gorta 2007.  Uganda. http://www.gorta.org/countries/uganda.html. (Accessed on 
20/5/2007). 
 
Hornby, AS. 2000. Oxford Advanced Learner’s Dictionary of Current English. 6th edition. 
Oxford; Oxford University Press. 
 
Huntin, YJF, Hauri, AM & Armstrong, GL. 2003. Use of injections in health care settings 
worldwide: literature review and regional estimates.  British Medical Journal, 327:1075-
8. 
 
IHSD – see Institute for Health Sector Development. 
 
Institute for Health Sector Development (IHSD). 2000. Uganda: Country health briefing 
paper. http://www.dfidhealthrc.org/publications/Country_health/Uganda.PDF. (Accessed 
on 12/11/2007). 
 147
 
Israel, GD. 2003. Determining sample size. http://edis.ifas.ufl.edu/PD006. (Accessed on 
21/5/2007). 
 
John Snow Incorporated (JSI). 2005. Overview of Making Medical Injections Safer 
project. 
http://potalprd1.jsi.com/portal/page/portal/MMIS_WEBSITE_PGG/MMIS_HOMEPAGE_
PG. (Accessed on 12/11/2007). 
 
JSI – see John Snow Incorporated. 
 
Kane, A, Lloyd J, Zaffran, M, Simonsen, L & Kane, M. 1999. Transmission of Hepatitis 
B, Hepatitis C and Human Immunodeficiency Viruses through unsafe injections in the 
developing world: model based regional estimates. Bulletin of the World Health 
Organization, 77(10):801-807. 
. 
Kerfoot, K. 2002: The leader as a synergist. 
http://www.certcorp.org/certcorp/certcorp.nsf/vwdoc/SynModel. (Accessed on 
20/5/2007). 
 
Kermode, M, Holmes, W, Langkham, B, Thomas, MS & Giffords. 2005. Safer injections, 
fewer infections: injection safety in rural North India. Tropical Medicine and International 
Health, 10(5):423-432. 
 
Khan, AJ, Luby, SP, Fikree, F, Karim, A, Obaid, S, Dellawala, S, Mirza, S, Malik, T, 
Fisher-Hoch, S & McCormick, JB. 2000. Unsafe injections and the transmission of 
Hepatitis B and C in a periurban community in Pakistan. Bulletin of the World Health 
Organization, 78(8):956-963. 
 
Kotwal, A, Priya, R, Thakur, R, Gupta, V, Kotwal, J, Seth, T. 2004. Injection practices in 
metropolis of North India: perceptions, determinants and issues of safety. Indian Journal 
of Medical Sciences, 58(8):334-344. 
 
Lloyd, JS & Milstein, JB. 1999. Auto-disable syringes for immunization: issues in 
technology transfer. Bulletin of the World Health Organization, 77(12):1001-1007. 
 
Logez, S, Hutin, Y, Halloway, K, Gray, R & Hogerzeil, HV. 2004. Could the WHO model 
list of essential medicines do more for safe and appropriate use of injections? Journal of 
Clinical Pharmacology, 44(10):1106-1113. 
 
Logez, S, Hutin, Y, Sonda, P, Thualt, J & Holloway, K. 2005. Safer injections following a 
new national medicine policy in the public sector, Burkina Faso, 1995-2000. 
BioMedCentral Ltd. http://www.biomedcentral.com/1471-2458/5/136. (Accessed on 
29/10/2007). 
 
Making Medical Injections Safer, Uganda (MMIS). 2004. Findings of the baseline 
supervisory visits in the districts of Mbarara, Mpigi, Nebbi and Pallisa. Kampala: MMIS. 
 
Making Medical Injections Safer, Uganda (MMIS). 2005. Evaluation of 1st phase 
implementation in Mbarara, Nebbi, Mpigi and Pallisa districts. Kampala: MMIS. 
  
Making Medical Injections Safer, Uganda. 2007. Program description. Kampala: MMIS. 
 148
  
Miller, MA, Pisani, E. 1999. The cost of unsafe injections. Bulletin of the World Health 
Organization, 77(10):808-811. 
 
Ministry of Health of Uganda. 2002. Uganda pharmaceutical sector baseline survey. 
Kampala: Government Printer. 
 
Ministry of Health of Uganda. 2003. Uganda health facilities survey, 2002. Kampala: 
Government Printer. 
 
Ministry of Health of Uganda. 2004. National policy on injection safety and healthcare 
waste management. Kampala: Government Printer. 
  
MMIS – see Making Medical Injections Safer, Uganda. 
 
Mouton, J. 2001. How to succeed in your master’s and doctoral studies: a South African 
guide and resource book. Pretoria: Van Schaik. 
 
Mutungi, G. 2007. Findings of the midterm review of the Making Medical Injections 
Safer project, Uganda. Paper presented at the midterm review meeting of the MMIS 
project by the Ministry of Health of Uganda, 12 July, Serena Hotel, Kampala. 
 
Nersesian, P, Cesarz, V, Cochran, A, Mboyane, J & Schmidt, K. 2004. Safe injection 
and waste management: a reference for logistics advisors. Arlington: John Snow 
Incorporated. 
 
PATH – See Program for Appropriate Technology in Health. 
 
Polit, DF & Hungler, BP. 1995. Nursing research: principles and methods. 6th edition. 
Philadelphia: Lippincott Williams & Wilkins. 
 
Priotto, G, Ruiz, A, & Kyobutungi, C. 2003. Injection use in Mbarara district, Uganda: a 
population survey. WHO/BCT/03.10. Geneva: WHO. 
 
Program for Appropriate Technology in Health. 2001. Giving safe injection: using auto-
disable syringes for immunization. PATH/SEA/01.9, immunization V.2. Seattle: PATH. 
 
Quick, JD, Rankin JR, Laing, RO & O’Connor, RW. 1997. Managing drug supply: the 
selection, procurement, distribution, and use of pharmaceuticals. 2nd edition. 
Connecticut: Kumarian Press. 
 
Reeler, AV. 2000. Anthropological perspectives on injections: a review. Bulletin of the 
World Health Organization, 78(1):135-143. 
 
Saks, M & Allsop, J. 2007. Researching health: qualitative, quantitative and mixed 
modes. London: Sage. 
 
Simonsen, L, Kane, A, Lloyd, J, Zaffran, M, & Kane, M. 1999. Unsafe injections in the 
developing world and transmission of blood borne pathogens: a review. Bulletin of the 
World Health Organization, 77(10):789-800. 
 
Somekh, B & Lewin, C. 2005. Research methods in the social sciences. London: Sage. 
 149
 
Talaat, M, El-Oun, S, Kandeel, A, Abu-Rabei, W, Bodenschatz, C, Lohiniva, AL, Hallaj, 
Z, and Mahoney, FJ. 2003. Overview of injection practices in two governorates in Egypt. 
Tropical Medicine and International Health, 8(3):234-241. 
 
Trochim, WM. 2006. The research methods knowledge base.  
http://www.socialresearchmethods.net/kb. (Accessed on 29/10/2007). 
 
Uganda Travel Guide. 2007. Mpigi district information. 
http://www.ugandatravelguide.com/mpigi-district.html. (Accessed 27/10/2007). 
 
United Nations, Department of Economic and Social Affairs. 2004. Republic of Uganda: 
Public administration and country profile.  
http://unpan1.un.org/intradoc/groups/public/documents/un/unpan023292.pdf. (Accessed 
on 16/2/2008). 
 
Wikipedia, the free encyclopedia. 2006. Sv “Uganda”. http://www. 
wikipedia.org/wiki/Uganda. (Accessed on 21/5/2007). 
 
  
World Health Organization. 1999. Safety of Injections: WHO joint statement. Geneva: 
WHO. 
 
World Health Organization. 2000. Aide-Memoire Revisions: Aide-Memoire for a national 
strategy for safe and appropriate use of injections. http://whqlidoc.who.int/aide-
memoire/a71914.pdf. (Accessed on 29/10/2007). 
 
World Health Organization. 2001a. Health research methodology: a guide for training in 
research methods. 2nd edition. Manila: WHO. 
 
World Health Organization. 2001b. Tool for the assessment of injection safety. 
WHO/BCT/01.02. Geneva: WHO.  
 
World Health Organization. 2002a. First do no harm: introducing auto-disable syringes 
and ensuring injection safety in immunisation systems of developing countries. Geneva: 
WHO. 
  
World Health Organization. 2002b. Injection practices: rapid assessment and response 
guide. WHO/BCT/02:11. Geneva: WHO.  
 
World Health Organization. 2002c. Fact sheet number 231. Geneva: WHO. 
 
World Health Organization. 2003a. Guiding principles to ensure injection device 
security. WHO/BCT/03:12. Geneva: WHO. 
  
World Health Organization. 2003b. Procuring single-use injection equipment and safety 
boxes: a practical guide for pharmacists, physicians, procurement staff and program 
managers. WHO.BCT/03.04. Geneva: WHO.  
 
World Health Organization. 2003c. Pilot-testing of the WHO tools to assess and 
evaluate injection practices. WHO/BCT/03.10. Geneva: WHO. 
 
 150
World Health Organization. 2004. Safety of injections: global facts and figures. 
WHO/EHT/04.04. Geneva: WHO. 
  
Youwang, Y, Guangping, Z, Yu, C, Anqiang, Z, Yong, G & Hongping, A, 2006. Study on 
the injection practices of health facilities in Jingzhou District, Hubei, China. Indian 
Journal of Medical Science, 60(10):407-416. 
 
 
 
 
 
ANNEXURE A 
 
Permission from the Research and 
Ethics Committee of the Makarere 
University Medical School, Kampala, 
Uganda 
 
 
 
 
 
 
 
 
 
ANNEXURE B 
 
Permission from the University of South 
Africa, Health Studies Research and 
Ethics Committee 
 
 
 
 
 
 
ANNEXURE C 
 
Permission requested and granted by 
the District Health Officer of the Mpigi 
district 
 
 
 
 
 
 
 
ANNEXURE D 
 
Data collection instruments 
 
 
 
 
 
 
